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Abstract 
Current lifestyle with high-energy diets and characterized by sedentary is triggering an alarming 
growth in obesity. Obesity along with metabolic syndrome-related co-morbidities (i.e. insulin 
resistance, atherosclerosis, sleep apnoea, depression, asthma, hypertension and the alteration of 
blood lipid transport) are the most apparent consequence of the excess energy. 
Under conditions of excess dietary energy, the body cannot easily dispose of the excess 
amino-N against the evolutively-adapted schemes that prevent its wastage; thus ammonia and 
glutamine formation and urea excretion are decreased. High lipid and energy availability limit the 
utilisation of glucose, and high glucose spares the production of ammonium from amino acids, 
decreasing the synthesis of glutamine and its utilisation by the intestine and kidney. In contrast, 
high protein diets enhance protein synthesis and growth, and the synthesis of non-protein-
N-containing compounds. But these outlets are not enough; consequently, less-conventional 
mechanisms are activated, such as increased synthesis of NO∙followed by higher nitrite (and nitrate) 
excretion and changes in the microbiota. 
In this study we studied how the initial phase of development of metabolic syndrome can affects 
the function of liver as main site of amino-N metabolism, and to determine whether doubling the 
protein content in the diet induced significant changes in enzyme of amino acids metabolism along 
intestine and on liver. 
The common result obtained by these studies is that, both in case of hyperlipidic or hyperproteic 
diets, elimination of excess N is necessary but cannot be easily carried out through the metabolic 
pathways/tissues we evaluated, although possible alternative pathways have been taken into 
consideration. 
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1.1 The metabolic syndrome 
The metabolic syndrome (MS) is a widely recognized clustering of components including insulin 
resistance (IR)/diabetes, hyperlipidemia, arterial hypertension and obesity, often associated with 
hyperuricemia, small dense LDL, endothelial inflammation
1,2,3
, hypoandrogenism, depression, 
hepatic steatosis, hyperuricemia
4
, and sleep apnoea
5
, even if the number of diseases that may fall 
under the umbrella term of MS grows rapidly
3,6
. This cluster of interrelated biochemical, endocrine 
and pathological disorders is mainly a consequence of social development
7
 and it is probably due, in 
a large proportion, to the access to rich, abundant and varied food, to sedentary lifestyle, and to the 
other perks of modern-day life in most human societies
2
. In fact, adult humans are unprepared for 
this high-load of nutrients and cannot process the excess food ingested because our cortical-derived 
desire overrides the mechanisms controlling appetite
3
. Indeed, this set of disorders is due not 
because we lack the biochemical mechanisms to use this excess of energy, but rather, because we 
are unprepared for excess and adapted to survive scarcity
8
. Furthermore, in condition of high load 
of nutrients, the ammonium generation and transfer processes
9
, another key pathogenic element of 
MS, don't work properly due to our tendency to preserve amino-N for the food shortage period
10,11
. 
Beside of environmental and psychosocial, increasing evidence suggests that there is genetic and 
epigenetic basis for MS
3,12,1
.  
The concept of the MS has existed for, at least, 100 years. It was first described, independently, 
in the 1920s by two physicians, as the clustering of hypertension and diabetes mellitus type 2 
(T2DM)
13,14
. Then, in the 1960s, several scientists, working independently in different countries, 
have published their observations on the clustering of various components of the metabolic 
syndrome, hyperlipidemia, obesity and T2DM, hypertension, and coronary artery disease, giving 
several names to it
15,16,17
 as shown in Table 1. In the early 1980s, Hanefeld and Leonhardt
18 
introduced the term metabolic syndrome (metabolischesSyndrom) which included T2DM, 
hyperinsulinaemia, obesity, hypertension, hyperlipidemia, gout, and thrombophilia. In the late 
1980s, Gerald M. Reaven
19
 hypothesized that IR was the common etiological factor for a group of 
disorders, consisting of impaired glucose tolerance, hyperinsulinaemia, high levels of very low-
density lipoprotein (VLDL), low levels of high-density lipoprotein (HDL) and hypertension. 
Reaven named the sum of these disorders Syndrome X in an attempt to stress its unknown aspects. 
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Terms Author 
Hypertension–hyperglycaemia–hyperuricaemia syndrome  Kylin, 1923 
Metabolic trisyndrome (trisyndromemetabolique) Camus, 1966  
Plurimetabolic syndrome Avogaro and Crepaldi, 1967 
Syndrome of affluence (wohlstandssyndrom) Mehnert and Kuhlmann, 1968 
Metabolic syndrome (metabolischesyndrom) Hanefeld and Leonhardt, 1981 
Syndrome X Reaven, 1988 
Deadly quartet Insulin Kaplan, 1989 
Insulin resistance syndrome  DeFronzo and Ferrannini, 1991 - Haffner, 1992 
Table 1. Names given to the clustering of metabolic syndrome disorders. Adapted from Sarafidis et al. 20 
 
In the same period, Kaplan
21
 renamed the syndrome the deadly quartet for the combination of 
upper body obesity, glucose intolerance, hypertension and hyperlipidemia. During the following 
years, among the most active researchers in the field, the term insulin resistance syndrom
22
, 
dysmetabolic syndrome
23,24
 and metabolic syndrome
2,25
 was used to describe this entity, considering 
IR as the key element defining of the syndrome.  
As the absence of an international explanation for the syndrome, in 1998, WHO
26
 attempted to 
define the MS, looking for a working definition that would be open to possible future changes 
according to new evidences. WHO determined a number of criteria corresponding to the major 
characteristics of the syndrome. In particular, the main proposed component of the syndrome was 
IR. Apart from that, the diagnosis of the syndrome required the presence of at least two of the 
variables: hypertension, elevated triacylglycerols (TAG), low HDL-cholesterol, obesity, and 
microalbuminuria
27
. Since then, there have been several attempts to define the MS
28,29,30
, even if 
they should not be considered as strict classifications but rather as working definitions that help 
towards the formulation of a complete and globally accepted definition of the syndrome. 
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1.1.1 The insulin resistance 
The most accepted and unifying hypothesis to describe the pathophysiology of the MS is IR
2,31
. 
IR is characterized by decreased sensitivity to glucose and low peripheral glucose uptake, which 
often develops into full T2DM
32,35
.  
Despite periods of feeding and fasting, plasma glucose remains in a narrow range - between 4 
and 7 mM in normal individuals
36
 - governed by the balance between glucose absorption from the 
intestine, production by the liver and uptake and metabolism by peripheral tissues. Insulin increases 
glucose uptake in muscle (up to 75%)
36
 and white adipose tissue (WAT)
34,37
, and inhibits hepatic 
glucose production, thus working as the primary regulator of blood glucose concentration.  
Insulin promotes glucose uptake by stimulating the translocation of the glucose transporter 4 
(GLUT4) from intracellular sites to the cell surface
38
. Animal studies have demonstrated that insulin 
resistance is associated with a decreased translocation of glucose transporters to the plasma 
membrane in muscle cells and an attenuate expression of GLUT4 in muscle cells
39
. Insulin also 
stimulates cell growth and differentiation, and promotes the storage of substrates in WAT, liver and 
muscle by stimulating lipogenesis, glycogen and protein synthesis, and inhibiting lipolysis, 
glycogenolysis, gluconeogenesis, and protein breakdown (Figure 1). Figure 1 Furthermore, insulin 
has an effect in cells not normally considered insulin sensitive, including neurons
40,41
, pancreatic 
islet cell
42,43
 and red blood cells
44
.  
When normal circulating levels of insulin can't regulate properly all these processes in organs 
and tissues, like liver, skeletal muscle and WAT, IR or deficiency occurs and producing raising in 
fasting and postprandial glucose and lipid levels
36
. Thus, by definition, IR is a defect in signal 
transduction
38
 and its aetiology is still unclear
32
. In condition of IR, glucose entrance to muscle is 
minimized and decreased blood flow constrains glucose from adipose tissue uptake, thus most of 
the remaining glucose could only be used in significant amounts by brown adipose tissue (BAT), by 
the liver, by the intestine and probably by the microbiota
45
. BAT uses glucose to sustain 
thermogenesis and for lipid storage, even if this way may represent a significant possibility for 
rodents, but for humans is limited due to a smaller BAT presence
46
. Liver uses the glucose for lipid 
synthesis
47
 and energy utilization, including thermogenesis. Lipogenesis has to be carried out 
because of an already large excess of dietary fatty acids and TAGs, temporarily stored in the liver, 
are waiting for their eventual release as VLDL. But in the same time, the process is limited by the 
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already excessive availability of acetyl-CoA, because the high levels of glucose fully inhibit the 
ketone pathway
48
. Other possible pathways for glucose disposal include glucose diffusion across the 
intestinal wall where it is taken up and metabolizated by microbiota, thus participating in the 
handling of excess substrate.  
In the past decades, researchers tried to define the biological mechanisms that lead to the 
diseased state. These were recognized in lipid accumulation, systemic inflammation, activation of 
the unfolded protein response due to the endoplasmic reticulum (ER) stress and change of 
gastrointestinal microbiota
37,35
. Although other additional mechanisms have been considered, these 
four represent different aspects of metabolic control that ultimately may converge on common 
pathways to regulate insulin action. 
 
 
Figure 1. Insulin Action.  
In the fed state, dietary carbohydrate (CHO) increases plasma glucose and promotes insulin secretion from the pancreatic β cells. 
Insulin has numerous actions to promote storage of dietary calories, but only some are illustrated here. In the skeletal muscle, 
insulin allows glucose entry and glycogen synthesis. In the liver, insulin promotes glycogen synthesis and de novo lipogenesis 
and inhibits gluconeogenesis. In the adipose tissue, insulin suppresses lipolysis and promotes lipogenesis. (Right) In the fasted 
state, insulin secretion is decreased. The drop in insulin serves to increase hepatic gluconeogenesis and promote glycogenolysis. 
Hepatic lipid production diminishes while adipose lipolysis increases. Adapted from Samuel et al.37 
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Lipid accumulation 
The metabolic alterations induced by insulin resistance are a direct consequence of the excess 
availability of dietary lipid responsible of the accumulation of fat in a number of locations of WAT. 
Most of the fat is contained in large vacuoles
49
 within specialised cells, the adipocytes; the 
function of this depot is to supply energy to the whole organism under conditions of scarcity of 
energy
50
, even if they are contained in other cells
51
, where they are used for their own metabolism. 
The total lipid content in a rat (i.e. Wistar strain) is in the range of 10-15% of body weight
52
, 
irrespectively of dietary lipid and energy intake; half of these lipids are stored in WAT
53
 and the 
other half are stored, mainly as TAG
52
, in other tissues such as skeletal muscle
54
, liver
37
, heart
49
 to 
carry out other functions: muscle contain adipose tissue, interspersed in its fibres
52
, directly 
involved in supplying energy during exercise, liver contains a sizeable proportion of lipid directly 
related to the production and export of energy through lipoproteins
55
, heart store TAG mainly as an 
important cell-autonomous energy source
56
. These depots sites in storage-specialized (adipose) or 
not-specialized (liver, muscle, heart) tissues reacted increasing their size in parallel in front of a 
hyperlipidic diet
52
. The storage of fat in adipose and in non-adipose tissues may lead to an 
imbalance in lipid homeostasis and inducing toxicity in the tissue, a phenomenon termed 
lipotoxicity
49
. The relationship between the lipid accumulation in non-adipose tissues and the 
development of IR is depicted in Figure 2. 
Skeletal muscle is extremely important for the development of systemic IR because it is the 
tissue in which most of the insulin-dependent disposal of glucose occurs. Mounting evidence 
indicates that elevated intramyocellular lipid (IMCL) concentrations are associated with diminished 
insulin sensitivity in skeletal muscle
57
. This lipid accumulation is not only likely due to enhanced 
fatty acid uptake into the muscle, but also to a diminished mitochondrial lipid oxidation
57
. However, 
the mechanism by which increased IMCL accumulation induces insulin sensitivity in this tissue is 
still debated. During obesity, IMCL and bioactive IMCL metabolites (e.g. ceramides, diacylglicerol 
(DAG) and long-chain fatty acyl-CoAs) accumulate and may cause cellular dysfunction and IR
54
. 
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Figure 2. Lipid accumulation in adipose and non-adipose tissues 
A rich diet, leading to body weight gain, will increase adipocyte size. Adipocyte hypertrophy in obesity is accompanied by 
disturbances in lipid metabolism and alterations in adipokine secretion, which a shift toward a pro-inflammatory phenotype. The 
secretion of pro-inflammatory factors is further boosted by the infiltration of several adaptive and innate immune cells into the 
adipose tissue in obesity. Together, the impairments in lipid metabolism and the secretory function of adipose tissue not only 
induce insulin resistance locally within the tissue (via autocrine/paracrine effects) but also have detrimental effects at the whole-
body level. The reason for this is that adipose tissue dysfunction in obesity is accompanied by lipid spill over in the circulation 
and subsequent lipid accumulation in non-adipose tissues. Adapted by Goossens et al.58 
 
When DAGs accumulate, activate protein kinase C (PKC) that trigger a serine/threonine kinase 
cascade, leading to phosphorylation of serine/threonine sites on insulin receptor substrates (IRS-1, 
IRS-2). This reduces the ability of the IRS to activate phosphatidylinositol 3-kinase, which 
ultimately results in a reduced GLUT4 translocation to the cell membrane (Figure 3). In this way, 
increased DAGs concentrations may decrease insulin-stimulated muscle glucose uptake
59,54
. 
Instead, high levels of ceramides, potent lipid-signalling molecule, can cause IR by inhibiting the 
ability of insulin to activate the insulin signal transduction pathway and/or via the activation of c-
Jun N-terminal kinase (JNK). JNK is responsible of the serine phosphorylation of IRS-1, rather than 
the normal tyrosine phosphorylation. Serine phosphorylation impairs insulin signaling and causes 
IR
60
.  
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Figure 3. Molecular mechanisms of skeletal muscle insulin resistance 
Increases in intramyocellular fatty acyl CoAs and diacylglycerol due to increased delivery from plasma and/or reduced oxidation 
due to mitochondrial dysfunction trigger a serine/threonine kinases cascade initiated by novel protein kinase C. This ultimately 
leads to activation of serine residues on IRS-1 and inhibits insulin-induced PI3-kinase activity, resulting in reduced insulin-
stimulated muscle glucose transport and reduced muscle glycogen synthesis. DAG, diacylglycerol; GSK3, glycogen synthase 
kinase-3; PH, pleckstrin homology domain; PI3, phosphatidyl inositol 3-kinase; PTB, phosphotyrosine binding domain. From 
Jornayvaz et al.61 
 
Similar to what just described for skeletal muscle, lipid can accumulate in hepatocytes when IR 
occurs. Liver receives via portal vein, most of the nutrients extracted from the diet and already 
shifted out by other splanchnic bed organs, especially the intestine and, probably, mesenteric 
adipose tissue
62
. In any case, liver controls the flow of glucose into the systemic blood, and detains 
or processes many amino acids and short-chain fatty acids. In condition of excess of nutrients and 
of a failure of the insulin system, liver may loss its functionality often provoking non-alcoholic fatty 
liver disease (NAFLD)
63
, associated to insulin resistance. In detail, accumulation of lipid in liver 
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impairs the ability of insulin to regulate gluconeogenesis and activate glycogen synthesis while 
lipogenesis remains unaffected
37
. However, it is not completely known how liver steatosis leads to 
insulin resistance. Likely, very similarly as in skeletal muscle, not the TAG per se, but the lipid 
intermediates (such as DAGs) are important for the development of IR. Hepatic insulin resistance is 
also associated with increased insulin plasma concentrations, which in turn stimulates de novo 
lipogenesis and therefore enhances liver steatosis further. These data indicate that liver steatosis 
results in a vicious cycle by causing insulin resistance, which again promotes hepatic lipid 
accumulation. 
 
Inflammation 
Inflammation is part of the complex biological response of body tissues, organs or organism to 
harmful stimuli, such as pathogens, damaged cells, or irritants. The response is mainly performed 
by immune system agents (cells and proteins), especially against whole organisms, proteins, or 
large materials susceptible to becoming allergens, that is, parts of invading extraneous materials or 
organisms. Other locally derived responses are generated from the site of aggression, such as the 
emission of signalling compounds (histamine
64
 and eicosanoids
65
 and cytokines
66
) and nervous 
system signals (pain, itching, heat, and hypersensitivity)
67
. Blood flow and capillary permeability 
play key roles in the response to localized aggression by causing inflammation
68
.  
The mechanism of inflammation was described in I century AD by Aulus Cornelius Celsus in his 
medical work De Medicina. In this treatise, he explains the classic signs of acute inflammation 
(from inflammare, to set on fire) as rubor (redness), turgor (turgidness, swelling), calor (heat), and 
dolor (pain); only one century later, Aelius Galenus identified functio lesa (loss of function) as the 
fifth sign of the acute inflammation. Redness and heat are consequences of increased blood flow, 
and turgidness is a sign of edema, that is, altered capillary permeability that does not allow for 
sufficient venous return of fluid, increasing the extracellular (interstitial and plasmatic) space. Pain 
is largely a consequence of histamine and cytokine release by affected tissues
69
. Inflammation 
typically ceases within a relatively short time with the elimination of causative agents; but, as well, 
it may become chronic when elimination is not complete and the defensive activity of the immune 
system becomes generalized
68
. 
The classical inflammation characteristic just described are not coincident with that found in the 
WAT in MS because the massive incorporation of immune cells into tissue, secretion of cytokines, 
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relative hypoxia, and modification of cell metabolism are not accompanied by an increase in blood 
flow, by an increased endothelial permeability to water, by the appearance of edema, or by an 
altered lymph recovery
68
. In fact, the presence of edema is a secondary consequence of altered 
blood pressure and endothelial damage, but it is not centred in the WAT. The inflammation that 
characterizes MS is rather a permanent low-level inflammation and it's not derived from a previous 
acute phase, but is caused by the inability of the body to cope with the continuous influx of 
excessive energy substrates. Inflamed WAT responds to the ‗invasion‘ of nutrient availability by 
reducing its blood flow
70,71
, thereby decreasing the availability of substrates, but also causing 
increased generation of oxidative free radicals
72
 and generalized hypoxya
73
 that results in the 
glycolytic anaerobic production of lactate and acidosis
74
. 
Most researches have been recognized the endothelium as the primary tissue where inflammation 
takes place
75
, (mainly) in the liver, WAT, muscle, intestine, and brain. Inflammation is probably the 
consequence of a breach in homeostasis (i.e. oxygen or nutrient availability and remote or paracrine 
signalling) that endangers the cells forming the vessel itself.  
The initial step of inflammation probably occurs in the WAT as cannot absorb, manage and 
eliminate an overload of nutrients. This state of suffering and tissue stress is signalized with the 
production of cytokines such as tumor necrosis factor (TNF-α) and interleukin 6 (IL-6) that elicits 
the incorporation of immune system cells such as macrophages
76,77
. Macrophage activation 
enhances the secretion of proinflammatory cytokines and increases IR
78
 and TG accumulation
79
. 
TNF-signaling activates intracellular kinases, such as JNK and IkB kinase (IKK), which lead to 
increased serine phosphorylation of IRS-1, rather than the normal tyrosine phosphorylation causing 
impairment in insulin signaling. TNF- and IL-6 also activate the Protein-1 (AP-1) and nuclear 
factor -light-chain-enhancer of activated cells (NF-B) which cause increased production of 
proinflammatory cytokines, thus triggering inflammation
80
. The cytokines can have a paracrine 
effect, but they can also be secreted into plasma and affect other organs. In Figure 4 are depicted the 
hallmarks of obesity-induced inﬂammation in adipocytes. 
Another mechanism leading to insulin resistance and thus to inflammation comes from the action 
of the saturated fatty acids (SFA). SFA activate the tool-like receptor 4 (TLR4), an important 
receptor of the innate immune system up-regulated in case of inflammation, that induces activation 
of JNK and IKK. In turn, JNK and IKK up-regulate NF-B and AP-181,82.  
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Immune system intervention in inflammatory process provokes a glucorticoid response
83
 that 
diminish inflammation caused by immune cells but in the mean time alters not only the response of 
the insulin system
84
 but also the handling of amino acids
85
 and liver glucose output
85
, enhance 
overall lipogenesis and fat deposition
85
, bone loss/osteoporosis
86
, and, in the medium to long terms, 
interference with estrogens and androgens
87
.  
 
a 
 
b 
c 
d 
Figure 4. Hallmarks of metabolic inflammation in adipocyte  
The hallmarks of obesity-induced inﬂammation are that it (a) is metabolic—a nutrient-induced inﬂammatory response 
orchestrated by metabolic cells; (b) is moderate—low-grade and local expression of inﬂammatory mediators induced by stress 
sensors such as IKK and JNK; (c) creates a modiﬁed milieu—altered composition of immune cells favouring a proinﬂammatory 
tissue environment; and (d) is maintained—chronic maintenance of the inﬂammatory state without apparent resolution. 
(Abbreviations: IKK, inhibitor of κkinase; JNK, c-jun N-terminal kinase; PKR, protein kinase R; TNF-α, tumor necrosis factor-α, 
IL-1β interleukin 1β, CCL2, chemokine (C-C motif) ligand 2). Adapted from Gregor et al.79 
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Another major metabolic organ where inflammatory pathways interfere with normal metabolism 
and disrupts proper insulin signaling is the liver. In contrast to adipose tissue, the liver does not 
goes through an infiltration of macrophages during the onset of obesity but instead undergoes an 
activation of inflammation within cells of the liver
69,81
, including the resident macrophage-like 
Kupffer cells
79
 and a substantial gathering of hepatic recruitment of CCR2
+
myeloid cells that 
promote hepatosteatosis
88
. In animal models of obesity, inflammatory cytokine expression is 
increased in the liver compared with lean controls
33
. Indeed, obesity is associated with 
hepatosteatosis that often leads to the more advanced inflammatory state of steatohepatitis. As 
already described above, inflammatory mediators, especially activation of the Nuclear factor -
light-chain-enhancer of activated  cells (NF-κB) pathway, have the ability to inhibit insulin 
signaling. An operative insulin signaling is responsible to inhibit gluconeogenesis but in obese 
conditions this regulation is lost and hepatic glucose production subsequently contributes to 
hyperglycaemia. JNK kinase is also activated in the liver during obesity, causing glucose 
intolerance and increased glucose and lipid production in the liver. More inflammatory mediators 
and acute-phase reactants activated by inflammation are serum levels of cytokines such as CRP, 
PAI-1, serum amyloid A, and IL-6
78
. Some of these cytokines have been shown to have adverse 
metabolic effects on peripheral organs
79
, so that the liver inflammatory mediators in obesity may be 
a strong contributor to the malfunction of peripheral tissues under such nutrient excess. If the 
inflammation in the liver escalates, cells may die, resulting in the recruitment of immune cells and 
in steatohepatitis
63
. Thus, the liver remains an important site where metabolic and immune cell 
signals merge to limit the tissue‘s response to nutrients. 
 
ER stress and unfolded protein response 
During the last decade, ER stress has emerged as a new player in the onset of insulin resistance. 
Once more time, the excess of substrate availability and deficit of oxygen (hypoxia) provoke a 
defective protein synthesis that fuels proteasome activity. Moreover, ER stress appears to act 
directly as a negative modulator of the insulin signaling pathway but also indirectly by promoting 
lipid accumulation
89
. 
ER is a multifunctional organelle essential for the synthesis, folding, and all processing of 
secretory and transmembrane proteins
90
. Environmental (calcium or other ions, excess or lack of 
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nutrients, infection, changes in the redox state
68
), pathogenic (decreased adipose tissue blood flow 
responsible of hypoxia
71
), and genetic factors can disrupt ER function causing an accumulation of 
misfolded and unfolded proteins in the ER lumen, a condition termed ER stress.  
ER stress activates a signaling network called the Unfolded Protein Response (UPR) to alleviate 
this stress and restore ER homeostasis, promoting cell survival and adaptation. However, under 
irresolvable ER stress conditions, the UPR promotes apoptosis. In higher eukaryotes, the UPR is 
initiated by three ER transmembrane proteins: Inositol Requiring 1 (IRE1), PKR-like ER kinase 
(PERK) and Activating Transcription Factor 6 (ATF6). During unstressed conditions, the ER 
chaperone, immunoglobin binding protein (BiP) binds to the luminal domains of these master 
regulators keeping them inactive. Upon ER stress, BiP dissociates from these sensors resulting to 
their activation
91
. Upon ER stress, PERK phosphorylates the α subunit of eukaryotic translation 
initiation factor 2 (eIF2α) causing a reduction of mRNA translation and thus decreasing the load of 
new proteins in the ER, phosphorylation of eIF2α by PERK allows the translation of activating 
transcription factor 4 (ATF4) that induces transcription of genes involved in amino acids synthesis 
and apoptosis. PERK also phosphorylates the nuclear factor erythroid 2 (NRF2), an antioxidant-
response transcription factor. Phosphorylation of eIF2α by PERK promotes the expression of the 
growth arrest and DNA damage-inducible protein (GADD34) that bind the eukaryotic 
serine/threonine phosphatase protein phosphatase 1 (PP1) to direct eIF-2α dephosphorylation and so 
reversing the shut-off of protein synthesis initiated by stress-inducible kinases and facilitating 
recovery of cells from stress
92
. ATF4 also participates in the retro control of PERK signaling
91
. 
Under stress conditions, IRE1 phosphorylates itself and reveals its endoribonuclease activity that is 
responsible for the unconventional splicing of the X box-binding protein 1 (XBP1) mRNA and its 
translation into the transcription factor XBP1s
93
. XBP1s up regulates the transcription of genes 
encoding ER chaperones components of the ER-associated protein degradation machinery and 
phospholipids' biosynthesis. Furthermore, IRE1 has also a nonspecific endoribonuclease activity 
that contributes to the reduction of protein accumulation in the ER. IRE1 also recruits the scaffold 
protein tumor necrosis factor receptor-associated factor 2 (TRAF2) that regulates activation of NF-
B and JNK and plays a central role in the regulation of cell survival and apoptosis. Finally, 
accumulation of misfolded proteins in the ER results in the proteolytic cleavage of ATF6. The 
cytosolic portion of ATF6, an active transcription factor, transactivates genes encoding ER 
chaperones, ER-associated protein degradation components, and protein foldases. It is important to 
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underline that several ATF6 homologs have been identified that share the same processing 
mechanism with ATF6 and that could play tissue-specific roles
94
.  
Sustained ER stress can lead to ER stress-associated cell death in fact UPR sensors are closely 
connected to apoptotic pathways.  
The pioneer work
95
 that linked the interrelationship between ER stress, inflammation and insulin 
resistance showed an over expression of UPR markers in the liver and adipose tissue of obese 
rodents. 
UPR activation has been proposed to participate in the low-grade inflammation observed in 
obesity in the liver, WAT and muscle. Indeed, the three arms of the UPR described above, are 
intimately connected to inflammatory pathways as the activation of NF-kB and JNK responsible of 
the synthesis of proinflammatory cytokines. These themselves proinflammatory cytokines, could 
activate ER stress by a feed-forward and non-elucidated mechanism, and thus help to maintain an 
inflammatory state
96
.  
ER stress involves insulin-sensitive tissues in different way. In the hepatic tissue, ER stress could 
contribute to the development of IR in three different ways: modification of transcription of key 
hepatic enzymes involved in gluconeogenesis or lipogenesis, stimulating stress kinases that interfere 
with insulin signaling, promoting fat accumulation in hepatocytes
97,98
.  
In WAT, the contribution of the ER stress to impaired insulin signaling has yet to be confirmed, 
but it appears that ER stress clearly plays a role in modulating adipose tissue lipolysis
99
, in the 
deregulation of adipokine secretion, frequently observed in obesity and IR, in a decreasing of both 
leptin and adiponectin secretion and an increase of IL-6 secretion, and in promoting inflammatory 
pathways through the activation of PERK/ IKK pathway
100
.  
In muscle, ceramides inhibit insulin signaling. Several studies have addressed the role of ER 
stress to mediate palmitate-induced IR in muscle cells
101
.  
In conclusion, although recent literature highlights ER stress an important player in the 
regulation of insulin signalling WAT, liver, muscle, most of the studies have been performed in 
vitro, thus, further novel in vivo experimental data will be necessary to confirm the hypothesis that 
ER stress promotes IR. 
 
Gut microbiota 
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An increasing body of literature has suggested gut microbiota as contributing to the generation of 
obesity, obesity-associated inflammation and IR 
102,103,104,105 
(Figure 5). 
The healthy human gut microbiota is comprised of 10
14
 microorganisms, which exceeds the 
number of human cells in the body by ten-fold
104
. Collectively, the human microbiota encodes 150 
times more genes than the human genome (3-4 million). This enables the gut microbiota to perform 
diverse metabolic activities not encoded in the human genome
106
. The phylum Firmicutes 
(including Clostridium, Enterococcus, Lactobacillus and Ruminococcus) and Bacteroidetes 
(including Prevotella and Bacteroides genera) constitute over 90% of known phylogenetic 
categories and dominate the distal gut microbiota. Factors influencing the microbiota composition 
may include age, diet, antibiotics and mode of delivery at birth
104
 (Figure 5).  
 
Figure 5. Diet-induced dysbiosis affects disease susceptibility  
Diet is implicated as a contributing factor for obesity and T2DM by having direct effects on host metabolism and/or immune 
responses and influences the composition of the microbiome that, in turn, affects host immunity and metabolism and alters 
susceptibility to disease. Adapted by Brown et al.107 
 
In mouse models of obesity, the composition of the microbiota is altered, a phenomenon known 
as dysbiosis. More in detail, obesity is associated with differences in gut microbiota at the phylum 
level, with a greater proportion of Firmicutes than Bacteroidetes in obese individuals compared with 
normal weigh individuals
108
. This change is associated with an increased representation of bacterial 
pathways associated with polysaccharides fermentation and fecal short chain fatty acids (SCFA) 
production. In fact, germ-free mice are resistant to high-fat diet–induced obesity because of a lack 
of fermenting bacteria that can process complex polysaccharides and resultant reduced SCFA 
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production
109
. SCFA (acetate, butyrate and propionate predominantly) are produced by gut 
microbiota and play an integral role in communication between microbiota and host, in addition to 
being an energy source for a host.  
Furthermore than SCFA, in MS, sizeable levels of lipopolisaccharide (LPS) have been found in 
serum
4
 as obesity is linked with increased intestinal permeability due to a reduced expression of 
genes encoding for proteins of the tight junctions. LPS is unique glycolipids in the cell wall of 
gram-negative bacteria, also known as bacterial endotoxins that may trigger acute and chronic 
inflammation leading to immune cell activation and cytokine release. Modulation of gut microbiota 
of mice fed high fat diets (HFD) increases intestinal permeability and LPS infusion in mammals 
leads to the appearance of factors known to be associated with the MS: elevated levels of 
proinflammatory markers, dyslipidemia, fasting hyperglycaemia, insulin resistance, and obesity
110
.  
Other than SCFA and LPS, the microbiota, through their activity in the lumen, also produce 
bioactive metabolites, such as bile acid derivatives that are responsible for influencing systemic 
insulin sensitivity, inflammation, and energy metabolism
111
. 
MS is characterized by an altered N metabolism responsible to excrete nitrate and nitrite in the 
saliva. Salivary nitrate is rapidly reduce to nitrite by nitrate reductase expressed by microorganism 
in the mouth
112
. Nitrite is a source of nitric oxide (NO·) in the alimentary canal responsible to kill 
bacteria in the stomach
112
 and probably of the bactericidal effect on gut microorganism
9,4
.  
Despite the growing number of studies linking alterations in the microbiota to obesity and or 
insulin resistance, it remains to be established whether these are the cause or the consequence. 
Despite persuasive data in mouse models, the link between the microbiota and MS in humans is less 
compelling
109
. 
 
1.1.2 Obesity and high fat diets 
Even if in an early definition of the insulin resistance syndrome Reaven
20
 did not include any 
marker of obesity, at now days, it is clear that in most cases obesity, particularly visceral (or central) 
obesity, is important for the development of many of the other MS components and downstream 
manifestations. In fact, in the western countries the MS is driven by the growing obesity 
‗epidemic‘6.  
Obesity is often defined simply as a condition of abnormal or excessive fat accumulation in 
adipose tissue, to the extent that health may be impaired
113
. The underlying disease is the 
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undesirable positive energy balance and weight gain. However, obese individuals differ not only in 
the amount of excess fat that they store, but also in the regional distribution of that fat within the 
body. The distribution of fat, induced by weight gain, affects the risks associated with obesity and 
the kinds of disease that result. Indeed, excess abdominal fat is as great a risk factor for diseases as 
is excess body fat per se.  
A useful, albeit crude, population-level measure of obesity is the body mass index (BMI), a 
simple index of weight-for-height that is commonly used to classify underweight, overweight and 
obesity in adults. It is defined as the weight in kilograms divided by the square of the height in 
meters (kg/m
2
). The World Health Organization (WHO) considers a BMI of less than 18.5 as 
underweight and may indicate malnutrition, an eating disorder, or other health problems, while a 
BMI greater than 25 is regarded overweight and above 30 is considered obese
114
. However, BMI 
does not account for the wide variation in body fat distribution and may not correspond to the same 
degree of fatness or associated health risk in different individuals and populations
113
, i.e. it does not 
take in account sex, ages and race difference. In cross-sectional comparisons, therefore, BMI values 
should be interpreted with caution if estimate of body fat is required. Other methods than the 
measurement of BMI, are more valuable in identifying individuals at increased risk from obesity-
related illness due to abdominal fat accumulation. Over the past decades, it has become accepted 
that a high waste: hip ratio and increases waist circumference indicates abdominal fat accumulation 
and associated ill health.  
Obesity and overweight are the consequence of the evolutionary inadequacy: the human body is 
unprepared for a dietary excess of nutrients, especially lipids. In fact, humans have incorporated in 
their genes the mechanisms needed for survival against scarcity between periods of food availability 
and have developed mechanisms to store adequate energy reserves, to limit glucose utilization, to 
preserve protein, and to control energy expenditure in order to maintain thermal homoeostasis at the 
lowest possible cost
4
. This condition that fit for early human ancestors is no longer adequate at 
nowadays because food availability is no longer a problem for a large part of Humankind. Excess 
energy, largely lipids, wreaks havoc on the finely tuned homoeostatic mechanisms controlling 
energy availability and usage, with the known consequences of difficulties in the elimination of 
excess available energy. In this condition, a ―starvation-like condition‖45 is generated due to the fact 
that in scarcity there is mobilization of the lipid store to cover body energy needs thus preventing 
the oxidation of glucose. Furthermore, high glucose availability promotes the protection of dietary 
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amino acids, in excess too. Finally, excess of dietary glucose could be removed by lipogenesis, lipid 
oxidation and fat deposition, short term adaptation that cannot be maintained indefinitely, by 
thermogenesis, turnover and growth that have a limited span of application or by long-term 
adaptations, affecting tissue structure and function. However, in all cases, these measures represents 
a forced adaptation of mechanisms not created for these purposes and then, in the medium and long 
term, they can produce changes we recognize largely as inflammation, the molecular basis of the 
MS
45
.
Obesity is a human disease which is only found in humans and in the animals bred for human 
use often specifically selected for high fat content
115
. In fact, in the wild, healthy animals tend to
maintain a similar body size, and there is no obesity, but neither is there extreme thinness, because 
of selective predator pressure. According to ponderostat/lipostatic model the body weight and the 
amount of body fat are fairly well maintained in spite of a wide range of variation in food 
availability and expenditure at the levels established by the genetic and epigenetic blueprint. In 
humans, even the obese tend to maintain their anomalously high weight due to the ponderostat 
system that is probably misadjusted to a higher setting than the optimal
116
.
Considering that humanity is facing a new epidemic already nicknamed ‗‗Prosperity‘s 
Plague‘‘117, elucidating the causes involved in the pathophysiology of obesity and its related
disorders, finding effective therapies and minimizing the enormous costs of the related healthcare 
are some of the most critical endeavours in modern medical research. 
For this purpose, HFD have been used since the 1940s to obtain rodent models of obesity
118
 and
thus investigating deeper the metabolic derangements typifying this pathologic state. HFD with fat 
content between 20% and 60% expressed as energy as fat have been used. The main fat component 
varies between either animal components or vegetable oils
119
. In most of these diets carbohydrate
was substituted by fats. Hyperlipidic synthetic diets are alien to rodents, which tend to decrease 
food intake to maintain the energy intake within tolerable limits. In order to increase energy intake, 
HFD with high palatability, comparable to those eliciting high intakes in humans, were developed. 
They were based on a variety of foods sharing their palatability and high energy density. These 
diets reflect more accurately, the variety of highly palatable, energy dense foods that are prevalent 
in western society and associated with the current obesity pandemic. They were named collectively 
―cafeteria diets‖ (CAFD)120. In this model, the experimental animals are allowed free access to
standard chow and water while concurrently offered highly palatable, energy dense, human food ad 
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libitum. As CAFD are more energy dense than the standard rat pellet diets and are ingested in larger 
amounts, they rapidly promote weight gain increasing the mass of body fat
62,121
. As a consequence, 
a number of metabolic syndrome symptoms appeared, such as glucose and insulin intolerance
122,123
, 
coronary heart disease, stroke, high blood pressure, fatty liver disease, diabetes, and certain 
cancers
124
. Exposure of young adult rats to a CAFD for one month, induces a number of metabolic 
changes that are at the limit of normality and corresponds to the initial stages of the MS
125
. 
Moreover, this diet engages hedonic feeding, consistent with the observed voluntary hyperphagia, 
alters feeding patterns
126
 and may also impact on sensory-specific satiety, a mechanism by which a 
diet containing different food increases ingestion relative to one lacking variety
127,128
. Although 
hedonic component, once obesity is well established, hyperphagia decreases and the complete 
withdrawal from cafeteria-style foods diminishes the impulse to feed
129,126
. However, the 
accumulated fat remains, and the metabolic consequences of excess energy intake, such as IR and 
hyperlipidemia, persist.  
The direct extrapolation of these findings to humans suggests that the availability and 
attractiveness of savoury energy dense foods may initially encourage consumption of larger snacks 
and meals, in terms of both volume, and critically, total energy content
130
. The variety of energy 
dense food drives over-consumption, and therefore, excessive weight gain. The effects of CAFD are 
more marked in males
131,132
; this may be because they have less anti-inflammatory
133,134
 estrogenic 
protection than females. More over androgens promote hypertension and cardiovascular disease
135
 
and low estrogens levels render males more susceptible to be affected by glucocorticoids
136
, which 
in turn decrease the anabolic effects of androgens
137
. 
Thus, it is generally accepted that CAFD can be used to generate a valid animal model for on 
late-onset hyperphagic obesity and they are suitable for the study of the effects of high-energy diets, 
because total protein intake is practically unaffected by the excess dietary energy (mainly from 
lipid) ingested
121
. 
 
1.2 Amino-N disposal in metabolic syndrome 
In condition of a high availability of food, as for example during HFD, the glucose oxidation is 
limited and the amino acids are preserved thus the body cannot easily dispose of the excess    
amino-N due to the evolutively adapted schemes that prevent its wastage, as mentioned before. In 
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these conditions,   acids are not even used to produce energy because the high availability of energy 
from others sources limits our body to do so
138
 and high amino acids in conjunction with high 
energy availability can generate a paradoxical scarcity of ammonia leaving a large stock of    
amino-N.  
Amino-N conversion into ammonia is largely done in muscle and in liver by purine nucleotide 
cycle
139
, idle under excess of energy availability. Furthermore, in muscle there is no other major 
way to produce ammonia
140
. So, muscle cannot use glucose, its standard feed during exercise 
because blood lipids limit glucose uptake
141
 and favour fatty acids oxidation, then, cannot use 
amino acids as energy source in significant amounts
142
 and cannot use their N to produce and 
release glutamine. Muscle cannot even use branched-chain amino acids
143
, oxidised in muscle in the 
postprandial state to preserve glucose, because excess of nutrients hamper this process and its 
timing. Glutamine is the main form of blood transport of ammonia toward intestine and kidney
144
 
where glutaminases release ammonia for its disposal as urea
145
 or as ammonium ion
146
. Lower 
muscle synthesis of glutamine results in lower splanchnic synthesis of carbamoyl-P and so a low 
production of urea. In condition of high load of nutrients, mainly lipid, urea synthesis is 
decreased
121
 even if there is not a massive accumulation of body-N
147
 and, despite amino acid 
catabolism is restricted, the excess of N is lost, not in the recognized way of urea formation
148
. As a 
consequence, non conventional mechanisms are activated as there is no body storage of surplus N. 
A small proportion of N is excreted as N2 gas
149
 by unknown pathways or as urinary nitrate
150
 and 
nitrite, uric acid, creatine, peptides, amino acids, and ammonium ions
151
. Little ammonium amount 
are also excreted by lungs
152
. The inefficiency of urea cycle under the conditions of excess of 
energy and amino-N availability indirectly gives advantage to the production of NO·. NO· is 
synthesizes from arginine by NO synthase
153
 (NOS). In addition to NO, NOS yields citrulline which 
can be used to regenerate arginine
154
. The main function of NO· is relaxing smooth muscle of small 
vessels and thus increases blood flow and lowers arterial tension
155
, creating the obese paradox, that 
is decreased severity of the consequences of heart failure in the obese
156
. 
The metabolic effects of the imbalance between amino- and ammonia-N are considerable and 
should be studied deeply since probably a number of the unexplained phenomena of MS are related 
with the profound alteration on N homeostasis. The consequence of the excess dietary protein and 
our inability to eliminate have been not studied in details but the few studies suggest that excess of 
protein is harmful in the long term for humans. 
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1.3 High protein diets and their differences with high fat diets 
Amino acid metabolism has been only barely studied if compared to carbohydrates and lipids, 
consequently the knowledge of N metabolism in man is much more limited that the detailed 
information available about the metabolic effect of carbohydrates and lipids on energy partition. 
Curiously, the study of proteins has been poorly treated even if they are a key nutritional source of 
energy. Several reasons could explain this lack of researches: the large number of different 
molecular species, the multiple catabolic pathways followed by their hydrocarbon skeleton, the 
methodological difficulties of marking the destiny of N, a multiplicity of functional amino acid 
pools coupled with an active interorgans metabolism and the superficial knowledge of their 
catabolic path and regulation in mammals
9
. Despite the lack of information available, the protein 
has had for almost fifty years a starring role in the development of hyperproteic diets (HPD), very 
low energy, for treatment of obesity and related diseases
157,158
 with mixed success
159,160,161
. Most of 
the discussion about their effects has been centred on their ketogenic nature
162
, even if more basic 
knowledge are necessary to interpret the result obtained.  
One important factor to consider is the definition of a HPD. The protein content of a diet can be 
determined in different ways: the absolute amount of the protein, the % of total energy as protein 
and the amount of protein ingested per kg of body weight
163
. In a neutral energy balance and weight 
stable, dietary protein should account for 10-15% energy equivalent to 0.8-1 g per kg of body 
weight per day, as recommended by WHO
164
. This level of protein recommended is determined by 
the minimum daily intake required to maintain nitrogen balance, so preventing the catabolism of 
own protein stores
165
. Whereas, to be considered high protein and to be effective for weight loss and 
weight maintenance, a diet should be contained 20-35% of energy derived from proteins
166,167
 in 
energy restricted diet. There are not sufficient studies to determine a tolerable upper limit of 
proteins, even if, the lack of an upper limit on protein intake does not necessarily mean that there is 
no potential for danger at very high levels of protein consumption and certain, the difference 
between a high-protein diet and an excessive protein diet must be taken into account. A very high 
amount of protein intake might be considered in relationship to osteoporosis
168
, kidney stones, renal 
failure
169
, some types of cancer
170,171
, changes in microbiota
172
 and metabolic changes in liver 
parenchyma cells
173
 due to the large amount of amino acids carried by portal vein that liver should 
Introduction 
 
23 
extensively remove in order to maintain relatively low and constant concentration in the peripheral 
blood.  
Conversely to CAFD, HPD decrease both food intake and growth of rat
174,175
 which implies 
changes in protein metabolism. Furthermore rats fed with an high load of protein (more than 35% of 
protein-derived energy) had a lower WAT mass if compared with a control isocaloric diet
174
, 
probably because HPD result in a limited availability of energy for metabolic activities in spite that 
the Energy cost of growth was similar to control group. The depression of food intake is associated 
with elevated concentrations of essential amino acids in plasma
175
. As the rats adapts to HPD the 
capacity of the liver to degrade most amino acids increases and the concentration of amino acids 
other than branch-chain amino acids (BCAAs) in the peripheral blood do not exceed those of 
animals consuming much less protein
175
. On contrary, in rats fed with CAFD the sums of 
concentrations of amino acids in plasma increase slightly even if not significantly
121
. The sensitivity 
of the adaptive mechanism to increasing protein intake is exemplified by the incremental increases 
observed in liver glutamic oxaloacetic transaminase (GOT)
175
, glutamate-pyruvate transaminase 
(GPT)
176
, serine dehydratase (SDH)
175,176
 activity, which were almost directly proportional to the 
degree of dietary amino acid excess. The opposite thing happens in the liver activity of CAFD rats. 
Serine dehydratase activity in control males is slightly higher than in CAFD rats, while significantly 
results can be found in SDH gene expression but, being an example of substrate-controlled 
activity/expression, both are correlated
62
; GPT activity decreases in CAFD rat liver.  
The increase in amino acids catabolism during HPD, as stated above, is accompanied by a 
greeter need for urea likely due to rise of urea cycle enzyme activity
177,178
. In fact, the observed 
differences in enzyme activities are due to discrepancy in the actual enzyme concentrations rather 
than to an effect of activators, inhibitors, or an alteration in the kinetics properties of enzyme 
molecules
178,179
. 
In conclusion, rats are able to adapt to a wide range of dietary levels of proteins and N partioning 
is adjusted to protein availability in the diet. Despite this makeable ability, rats accustomed to a 
HPD when are allowed to select between a high and a low protein diet will reduce their protein 
intake within few days to obtain a moderate proportion of calories from protein. The proportion of 
total calories selected as protein under these conditions depends on both the protein content and the 
amino acids composition of the diets offered and on the amino acid-catabolic state of the animal
175
 
and it must be taken into account that HPD are not uniform and can vary considerably in relation to 
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the percentage of energy that represents proteins, the type of protein used and the duration of their 
dispensation. Thus, in most cases it is difficult to establish comparison between different 
experiments.  
 
1.4 Outline of nitrogen metabolism 
Proteins, ingested with diet or intracellular, undergo to proteolysis responsible of their 
breakdown into amino acids.  
Among more than 300 amino acids in nature, only 20 of them (α-amino acids) serve as building 
blocks of protein. However, non-protein α-amino acids (e.g. ornithine, citrulline) and non α-amino 
acids (e.g. taurine and b-alanine) also play important roles in cell metabolism, some amino acids are 
important regulators of key metabolic pathways that are necessary for maintenance, growth, 
reproduction
180
, and immunity in organisms
180
, therefore maximizing efficiency of food utilization, 
enhancing protein accretion, reducing adiposity, and improving health
181
. 
In animal, amino acids can undergo to degradative oxidation when not necessary for synthesis of 
proteins, when amino acids exceeds the metabolic demand for synthesis of proteins i.e. during HPD, 
when carbohydrates are not available or not used correctly in order to generate energy
182
 i.e. during 
fasting o diabetes. Although each amino acids has its own unique catabolic pathway(s), the 
catabolism of many amino acids exhibits a number of common characteristics in organisms
182
. 
Important metabolites of amino acids include NH4
+183
, CO2, long-chain and short-chain fatty 
acids
183
, glucose
184
, H2S
183
, ketone bodies, NO·
185
, polyamines
185
, urea
186
, uric acid
184
, and other 
nitrogenous substances with enormous biological importance
183
 (Figure 6). Complete oxidation of 
amino acids carbons occurs only if their carbons are ultimately converted to acetyl-CoA, which is 
oxidized to CO2 and H2O via the Krebs cycle and mitochondrial electron transport system (Figure 
6).  
Whereas part of NH4
+
, generating from amino acids metabolism and during the purine and 
pyrimidine catabolism, is reused in several biosynthetic pathways (amino acids
62
, nucleotide
187
, 
biogenic amines
188
) or in mammals excreted as urea mainly in liver.  
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Figure 6. Schematic representation of amino acid catabolism in mammals 
The pathways followed by carbons skeletons and by NH4
+ groups of amino acids are separated but interconnected. From Nelson 
et al.182 
 
NH4
+
 are continually produced and used in mammalian cells. NH4
+ 
is a very toxic compound for 
animal tissues especially for brain where it provokes irreversible damage. The mechanisms leading 
to these severe brain lesions are still not well understood, but recent studies show that ammonium 
exposure alters several amino acid pathways and neurotransmitter systems, cerebral energy 
metabolism, NO· synthesis, oxidative stress and signal transduction pathways
189
. For this reason, 
NH4
+ 
is converted in a non-toxic compound and transported by blood from extra-hepatic tissues to 
the liver and then to kidney where is excreted by urea. Since urea excretion requires equal 
proportions of amino and ammonium, any -NH2:NH3 ratio above 1·00 represents a relative excess 
of amino groups. The ratio amino-N:ammonium-N in most dietary proteins is close to 2, which is 
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responsible of the preservation of N under conditions of starvation, but in the end requires the 
mineralization of about half of all amino-N to ammonia under normal feeding conditions
9
. 
Several enzymes/pathways are responsible to convert amino group into ammonium, mainly in 
the liver
62
: glutamate dehydrogenase
190
 (EC 1.4.1.2), glutaminase
191
 (EC 3.5.1.2), purine nucleotide 
cycle, i.e. AMP deaminase
139
 (EC 3.5.4.6) with serine dehydratase
192
 (EC 4.3.1.17), and the glycine 
cleavage system protein H
193
. Other sources are amine-oxidases (EC 1.4.3.4) and amino acid 
oxidases (EC 1.4.3.2). (For all cited enzymes, EC numbers and gene name were taken by Uniprot 
database http://www.uniprot.org). 
Glutamate and glutamine has got an important role in amino acids metabolization and 
ammonium transport. NH4
+
, removed from amino acids, are transferred to α-ketoglutarate in liver 
cell cytosol generating glutamate that move to mitochondria where lost NH4
+
. In tissues other than 
liver, NH4
+ 
in excess is incorporated to glutamine and transferred to liver mitochondria. In muscle, 
NH4
+ 
in excess are transferred to pyruvate to form alanine that transfer NH4
+ 
from muscle to liver. 
The separation of the α-aminic group is the first step in catabolism of amino acids and it is 
promoted by aminotransferase. Aminotransferase, both cytosolic and mithocondrial enzymes are 
just involved in transferring amino group between amino acid and keto acid pairs without 
generating or consuming free ammonium ions. An example of aminotransferase is depicted in 
Figure 7. Several aminotransferase are specific for α-ketoglutarate as NH4
+ 
receiving but diverge for 
the amino acids donor of NH4
+
 for this reason these enzymes take their name for the amino acid 
donor. Reactions catalyses by aminotransferase are reversible and they have an equilibrium constant 
equal to 1. Important humans transaminase are aspartate aminotransferase
194
 (EC 2.6.1.1), alanine 
aminotransferase
195
 (EC 2.6.1.2) and branched-chain amino-acid aminotransferase
196
 (EC 2.6.1.42).  
 
Figure 7. The transamination reaction catalyzed by alanine aminotransferase. From Liu et al.195 
 
As mentioned before, NH4
+ detached from amino acids, is transferred to α-ketoglutarate to yield 
glutamate. In the mithocondrial matrix, glutamate is deaminated by glutamate dehydrogenase.  
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Glutamate dehydrogenase
197
 is an enzyme localized predominantly in the mitochondrial matrix 
and catalyzes the reversible oxidative deamination of glutamate to produce α-ketoglutarate and a 
free ammonium ions (Figure 8). Although in vivo the reaction proceeds predominantly toward the 
direction of the oxidative deamination of glutamate, probably due to the high concentration of 
glutamate and low level of free ammonium ions usually present inside the mitochondria under 
baseline conditions. This enzyme is encoded by two human genes, GLUD1 and GLUD2 encoding 
two glutamate dehydrogenase isoenzymes. GLUD1 is a housekeeping gene widely expressed in 
human tissue, including liver, kidney, brain, heart, intestine, skin. GLUD2 is expressed in retina, 
brain and testicular tissue. NAD
+
 (or NADP
+
) is a cofactor for the glutamate dehydrogenase 
reaction. Based on which cofactor is used (NAD
+ 
or NADP
+
), glutamate dehydrogenase enzymes 
are divided into the following two classes: NADH dependent (EC 1.4.1.2) and NADPH dependent 
(EC 1.4.1.4)
197,190
. The blended action of transaminase and deamination is called transdeamination. 
 
Figure 8. Glutamate dehydrogenase reaction. From Adeva et al.191
 
 
Glutamate is the pivotal compound involved in NH4
+
 metabolism, while glutamine it is for 
transport. Glutamine is form by the reaction between NH4
+
 and glutamate catalyzed by glutamine 
synthetase. Glutamine synthetase (EC 6.3.1.2)
191
 is a cytosolic enzyme, encoded by human gene 
GLUL, that catalyzes the synthesis of glutamine from glutamate and free ammonium in an ATP 
dependent reaction (Figure 9). Its expression and activity have been detected in adult human skin, 
liver
62
, WAT
134
, brain and GI tract, especially in the stomach
191
. The reaction required ATP and 
occurs in two steps through the formation of an intermediate, γ-glutammil phosphate, and ADP. 
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Figure 9. Glutamine synthetase reaction. Adapted from Adeva et al.191
 
 
As glutamine is the main non-toxic form of NH4
+ 
transport, it is present in higher blood 
concentration than other amino acids
182
. The surplus of glutamine is transferred to liver and kidney 
where is converted to glutamate and NH4
+
 by glutaminase. Glutaminase (EC 3.5.1.2)
191
 is a 
phosphate-activated mithocondrial matrix enzyme that catalyzes the hydrolysis of the amide group 
of glutamine to the stoichiometric amount of glutamate and free ammonium ion (Figure 10).  
Two human genes, Gls and Gls2, encode a mRNA transcript that undergoes tissue-specific 
alternative splicing generating several isoenzymes. Gls encodes a mRNA transcript that undergoes 
tissue-specific alternative splicing generating three variants that are translated into three human 
glutaminase isoenzymes: Glutaminase-1 or Kidney type, Glutaminase C, and Glutaminase M. Gls2 
encodes glutaminase-2 or liver type glutaminase a protein functionally similar to kidney type by 
smaller insize
191
. Glutaminase-1 or Kidney type expression has been detected prevalently in kidney 
and brain
198
, Glutaminase C is expressed principally in pancreas and cardiac cell but also in kidney, 
lung and placenta
198
. Glutaminase M is expressed in cardiac and skeletal muscle
198
. Glutaminase-2 
or liver type glutaminase distribution is not well defined. While normal human hepatocytes express 
liver-type glutaminase, hematoma cells express the kidney isoform
191
.  
 
Introduction 
 
29 
 
Figure 10. Schematic representation of mechanism of action of L- glutaminase. From Elshafei et al.199  
 
Serine dehydratase catalyzes the deamination of L-serine and L-threonine to yield pyruvate
192 
and requires pyridoxal phosphate as a cofactor (Figure 11). It is encoded by SDS gene which 
expression is controlled only by serine availability
200
. In mammals, the enzyme is found 
predominantly in the liver. Extensive studies demonstrated that the enzyme has been found to play 
an important role in gluconeogenesis since its activity is remarkably induced by the consumption of 
HPD
192
, starvation, and CAFD
201
.  
 
Figure 11. The enzymatic reaction of serine dehydratase. From Sun et al.192 
 
AMP deaminase is the first enzyme of purine nucleotide cycle and catalyzes the breaks up the 
AMP (Figure 12) generated by adenylate kinase under conditions of scarcity of ATP
202
 as a way to 
control glycolysis, often in conjunction with ammonium production
203
.  
 
Figure 12. The enzymatic reaction of AMP deaminase. From Lowenstein204 
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The several functions of AMP-deaminase in liver, do not seem to include a significant role in the in 
situ production of ammonium
205
, contrary to what happens in muscle where the purine nucleotide 
cycle as a main mechanism for mineralization of amino-N. 
There are three isoforms encoded by the respective genes: AMPD1 encodes AMPDI206 that 
catalyzes the deamination of AMP to IMP in skeletal muscle. AMPD2 encodes AMPDII206 expressed 
in non muscle tissues as liver and AMPD3 encodes AMPDIII mainly expressed in the erythrocyte.  
Glycine cleavage system is the principal pathway by which glycine is catabolized in mammals. 
This multicomponent system resides exclusively in the mitochondrial compartment and catalyzes 
the tetrahydrofolate-dependent cleavage of glycine to yield carbon dioxide, ammonia, N5,N10-
Methylene-H4 folate, and one reducing equivalent as NADH + H
193
 (Figure 13). 
 
Figure 13. The enzymatic reaction catalyzes by glycine cleavage system. From Kikuchi et al.207 
 
The glycine cleavage system is widely distributed in animals, plants and bacteria and consists of 
three enzymes and a carrier protein: P-protein, (EC 1.4.4.2) a pyridoxal phosphate-containing 
protein expressed by GLDC gene, T-protein (EC 2.1.2.10), a protein required for the 
tetrahydrofolate-dependent reaction, expressed by AMT gene, H-protein, (EC 1.8.1.4) a protein that 
carries the aminomethyl intermediate and then hydrogen through the prosthetic lipoyl moiety 
expressed by GCSH gene, and L-protein, a common lipoamide dehydrogenase
207
. Glycine cleavage 
system represents the major pathway of glycine and serine catabolism in vertebrates and its activity 
is detectable in the liver, kidney and brain
207
. Recently, we found that WAT expresses the H protein 
of the glycine cleavage system, least so far not described
134
.  
Monoamine oxidases are a family of mitochondrial-bound flavoproteins located in the 
mitochondrial outer membrane that catalyze the oxidative deamination of monoamine 
neurotransmitters, neuromodulators, primary, secondary, and some tertiary xenobiotic amines and 
hormones to the corresponding aldehydes
208
. This reaction requires flavin adenine dinucleotide 
(FAD) as a covalently bound redox cofactor (Figure 14). 
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Figure 14. The enzymatic reaction catalyzed by monoamine oxidase. From Bortolato et al.209 
As the aldehydes produced by monoamine oxidases are toxic species, have to be converted in 
less harmful metabolites. Thus, this enzyme is functionally coupled with a NAD(P)
+
-dependent
aldehyde dehydrogenase, which oxidizes the aldehyde to the corresponding carboxylic acid; 
alternatively (depending on the location and the intracellular conditions), aldehydes can be reduced 
to alcohols or glycols by aldehyde reductase or alcohol dehydrogenase. The role of monoamine 
oxidases in the homeostasis of monoamine neurotransmitters and xenobiotic amines is essential to 
modulate the neuroendocrine regulation of the central nervous system and many peripheral 
organs
209
. In higher vertebrates, the monoamine oxidase family comprises two isoenzymes, termed
A and B
209
, which, despite a substantial structural overlap, are remarkably different for substrate
preference, inhibitor selectivity, anatomical distribution, and functional role in behavioural 
regulation
195
. These enzymes are encoded by MAO-A and MAO-B genes. Although both isoenzymes
are expressed in most tissues, only MAO-A is characteristically abundant in fibroblasts and 
placenta; in contrast, MAO-B is the only isoenzyme expressed in platelets and lymphocytes. 
L-Amino Acid Oxidases are enzymes found in several organisms, including mammals, insects, 
fungi, bacteria, snakes and even in plants
210
. L-Amino Acid Oxidases are flavoenzymes belonging
to the class of oxidoreductases that catalyze the stereospecific oxidative deamination of L-amino 
acids (Figure 15). L-Amino Acid Oxidases are considered to be a class of multifunctional enzymes 
in view of their ability to produce hydrogen peroxide and ammonia, their participation in cell 
metabolism, and their possible protective effects, including their antiseptic and antimicrobial 
activities on different organisms
210
. Kinetic studies suggest that LAAO present preferential catalytic
specificity for hydrophobic and aromatic L-amino acids, whereas their affinity for polar and basic 
amino acids is low. LAAO activity was first observed by Krebs in hepatic and renal tissue 
homogenates. Subsequently, LAAO was isolated from a rat kidney
210
. These enzymes are encoded
by IL4I1gene. 
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Figure 15. Mechanism of chemical reaction catalyzed by L-amino acid oxidases. From Izidoro et al.210 
 
Until the pioneering work of Windmueller on glutamine utilization by rat jejunum
211
, it was 
assumed that all dietary amino acids absorbed by the small intestinal mucosa entered the portal 
circulation intact and became available to extra intestinal tissues. Studies over the last decades have 
demonstrated extensive catabolism of non essential amino acids in intestinal mucosa
184,212,213
 and 
that catabolism dominates the first-pass intestinal utilisation of dietary essential amino acids
214
. 
Intestinal tissue has a high rate of protein metabolism, which is directly linked to the high rates of 
proliferation, protein secretion, cell death and desquamation of various epithelial and lymphoid cells 
within the mucosa. The relatively high rates of first-pass metabolism of dietary amino acids may be 
a phenomenon that is largely confined to the small intestine rather than the stomach or large 
intestine
212
. In fact, the small intestine, beside to be the primary organ responsible for terminal 
digestion and absorption of dietary nutrients, is a major site for extensive catabolism of amino acids 
in humans and animals, therefore modulating the entry of dietary amino acids into the portal 
circulation and the pattern of them in plasma
145
. Intestinal mucosa amino acids metabolism plays an 
important role in regulating intestinal functionality through several mechanism: dietary glutamine, 
aspartate, glutamate and arterial blood glutamine are the main fuel for small intestinal mucosa and 
are responsible for providing required for intestinal ATP-dependent metabolic processes
213
, 
ornithine, a product of arginine, is the precursor for polyamine synthesis, which is essential to 
proliferation, differentiation and repair of intestinal epithelial cells
215
, arginine is the physiologic 
precursor of NO·, which plays an important role in regulating intestinal blood flow, integrity 
secretion and epithelial cell migration
216
, glutamate, glycine and cysteine are precursor for the 
synthesis of glutathione, a tripeptide critical for defending the intestinal mucosa against damage
217
. 
Arterial glutamine
218
, luminal glutamate
218
, aspartate
219
, and glutamine
218
 are extensively 
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metabolized by rat small intestine indicating that the most of glutamine and almost most of the 
glutamate and aspartate in the diet do not enter the portal circulation and are not available to extra 
intestinal tissue. Furthermore, in adult rat small intestine, CO2 account for the 60% of the total 
catabolised carbons of these three amino acids, indicating that amino acids, more than glucose, is 
the mayor fuel for small intestinal mucosa. Serine and glycine may be catabolised by small 
intestinal mucosa, however, direct evidence for their catabolism via pathways others than 
glutathione and nucleotide synthesis is lacking. Arginine
219
 is degradated by arginase II and to a 
much lesser extent by NO synthase. Studies indicate that most of the arginine utilisation is 
accounted for by the small intestinal mucosa, indicating that arginine is not available for extra 
intestinal tissues. Proline is metabolized by proline oxidase that in intestine has got a high activity 
and in this tissue start the proline oxidation in the body. BCCA are metabolised by small intestinal 
mucosa
196
 and their nitrogen is used for alanine syntheis
145
. Lysine, methionine, phenylalanine and 
threonine were traditionally considered not to be catabolised, even if some evidences show that 
small intestinal mucosa may play an important role in degrading dietary essential amino acids
184
. 
 
The urea cycle 
As already mentioned before, the amino nitrogen resulting from the utilization of amino acids 
for energy requirements is excreted largely as urea. 
The urea cycle (UC) is an enzyme system that converts ammonia into urea (Figure 16). It was 
discovered by Krebs and Henseleit in 1932
220
.  
Urea biosynthesis developed, as a survival mechanism, when primitive animals made the 
transition from the Devonian seas to a marshy terrestrial existence
221
. While most fish and 
amphibian larvae excrete ammonia from the gills directly into the surrounding water, terrestrial 
animals are not able to excrete enough water to dilute ammonia to a non toxic level without 
becoming dehydrated. In addition to ammonotelic and ureotelic organisms, there are uricotelic ones, 
such as most insects and terrestrial arthropods, birds and terrestrial reptiles that incorporate 
ammonia into purines, typically uric acid, which is practically insoluble in water and can be 
excreted (or stored within the developing egg) in solid form. Other animals excrete products derived 
from uric acid catabolism as alantoin. Others (i.e. sharks) excrete thrimethylamine oxide, an 
alternative form of ammonium detoxification to urea. Urea has the advantage of being non-toxic, 
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highly soluble in water as non-ionic; once synthesized, urea is transported to the kidney and then 
excreted.  
 
Figure 16. Schematic representation of urea cycle. Adapted from Agnelli et al.62 
 
The UC consists of five enzymes: carbamoyl-phosphate synthase (CPS) catalyzes the ATP-
dependent synthesis of carbamoyl phosphate from ammonia
201
, type I (EC 6.3.4.16) or from 
glutamine, type II (EC 6.3.5.5)
222
 and bicarbonate and may be considered "external" to the cycle 
proper. CPSI is located in mithocondrial matrix, primarily in the liver and small intestine
223
 and 
requires N-acetyl-L-glutamate (NAG) as allosteric activator
223
, but also provides the skeleton for 
the synthesis of ornithine. It is encoded by CPS1 gene. CPSII is located in cytoplasm
224
 and needs 
of Zn
2+ 
as cofactor
225
. It catalyses the first three steps of the identified pyrimidine biosynthetic 
pathway, is present ubiquitously in mammalian tissues
226
. This enzyme is a part of a large 
trifunctional polypeptide, called the CAD complex, which also contains the next two enzymes of 
the pathway, aspartate transcarbamylase and dihydro-orotase
226
. CPS2 is encoded by CAD gene. 
Ornithine transcarbamylase (OTC) (EC 2.1.3.3) is located in the mitochondrial matrix and 
catalyses the formation of citrulline and inorganic phosphate from carbamoyl phosphate and L-
ornithine
227
. It is encoded by OTC gene and it was detected in liver
62
, small intestine
228
, lung
228
 and 
WAT
73
. This reaction is therefore a part of urea cycle and also involved in intestinal synthesis of 
citrulline, which is released into the circulation. The proximal tubules of the kidneys take up most 
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of the circulating citrulline, which is then converted within the kidney to arginine and again released 
into the circulation
229
. 
 Argininosuccinate synthetase (ASS) (EC 6.3.4.5) and argininosuccinate lyase (ASL) (EC 
4.3.2.1) are cytosolic enzymes responsible for the biosynthesis of arginine from citrulline (and 
aspartate as a co-substrate). In detail, ASS synthesizes (N(omega)-L-arginino)succinate from L-
aspartate and L-citrulline. This enzyme exists in almost all organisms, because it is used by 
microorganisms to synthesize arginine. ASS is almost ubiquitous, with the higher levels found in 
the liver and the kidney while lowest levels are found in the intestine (in adults)
230
. Enzyme's 
regulation essentially acts on the expression of the ASS gene, since there is neither post-translational 
modification nor catalytic kinetic control
153
. Mechanisms of gene regulation differ greatly between 
tissues
230
. Gene expression in the liver is modulated by hormones and nutritional status: 
glucocorticoids, glucagon and glutamine increase ASS levels, whereas insulin, growth hormone and 
oleic acid decrease them, and the underlying mechanisms of this modulation have not been clearly 
established. Also, the regulating factors in the kidney are not yet known. In endothelial cells, the 
regulation of ASS expression seems to be closely related to the NOS expression
230
.  
ASL catalyzes the reversible breakdown of argininosuccinic acid into arginine and fumarate. 
ASL is expressed constitutively or inducible in many different cell types, but their degree of 
expression and the efficiency of their catalytic pathways vary between different tissue types
229
. This 
enzyme is encoded by ASL gene.  
The last enzyme of the cycle is arginase (ARG) (EC 3.5.3.1) responsible to hydrolyze L-arginine 
to the products L-ornithine and urea. In mammals, two arginase isoenzymes (arginase I and II) 
exist. They catalyse the same biochemical reaction but differ in cellular expression, regulation and 
subcellular localization; furthermore they are encoded by two different genes ARG1 and ARG2. 
Although arginase I in healthy adult mammals is expressed almost exclusively in the liver, it has 
recently been found to be highly induced in many tissues and cell types following exposure to a 
variety of cytokines and other agents
231
. We have found that this isoenzyme is also present in 
significant amounts in adipose tissue, completing a functional urea cycle in that disperse organ
134
. 
Arginase II protein is expressed as a mitochondrial protein in a variety of peripheral mammalian 
tissues, most prominently in kidney, prostate, small intestine and the lactating mammary gland.  
Individual UC enzymes are present in many tissues
232,233,229
, specifically, significant levels were 
found in kidney and small intestine
234
 while a full operative UC has been described for liver
154
. 
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Inborn errors in any of these enzymes can result in insufficient ammonia detoxification, leading 
to hyperammonaemia
235
.  
UC enzymes undergo dietary and hormonal influence. It has been shown that activities of UC 
enzymes are highest in response to starvation and high protein diet and are reduced to lower protein, 
free protein
234,154
 diet or HFD
236
. Variations in amino acid composition of dietary proteins have no 
effects on the enzyme activity. Increases in the enzyme activities generally correlate with increases 
in their corresponding mRNA levels, thus indicating that dietary regulation of enzyme level occurs 
primarily at a the expression level. Treatment with glucagon or cAMP analogs results in increased 
activities and mRNA abundance for the UC enzymes in rat liver and hepatoma cell lines
234
. 
Glucorticoids raise as well activities of UC enzymes in rat hepatoma cell lines, whereas precise 
correlations between enzyme activity and mRNA levels have not been determined.  
Insulin alone has little effect on mRNA urea cycle enzymes in hepatoma cell lines. Effects of 
growth hormone are unclear
234
. 
The UC represents one aspect of amino acid metabolism cantered around the amino acid L-
arginine and shares some enzymes with other pathways involved in arginine synthesis or catabolism 
as the citrulline-NO synthesis (Figure 16). In this pathway, arginine is converted into NO· by NOS 
(EC 1.14.13.39). NO· shows various biological functions such as neurotransmission, macrophage 
bactericidal and tumoricidal activities, and, as already mentioned, regulation of blood pressure. In 
addition to NO·, NOS yields citrulline that can be used to regenerate arginine by ASS and ASL. 
Thus, these three enzymes constitute a shunt or smaller cycle that can be regarded as bypassing the 
ornithine cycle. 
Three isoforms of NOS have been identified so far: neuronal or brain constitutive NOS (nNOS), 
vascular endothelial constitutive NOS (eNOS), and inducible NOS (iNOS). These enzymes are 
remarkable for three different reasons: for the rapidity with which they have been characterized, 
purified and cloned, for the complexity and number of reactions carried out by a medium-sized 
subunit of 125-155 kDa, albeit probably as a homodimer, and for the number and range of 
physiological and pathological roles in which they are involved
237
.  
nNOS was the first enzyme to be purified and cloned in rat. This enzyme, encoded by NOS1 
gene, is highly distributed in brain. Whereas eNOS, encoded by NOS3 gene, is probably responsible 
for the NOS activity of vascular endothelium in blood vessels
237
. Moreover, immunohistochemistry 
has revealed the presence of eNOS immunoreactivity in human lung, liver and skin blood vessels
237
. 
Introduction 
 
37 
nNOS and eNOS are clearly Ca
2+ 
and calmodulin-dependent
237
. The third type, the iNOS is Ca
2+ 
and calmodulin independent and its expression can be induced in many cell types with suitable 
agents such as bacterial LPS, cytokines, and other compounds
238
. This enzyme is encoded by NOS2 
gene 
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This thesis belongs to a wider line of research developed by the Nitrogen and Obesity Research 
Group which main goal was, and still, is to improve our knowledge of the physiologic, biochemical, 
and molecular mechanisms responsible of the onset and maintenance of obesity and to find novel 
ways to fight this disease. Group's main lines of research are: 
 investigation of the mechanisms controlling body weight that are responsible of the MS-
related diseases (obesity, diabetes, hyperlipidemia, etc); centred mainly in the splanchnic
bed and adipose tissue;
 the study of metabolism and endocrine regulation of WAT and BAT;
 general study of amino acids metabolism, using animal models.
My thesis project was conducted in parallel with another one lead by my companion of 
researches, Dr. Sofía Arriarán. Her research was focused on WAT, while mine was centred on the 
splanchnic bed. During our laboratory work, we took care, conjointly, of the animals used for our 
experiments and we developed ex novo some of the enzyme assays presented in our 
works
62,73,134,201,222,239
. We also carried out all experiments, statistical analysis and contributed to the
articles' writing and reviewing. The enzymatic essays that I developed are described more 
extensively in the Methods section.  
The ability of the organism to metabolize amino acids depends also on the amount, absolute and 
relative, amount of protein ingested in the diet. The outcome of the catabolic utilization of amino 
acids is urea production. So, diets with different content of protein might influence the hepatic 
capacity to produce urea, as much for the availability of amino acids coming from intestine as for its 
utilization from the liver.  
For these reasons, our hypothesis is that the liver ability to produce urea is essentially conditioned 
by:  
 the availability of dietary amino acids, related the intestinal capacity to metabolize them;
 the diet and hormonal environment that influence the activity of enzymes involved in the
metabolism of amino acids;
 the plasma levels of amino acids that reflect the interaction of amino acids with tissues.
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The main objective of this thesis was to investigate the effects of diets with different 
composition of macronutrients and the relationship between lipid/protein on energy partition and 
the amino acid metabolism of young adult rats of both sexes. This thesis was centered on the role of 
liver to produce urea in adult rats and the contribution of small intestine to the metabolization of 
amino acids. In the first case, the investigation was conducted using an obesogenic hyperlipidic, 
highly palatable diet, the "cafeteria diet" (CAFD). Its administration for a limited period of time 
simulates a pre-MS situation in which the immediate effects of the high-energy diet are less 
complicated by the additional disorders elicited by severe inflammation
240
. The study was done 
using rats of both sexes. We investigated, as well, the effect of these diets on blood flow 
distribution. In the second case, the investigation was carried on subjecting male rats to a HPD.  
To fulfill the objective, the changes produced on body composition, plasma parameters used as 
general markers of metabolism, quantitative and qualitative distribution of plasma amino acids, 
activity and expression of enzymes of splanchnic metabolism of rat were measured, compared and 
evaluated. 
The experiments conducted on liver (and WAT) were performed on Wistar rats, males and 
females, while the experiments conducted on small intestine and balances were performed on 
Zucker rats. We used two different rat strains to carry out the experiments because the initial 
experimental planning requires the comparison of genetic and dietary obesity. The decision to 
analyze only the dietary obesity on Wistar rat and not only on Zucker lean (Fa/-) was essentially a 
limitation due to time and the availability of funds. Consequently, the project was not completed in 
time to be part a completed of this thesis. 
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Specific methodological work 
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3.1 Development of methods for the determination of ornithine 
carbamoyl transferase and argininosuccinate synthase activities in 
rat tissues 
 
 
 
 
 
 
 
1 
 
Development of methods for the determination of ornithine carbamoyl 
transferase and argininosuccinate synthase activities in rat tissues. 
 
1. Introduction 
 
The urea cycle (Figure 1) transforms toxic ammonia into urea, a nontoxic metabolite, which 
urinary excretion poses no difficulties. In order to complete the measurement of the activity of all 
enzymes of urea cycle, we had to adjust/develop a number of viable specific methods not directly 
available. In particular, along the work described in the accompanying papers, it was necessary to 
develop assays for the evaluation of ornithine carbamoyl transferase (OTC) and argininosuccinate 
synthase (ASS) activity. Since the development of an assay for the second enzyme was more 
complicated than expected, the final steps of this development were done in collaboration with my 
companion in the Lab, Sofía Arriarán. In parallel to my work on OTC and ASS, she 
adjusted/developed methods to measure the activities of carbamoyl-P synthases, 1 and 2
1
 and 
argininosuccinate lyase (ASL). The method used for the measurement of arginase activity was 
already described
2
, but was, nevertheless, refined for our purposes. 
 
 
Figure 1: The urea cycle. Abbreviations: NAGS, N-acetylglutamate synthase; CPS, carbamoyl -P synthase; OTC, 
ornithine carbamoyl transferase; ASS, argininosuccinate synthase; ASL, argininosuccinate lyase; ARG, arginase; 
ORNT1, the mitochondrial ornithine transporter; AGC, aspartate-glutamate carrier; NOS, nitric-oxide synthase. From 
Lanpher et al.
3
 
2 
2. Ornithine carbamoyl transferase
OTC (EC 2.1.3.3) is a condensing enzyme of urea cycle, it is localized to the mitochondrial 
matrix and catalyzes the synthesis of citrulline from ornithine and carbamoyl-P in an ordered 
reaction as shown below: 
In all eukaryotes examined, the enzyme is a trimer with an approximate molecular weight of 38 
kDa; chemical evidence indicates that the subunits are identical in amino acid composition and 
sequence
4
. Like most mitochondrial enzymes, the enzyme is encoded by a nuclear gene (Otc),
synthesized outside the mitochondria and then transported into the organelle. It is expressed in a 
large variety of organisms from bacteria to mammals, mainly in hepatocytes and in epithelial cells 
of the intestinal mucosa
5
, nevertheless is not an abundant protein, making up only the 0,5-1 % of the
total mitochondrial proteome
6,7
.
The enzyme is regulated both by nutrients and hormones. In liver, OTC activity is highest in 
response to starvation and high protein diets and reduced to response to low protein or protein free 
diets. In small intestine, OTC activity decreases when dietary protein content increases. Variations 
in amino acid composition between different dietary proteins sources have little or no effects on its 
activity. Levels of OTC mRNA in liver and small intestine, are modestly or no affected by 
treatment with glucagon, dexamethasone, glucocorticoids, growth hormones and insulin
8
.
The main assay procedures for OTC activity fall into two general categories: colorimetric 
and radiochemical procedures. The first types measure the amount of citrulline produced through 
chemical-colorimetric procedures. The second ones rely on the separation of both citrulline and 
ornithine and on the measure of their radioactivity, as depicted in the Materials and methods 
section. Colorimetric procedures for citrulline rely on the formation of coloured complexes of 
citrulline, dyacetyl-monoxime and phenazone
9
. We decided not to use this procedure because the
colour complex is light-sensitive and diacetyl-monoxime also reacts with carbamido compounds 
other than citrulline, such as urea. The use of urease may correct this problem but, in doing so, may 
elicit further complications in the methods because is demonstrated that OTC is present in urease 
used as reagent in the enzyme activity measurement
10
.
3 
2.1. Materials and Methods 
A radiochemical method for measuring OTC activity was devised. The idea was to use 
14
C- 
carbamoyl-P or 
14
C-ornithine to generate 
14
C-citrulline. In first attempt, we tried to generate 
14
C- 
carbamoyl-P using 
14
C-KOCN (Hartmann analytic GmbH, Braunschweig-Germany) according to
the reaction: 
Equimolar amounts of KH2PO4 and KOCN containing 
14
C-KOCN were incubated at 37°C for 60
minutes to synthesize of 
14
C- carbamoyl-P. Then, the medium was neutralized with equimolar 
amounts of LiOH and HClO4 to promote the precipitation of Li3(PO4) and KClO4. The 
14
C label
should remain in the supernatant, with carbamoyl-P. The precipitate was removed by centrifugation 
at 4°C for 20 minutes at 13,000xg. In order to obtain a more complete precipitation and a good 
degree of purity, three volumes of chilled absolute ethanol were added to one volume of supernatant 
and left 4 hours at 4°C; then, the tubes were centrifuged again as described above. The final 
supernatant was recovered and dried under a gentle flow of nitrogen. The incorporation of 
14
C- 
carbamoyl-P to 
14
C-citrulline was measured as described by Goldstein and others
11
 with some
modifications. The 14C-citrulline label was measured with  a scintillation counter.  Unfortunately, 
under these settings, part of the 
14
C- carbamoyl-P was unused as carbamidic residue donor. This
was checked through paper chromatography: breakup of carbamoyl-P implies the release of 
phosphate. Thus, samples of the incubated cocktail were run on Whatmann #1 paper, using TRIS 
50mM, pH 8 as mobile phase, using sodium ortophosphate as standard. The dried chromatogram 
was sprayed with 600 g/L perchloric acid: 1N-HCL: 40 g/L ammonium molybdate: water 
(5:10:25:60 by volume). Yellow spots should indicate the presence of inorganic phosphate
12
.
The next attempt implied the analysis of the reaction rate starting with 
14
C-ornithine to 
obtain labelled citrulline. Using this approach, we tested thin layer chromatography (TLC) on 
plastic-backed silicagel sheets (SIL N-HR UV254 Macherey-Nagel GmbH, Co. KG-Germany) to 
separate a mixture of non-labelled amino acids and and so to find a good separation system; i.e. 
quite different Rf values for ornithine and citrulline. Sheets of 20x20 cm were used. Vertical lines 
were etched on the silicagel layer at 2 cm intervals to avoid mixing of samples. The samples were 
applied in successive depositions, altered with drying the spots with a hand-held hair dryer, on a 
line 2 cm far from the bottom of the sheet and covering the width of a lane. The eluent used was a 
50 mM tris buffer pH 7,5. Amino acids were revealed in the dry chromatograms with a 2.5 g/L 
ninhidrine in acetone spray
13
; the purple spots were enhanced by heating the sprayed chromatogram
with a hair dryer (Figure 2). After this trials, we started to perform the OTC essay. OTC was 
4 
measured used the incubation conditions described by McLaren and Ng
14
 with some modifications.
Frozen tissue samples were weighed and homogenized (1g/10 ml) in chilled 70 mM hepes buffer 
pH 7.4, containing 1 mM dithiothreitol, 50 mM KCl 1g/L Triton-X-100 and 1 g/L defatted bovine 
serum albumin using a mechanical tissue disruptor (IKA-T10 basic Ultra-Turrax, IKA, Staufen 
Germany). The assay mixture consisted of 70 mM hepes, pH 7.4 containing 50 mM KCl, 7 mM 
MgCl2, 20 mM unlabeled ornithine HCl, 14 mM carbamoyl-P, and 1 KBq/ml of labeled ornithine 
(Perkin Elmer Waltham, MA,USA). 
Figure 2 Dry chromatogram of no labeled amino acids revealed with a 2.5 g/L ninhidrine in acetone spray
13
.
Abbreviations: Orn, ornithine, Cit, citrulline 
The total volume of the complete assay mixture was 75 µl: 50 µl of assay mixture plus 25 µl of 
homogenate. The final concentrations in the reaction mixture were 47mM hepes, 33 mM KCl, 5mM 
MgCL2, 13 mM ornithine, 9 mM carbamoyl-P, and 1 KBq/ml of labeled ornithine. The usual 
procedure was to pipet  50 µl of the assay mixture into 1.5-ml Eppendorf tube for each sample and 
time of incubation. The tubes were incubated at 37°C in a dry block heater. The reaction was started 
by the addition of the homogenates. At time intervals, 100 µl of chilled acetone was added to the 
incubation tubes to stop the reaction. The time 0, was obtained when 100 µl of chilled acetone was 
added to the incubation tubes before adding the homogenate. After centrifugation at 5,000xg for 3 
minutes, the supernatants were transferred to plastic tubes and dried out in a vacuum-centrifuge 
concentrator (Speedvac, Jouan, Saint-Herblain, France). This way, the product of the reaction was 
concentrated at the bottom of the tube. This was dissolved in 25 µl of distilled water and the 
solution was used for TLC. In each TLC sheet a reference standard of labelled ornithine (1 KBq/ml) 
was included. The chromatogram is represented in figureFigure 3. A mixture of trichloromethane: 
methanol: acetic acid (1:2:2 by volume) was used as mobile phase to develop the cromatography. 
After development, the front was marked with pencil and the sheets were dried. Once dried, the 
5 
sheets were also marked horizontally and each lane was separated and horizontally cut in 1 cm 
serial cuts  from origin (included) to front. 
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Figure 3 Example of a chromatogram of labelled ornithine used as blank in silica gel sheets with a mixture of 
trichloromethane: methanol: acetic acid (1:2:2). Cm indicates the distance from the line of the deposition and the 
dpm indicates the disintegrations per minute encountered in that point.  
The pieces of sheets were placed into scintillation vials and counted. An example of chromatogram 
is shown in Figure 4. To limit interferences, the label in the citrulline area was expressed as a 
percentage of the total label counted in each TLC lane. These data allowed the calculation of newly 
formed citrulline; the value for each sample was plotted and was considered to be an expression of 
Vmax under the conditions tested. Protein content in each of the homogenates used for enzyme 
analysis was estimated with a colorimetric method
15
 and the enzyme activity was referred to the
homogenate protein content. 
If no specified, chemicals and compounds used for this experiment were obtained from Panreac 
(Castellar del Vallès, Barcelona, Spain) or from Sigma (St Louis, MO, USA). 
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Figure 4 Example of a chromatogram of the conversion of ornithine to citrulline of  rat liver homogenate. Each 
colour represents a different time of incubation. The first peak indicates labelled ornithine as shown in figure 3 and the 
second one represents the citrulline yeld. Cm indicates the distance from the line of the deposition of the sample and the 
dpm indicates the disintegrations per minute encountered in that point. 
3. Argininosuccinate synthase
Argininosuccinate synthase (ASS) (EC 6.3.4.5) catalyses the reversible ATP-dependent 
condensation of citrulline with aspartate to form argininosuccinate (AS): 
The mammalian enzymes have very similar properties and have a homo-tetramer structure, with 
a subunit size approximately of 46 kDa. The enzyme was first identified in the liver
16
 as the limiting
enzyme of the urea cycle, but most recently has been recognized as a ubiquitous enzyme in many 
mammalian tissues. The discovery of the arginine-citrulline nitric oxide synthesis pathway (Figure 
65) has increased the interest in this enzyme, which represents also a potential limiting step in the
NO synthesis. The highest ASS enzyme activities were found in the liver and kidneys
17
 and were
lower in the small intestine; these results have been confirmed later with expression data, both at the 
mRNA and protein levels
18
. The enzyme was initially described as a cytosolic in the liver
17
, but
posterior studies revealed that the enzyme is linked in part to the outer membrane of mitochondria
19
.
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Figure 5 Schematic representation of the three major functions of ASS in the mammalian organism. 
Abbreviations: CPS-I, carbamoyl-P synthase-I; OTC, ornithine carbamoyl transferase; ASS, argininosuccinate synthase; 
ASL, argininosuccinate lyase; NOS, nitric oxide synthase. 
ASS intracellular location and its regulation are quite different questions, probably related. In the 
liver, where arginine is largely hydrolysed to form urea and ornithine, the ASS gene (Ass1) is 
highly expressed and both hormones and nutrients
20
 are the major regulating factors
21
.
Glucocorticoids, glucagon and insulin, particularly, control the expression of the gene during 
development and in the adult. Diet, specially protein intake, increase ASS expression, protein levels 
and activity
22
. In contrast, in cells producing NO, where arginine is the direct substrate in its
synthesis, the Ass1 gene is expressed at low levels. Proinflammatory signals seem to be the main 
factors regulating expression of this gene; it is assumed that regulation of Ass1 gene expression is 
mainly exerted at the transcriptional level, but the molecular mechanisms controlling the regulation 
of the enzyme are still poorly understood. 
3.1. Material and methods 
Most of the few articles published about ASS enzyme activity, measure its activity coupled with 
ASL, a cytosolic enzyme that breaks, reversibly, argininosuccinate to yield arginine and fumarate. 
No specific method for the analysis of ASS in animal tissues has been found in the literature, and 
thus we had to develop a specific individual method that allows differentiating the activities of ASS 
and ASL. This is an obvious requirement for the study of both the function and regulation of urea 
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cycle under different physiological conditions, independently of assumptions on which enzyme 
controls or is controlled when analyses conjointly. Trying to develop a specific method for the 
determination of ASS activity, we encountered considerable methodological difficulties that largely 
explain why this task was not accomplished previously by others. We tried a number of different 
methodological approaches, in part based on the combined methods, but in most cases the tests 
failed.  
Our first try was a radiochemical method. The idea was to use a 
14
C-labelled amino acid, either
aspartate or citrulline in order to generate 
14
C-AS. Using this general approach, different options
were successively tested. In the first instance, we tried the same approach used for OTC that is to 
say the separation of the labelled amino acids using TLC (silicagel plates) after the incubation of the 
tissue homogenates with the labelled precursor, taking, as reference, the conditions described in 
papers 
23,24
. Using this approach, we tested TLC to separate a mixture of non-labelled amino acids,
to find a good separation system; i.e. quite different Rf values for citrulline, aspartate and AS. The 
conditions used were the same explicated above for OTC (Figure 6). 
Figure 6 Dry chromatogram of no labelled amino acids revealed with a 2.5 g/L ninhidrine in acetone spray
13
.
Abbreviations: Asp, aspartate; Cit , citrulline; ArgSucc,argininosuccinate; Mix, mixtures 
Considering that a quite different rf was obtained for citrulline, we decide to use this as labelled 
amino acid. Frozen tissue samples were weighed and homogenized in the same conditions 
explained for OTC. The assay mixture consisted of 70 mM hepes, pH=7.4 containing 50 mM KCl, 
7 mM MgCl2, 2 mM ATP, 13 mM unlabeled citrulline HCl, 9mM aspartate and about 1 KBq/ml of 
labelled citrulline (Perkin Elmer Waltham, MA -USA). The total volume of the complete assay 
mixture was 75 µl: 50 µl of assay mixture plus 25µl of homogenate, so the final concentrations in 
the reaction mixture were 47 mM hepes, 33 mM KCl, 5mM MgCl2, 1.3 mM ATP, 10 mM citrulline 
9 
and 6 mM aspartate . The procedure was exactly the same employed for OTC. In this case, a 
reference standard of 1 kBq/ml of labelled citrulline was included (Figure 7). 
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Figure 7 Example of a chromatogram of labelled citrulline used as blank in silica gel sheets developed with a 
mixture of trichloromethane: methanol: acetic acid (1:2:2). Cm indicates the distance from the line of the deposition 
and the dpm indicates the disintegrations per minute encountered in that point. 
Various solvent mixtures with different polarity were tested to determine the best method for the 
complete separation of AS and citrulline. 
The mixtures tried were: 
 trichloromethane: methanol: acetic acid (1:2:2 by volume) (Figure 8 plot A);
 1-butanol:methanol:ammonium hydroxide: water (33:33:24:10 by volume) (Figure 8 plot
B);
 2-propanol: metanol:ammonium hydroxide: water (33:33:24:10 by volume) (Figure 8 plot
C).
After development, the procedure followed was the same for OTC. The pieces of plates were placed 
into scintillation vials and counted. Unfortunately we didn't find any good mixtures giving us a 
complete separation of AS and citrulline (Figure 8). The desirable result was obtaining two peaks as 
achieved for OTC (Figure 4). 
As we didn’t get this result, after several tries, we followed another strategy. In an intent to 
use most of the information available for coupled enzyme analyses, we decided to measure the 
enzyme activity coupled with an excess of purified ASL to finally yield arginine and fumarate from 
the argininosuccinate formed in the ASS reaction. The problem was the absence, in the market, of 
adequate purified ASL enzyme to be used in a coupled reaction. Thus, we tried to purify it from a 
material rich in this enzyme activity: cotyledons of germinating pea seeds
25
.
Seeds of Pisum sativum L. cv. Onyx were bought in a grocery store; they were soaked in tap water 
and allowed to germinate by transferring them subsequently to moist filter paper in large pots in 
darkness at 23°C for the appropriate time. We ground about 12 g of cotyledons in a mortar and 
10 
pestle with 5 to 8 g of sand and 20 ml of extraction medium containing 400 mM mannitol, 50 mM 
morpholinopropane sulfonic acid buffer (pH 7.4), and 2.5 g/L defatted bovine serum albumin. After 
screening in a mesh (width 45 µm), the homogenate was centrifuged at 2,500xg for 5 minutes. The 
pellet obtained after centrifugation of the 2,500xg supernatant at 40,000xg for 10 minutes, was re-
suspended in extraction medium. Five ml of the 40,000xg supernatant were passed through a 
Sephadex G-25 column (9 x 1.5 cm), equilibrated with 50 mm K-phosphate buffer (pH 7.5). 
Protein-containing fractions of the eluate were collected. 37 µl of the eluate was mixed with an 
equal volume of AS. The tubes were incubated at 37°C for 15 minutes in a dry block heater. Then, 
95 µl of chilled acetone was added to the tubes to stop the reaction. For time 0, 95 µl of chilled 
acetone was added to the incubation tubes before adding the AS. After centrifugation at 5,000xg for 
10 minutes, the supernatants were transferred to plastic tubes and dried out with a gentle flow of 
nitrogen. Once dried, 650 µl of distilled water was added and the absorbance was read at 240 nm. If 
ASL had been presented in the eluate, it would have had to break the AS and to give fumarate and 
arginine (Figure 1). Reading the absorbance, we would have had to detect the presence of fumarate 
which absorption wave length is 240 nm. The measurement of ASL activity was even done on 
concentrated extract before passing it through the column. After considerable effort, several 
germination cycles, tries at extraction and separation by centrifugation followed by molecular size 
sieving with the Sephadex column, the idea was abandoned when the measurements of ASL activity 
in the concentrated extracts was barely higher than that of our samples. Most likely, the problem 
was that the purification step was not sufficiently precise to yield a pure enzyme (with enough 
specific activity and devoid of other urea cycle enzymes (ASS itself, AS). In any case, we tested the 
coupled reaction with liver samples, measuring the fumarate evolved with malate dehydrogenase, as 
in the measurement of ASL activity, and found no changes in NADH because of inadequate 
conditions, insufficient enzyme activity or other causes. Thus, we decided not follow this path and 
try other more promising avenues. 
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Figure 8 Example of chromatograms of the conversion of citrulline to arginosuccinate of a rat liver homogenate. 
Each colour represents a different time of incubation. In the plot A, the eluent used was a mixture of trichloromethane: 
methanol: acetic acid (1:2:2 by volume); in the plot B, the eluent used was a mixture of 1-butanol:methanol:ammonium 
hydroxide: water (33:33:24:10 by volume); in the plot C, 2-propanol:metanol: ammonium hydroxide: water 
(33:33:24:10 by volume).Cm indicates the distance from the line of the deposition of the sample and the dpm indicates 
the disintegrations per minute encountered in that point. The desirable result was obtaining two different peaks as 
shown in figure 4. 
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The next procedure tested was an enzymatic/radiochemichal method using 
14
C-Aspartate (Perkin
Elmer Waltham, MA -USA) in presence of α-ketoglutarate in order to generate 14C-oxaloacetic acid
by aspartate transaminase. Frozen tissue samples were weighed and homogenized in the same 
conditions explained above for OTC. The assay mixture consisted of 70 mM hepes, pH=7.4 
containing 50 mM KCl, 7 mM MgCl2, 2 mM ATP, 13 mM citrulline HCl, 9mM unlabelled 
aspartate, 12 mM α- ketoglutarate and about 1 KBq/ml of labelled aspartate. The total volume of the 
complete assay mixture was 75 µl: 50 µl of assay mixture plus 25µl of homogenate, so the final 
concentrations in the reaction mixture were 47 mM hepes, 33 mM KCl, 5mM MgCL2, 1.3 mM 
ATP, 10 mM citrulline and 6 mM aspartate and 9 mM α-ketoglutarate. The usual procedure was 
pipet 50 µl of the assay mixture into 1.5-ml Eppendorf tube for each sample and time of incubation. 
The tubes were incubated at 37°C in a dry block heater. The reaction was started by the addition of 
the homogenates. At time intervals, 0.08 U of aspartate transaminase was added to the incubation 
tubes to generate 
14
C-oxaloacetic acid from the remaining labelled aspartate. The reaction was 
allowed to develop for 20 minutes and stopped with 1 ml of ethanol. After centrifugation at 2,000xg 
for 5 minutes, the supernatants were transferred to plastic tubes and dried out with a gentle flow of 
nitrogen. Both pellet and supernatant were dissolved in scintillation liquid and counted. After 
several tries, the idea was abandoned after encountering all radioactivity in the pellet and not in the 
supernatant where 
14
C-oxaloacetic would have had to be.
The next procedure tested was the removal of the amino acids remaining free at the end of the 
incubation (i.e. not incorporated into AS) by means of their oxidation to nitrogen gas and hydroxy-
amino acids using just formed nitrous oxide
26
. Firstly, we tried this procedure without tissue
homogenate. The assay mixture consisted of 70 mM hepes, pH=7.4 containing 50 mM KCl, 7 mM 
MgCl2, 2 mM ATP, 13 mM citrulline HCl, 9mM unlabelled aspartate and about 1KBq/ml of 
labelled aspartate. We prepared 2M NaNO2 and 2.5 M HCl, we mixed equal volumes of them in 
order to generate nitrous acid. 5 µl of this mixture, just prepared, was added to 70 µl of the assay 
buffer in a 1.5 ml eppendorf, shacked and left at room temperature for 1 minute. The reaction was 
complemented with the selective separation of labelled 2 OH-butanodioic formed from aspartate by 
precipitation the latter with ethanol. After centrifugation at 2,000xg for 5 minutes, we counted 
supernatant and pellet. Because of we encountered the radioactivity in the pellet, we supposed that 
the 2OH-butanodioic was soluble in absolute ethanol. So, we tried the same experiment using 
unlabelled AS. The assay mixture consisted of 50 mM phosphate buffer, pH=7.5 containing 10 mM 
AS. 5 µl of the mixture NaNO2/HCl, just prepared, was added to 70 µl of the assay buffer in a 1.5 
ml eppendorf, shacked and left at room temperature for 1 minute. The reaction was complemented 
with the selective separation of the 2 OH-acids formed from AS by precipitation with ethanol. 
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Looking carefully at the tube and after several tries, it looked like the 2 OH-acids formed from AS 
wasn't soluble in absolute ethanol because a compound was visible at naked-eye. This way, we 
thought that we could take advantage of the different solubility in ethanol of hydroxy-amino acids 
(labeled) produced. As we assumed that the oxidation product of AS (or the amino acid itself) were 
not soluble, thus, we expected to collect 2OH-butanodioic in the supernatant after centrifuging out 
all label incorporated into AS. Since we were not sure what was the product(s) formed in the 
oxidation of AS, we considered more reasonable to measure the label "lost" in the aspartate pool 
than to measure that incorporated into the AS (assumedly spin-off in the precipitate). We tried this 
approach with liver homogenates. Frozen tissue samples were weighed and homogenized in the 
same conditions explained for OTC. The assay conditions and procedure were the same explained 
above in the experiment without homogenates. As the measurement of radioactivity didn't give the 
results foreseen, we modified the temperature of exposure of the sample to nitrous acids as 
suggested by Schmidt 
27
. We left the sample reacting with nitrous acids for 1 minute at 37°C. The
actual measurements of radioactivity obtained, however, did not stand to our theory, since there was 
a wide variation in radioactivity levels and most of it was found in the precipitate anyway. 
Afterwards, it was assumed that probably, under the conditions tested, the newly formed AS was 
broken up by the homogenate-native ASL and/or solubility in ethanol of the products of oxidation 
of AS, and both hydroxy and amino acids were largely insoluble in ethanol. 
At this point, we thought that the best way to find a good procedure was using a 
radiochemical method adopted in the first try. So, we repeat the first experiment with some 
differences. We employed labelled aspartate and not citrulline and we stopped the reaction with 10 
µl of 90% trifluoroacetic acid. We decided to test again a TLC to separate a mixture of non-labelled 
amino acids, to find a good separation system; in this case, we used the three different eluents 
explained above. The conditions of exposure were the same depicted above. As shown in Figure 10, 
the mixture that allow achieving the best separation was: trichloromethane: methanol: acetic acid 
(1:2:2 by volume). In this case, a reference standard of labelled aspartate (1kBq/ml) was included 
(Figure 10 plot A). Unfortunately, doing the experiment with liver homogenates, we didn't get a 
good separation (Figure 10 plot B). As we supposed that the presence of ASL in the homogenates 
could be a limiting factor, we tried to stem-off this problem by adding a large concentration of urea 
(300 mM) to the incubation buffer, because it can inhibits ASL
28
. Even this last try was not
successful because we didn't get a good separation. 
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Figure 9 Dry chromatograms of no labelled amino acids revealed with a 0.25% ninhidrine in acetone spray
13
. For 
the chromatogram A the eluate used was trichloromethane: methanol: acetic acid (1:2:2 by volume); for the 
chromatogram B the eluate used was 1-butanol:methanol: ammonium hydroxide: water (33:33:24:10 by volume); for 
the chromatogram C the eluate used was  2-propanol:metanol: ammonium hydroxide: water (33:33:24:10 by volume). 
Abbreviations: Asp, aspartate; Cit, citrulline; ArgS, argininosuccinate; Mix, mixtures. 
Figure 10 Plot A: example of a chromatogram of labeled aspartate used as blank in silica gel sheets. In the plot A, 
the eluent used was a mixture of trichloromethane: methanol: acetic acid (1:2:2 by volume). 
Plot B: example of chromatograms of the conversion of citrulline to arginosuccinate of a rat liver homogenate. 
Each colour represents a different time of incubation. Cm indicates the distance from the line of the deposition and the 
dpm indicates the disintegrations per minute encountered in that point. 
Considering the difficulty to isolate labelled AS and because of this strategy of labelling AS 
didn't give the expected results we decided to follow another strategy: measuring the decreasing of 
the labelled amino acids used for the synthesis. Thus the focus of the analysis was shifted to the use 
of a different approach, forfeiting 
14
C-labelling and reverting to biochemical methods of 
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measurement of metabolites instead. Reviewing bibliography in order to find a valid method for 
measuring of ASS, we found an article
29
 deals with studies about enzyme sequence mediating 
arginine synthesis in Saccharomyces cervisiae. One of this is ASS.  We decided to use the condition 
of incubation described in the article with some modifications in order to measure the decreasing of 
quantity of aspartate in the reaction. Particularly, we measured the remaining amino acid by means 
of a coupled reaction, transamination to oxaloacetate and reduction of oxaloacetateto malate with 
NADH as shown below: 
 
To develop this method we needed several attempts, several modification in concentration of 
reagents and enzymes and several precautions with metabolites interferences and strategies to 
eliminate the high OD caused by homogenate, but at the end, the procedure worked properly. 
Considering the complexity of the experiment, we decide to split it in two phases. 
 
Phase I: incubation to form AS 
Frozen tissue samples were weighed and homogenized in the same condition of homogenization 
explained above. The assay mixture consisted of 70 mM hepes buffer at pH 7.4, containing 100 mM 
citrulline, 168 mM ATP, 84 mM MgCL2, 12.4 mM aspartate. The total volume of the complete 
assay mixture was 85 µl: 3 µl of citrulline, 5 µl of ATP, 5 µl of MgCL2, 55 µl of homogenate and 
17 µl of aspartate. This resulted in final concentrations of: 3 mM ctrulline, 10 mM ATP, 5mM 
Mg
2+
, and 2,5 mM aspartate. The usual procedure was to pipet citrulline, ATP, MgCL2 and 
homogenate into 1.5-ml Eppendorf tube for each sample and multiplied the volume for the number 
of incubation time tested. The reaction was started with aspartate and was carried out at 37°C in a 
dry block heater. At defined time intervals, the reaction was stopped with 40 µl of 30 g/L HCLO4. 
To set the time 0, 40 µl of the acid was added to the incubation tubes before adding the aspartate. 
The tubes were vortexed and neutralized (pH 7-8) with 10 µl of 100g/L KOH containing 62 g/L 
KHCO3. This neutralization was necessary because the enzymes in the Phase II work at neutral pH. 
The tubes were maintained on ice during this process. Then, they were centrifuged at 8,000xg for 15 
minutes at 4ºC. The supernatants were transferred to a 1.5-ml Eppendorf tube and kept frozen at 
-20ºC until processed. 
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Phase II: measuring of remaining aspartate by means of aspartate transaminase and malate 
dehydrogenase. 
The assay mixture for this phase consisted of 66 mM phosphate buffer at pH 7.4, containing 3 mM 
NADH, 2.4 mM α-ketoglutarate. The total volume of the complete assay mixture was 225 µl: 25 µl 
of NADH, 25 µl of α-ketoglutarate, 175 µl of phosphate buffer. This resulted in final concentrations 
of 0.25 mM of NADH and 0.2 mM of α-ketoglutarate. The usual procedure was to pipet this 225 µl 
of mixture in each well and read the absorbance at 340 nm in a plate reader (Biotek, Winoosky, VT 
USA) in order to know the absorbance of NADH. After that, a volume of thawed supernatant of 
phase I, corresponding to 30 nmol of aspartate, was added and the absorbance was read again in 
order to know the absorbance of the sample. Then a mix composed by 50 µl of aspartate 
transaminase (1,2 UI/ml) (Roche Diagnostics, Basel, Switzerland) and 5 µl of malate 
dehydrogenase (1 UI/ml) (Roche Diagnostics, Basel, Switzerland) was prepared. The reaction starts 
when the enzymes are added to each well. The drop of absorbance was read during 20 minutes and 
at intervals of 30 seconds. The fall in NADH was used to determine the levels of aspartate at each 
incubation time. Its disappearance (versus time zero levels) was used to calculate the aspartate 
incorporated into arginino-succinate by the enzyme. As for OTC, protein content in each of the 
homogenates used for enzyme analysis was estimated with a colorimetric method and the enzyme 
activity was referred to the homogenate protein content. 
If no specified, chemicals and compounds used for this experiment were obtained from Panreac 
(Castellar del Vallès, Barcelona, Spain) or from Sigma (St Louis, MO, USA) . 
4. Discussion 
 
The aim of this investigation was to develop sensitive and feasible methods for OTC and ASS. 
For OTC activity, a radiochemical, reliable and economic method was developed. This method 
has got some advantages: it can be used in different tissues, it permits to avoid the employment of a 
non accurate colorimetric method, it employs the 14C-ornithine that has got a good stability in 
solution, it is developed by thin layer chromatography that guarantee the accountability of substrate 
and product, and then, it is characterized by the absence of significant amounts of radioactivity on 
the chromatograms in region other than those to which ornithine and citrulline migrate. 
For ASS activity, a new colorimetric method was developed. The main advantage was to 
measure the activity of ASS not coupled with the ASL one.  
Both methods presented have the advantage of simplicity; several samples can be analysed in 
parallel, requires a short time of incubation, repetitiveness, and requires minimal manipulation of 
the incubation medium.  
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Hyperlipidic diets limit glucose oxidation and favor amino acid preservation, hampering the elimination of excess dietary nitrogen
and the catabolic utilization of amino acids.We analyzedwhether reduced urea excretionwas a consequence of higherNO
𝑥
; (nitrite,
nitrate, and other derivatives) availability caused by increased nitric oxide production in metabolic syndrome. Rats fed a cafeteria
diet for 30 days had a higher intake and accumulation of amino acid nitrogen and lower urea excretion. There were no differences
in plasma nitrate or nitrite. NO
𝑥
and creatinine excretion accounted for only a small part of total nitrogen excretion. Rats fed a
cafeteria diet had higher plasma levels of glutamine, serine, threonine, glycine, and ornithinewhen comparedwith controls, whereas
arginine was lower. Liver carbamoyl-phosphate synthetase I activity was higher in cafeteria diet-fed rats, but arginase I was lower.
The high carbamoyl-phosphate synthetase activity and ornithine levels suggest activation of the urea cycle in cafeteria diet-fed rats,
but low arginine levels point to a block in the urea cycle between ornithine and arginine, thereby preventing the elimination of
excess nitrogen as urea. The ultimate consequence of this paradoxical block in the urea cycle seems to be the limitation of arginine
production and/or availability.
1. Introduction
Metabolic syndrome is a pathological condition, which devel-
ops from localized inflammation and is characterized by
the combination of a number of closely related diseases
(insulin resistance, obesity, hyperlipidemia, hypertension,
etc.) [1]. Administration of “cafeteria” diets [2] to rats has
been used as an animal model for the study of late-onset
hyperphagic obesity andmetabolic syndrome.Thismodel has
the advantage of being comparable to some human obesity
states induced by the excessive intake of energy-dense food [3,
4]. The effects of the cafeteria diet are more marked in males
[5, 6]; this may be because they have less anti-inflammatory
[7] estrogen protection than females. Low estrogen levels
render males more prone to be affected by glucocorticoids [8,
9], which in turn decrease the anabolic effects of androgens
[10, 11].
In rodents, prolonged exposure to a cafeteria diet results
in higher energy intake (mainly lipids) [5] and increased
body fat (obesity) but also affects lean body mass, favoring
growth and protein deposition [12, 13]. Although the hedonic
component of the cafeteria diet initially elicits an increase
in food consumption [14], once obesity is well established,
hyperphagia decreases to almost normal levels of food intake.
However, the large mass of accumulated fat remains, and
the metabolic consequences of excess energy intake—such as
insulin resistance and hyperlipidemia—persist [6, 15].
The study of nitrogen handling under hypercaloric diet
conditions has predominantly been limited to measuring
plasma amino acid levels [16–18], while less attention has
centered on pathways [19, 20] and nitrogen balances [21]. To
date, most research on dietary amino acid metabolism has
been directed toward the analysis of metabolic adaptation to
diets deficient in both energy and amino nitrogen [22–25] or
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has focused on specific regulatory pathways. Cafeteria diets
are suitable for the study of the effects of high-energy diets,
because total protein intake is practically unaffected by the
excess dietary energy (mainly lipids) ingested [5].
Dietary or body-protein amino acid nitrogen is spared
when other energy sources (such as fat or glucose) abound.
Thus, high-energy diet, such as the cafeteria diet, apparently
decreases overall amino acid catabolism, inducing a marked
decrease in the production of urea [26].The relative surplus of
2-amino nitrogen can maintain protein turnover and growth
[12], but the excess nitrogen must be excreted in some way.
The limited operation of the urea cycle suggests that there
may be more amino nitrogen available for the operation of
the nitric oxide (NO∙) shunt. Obese humans have been found
to excrete more nitrate than their lean counterparts, and loss
of NO∙ in expired air is proportional to body mass index
(BMI) [27]. In terms of nitrogen balance, it has been found
that cafeteria diet-fed rats show a higher “nitrogen gap,” that
is, the difference between nitrogen intake and the sum of its
accumulation and excretion in the urine and feces [21] than
control diet-fed animals.
The objective of the present study was to determine
whether cafeteria diet-fed rats show changes in the excretion
of nitrate/nitrite in comparison with age-matched animals
fed standard rat chow, investigating whether an increase in
the excretion of NO
𝑥
compensates for the decrease in urea
excretion.
2. Materials and Methods
2.1. Animals and Experimental Setup. All animal handling
procedures and the experimental setup were carried out
in accordance with the animal handling guidelines of the
European, Spanish, and Catalan Authorities. The Committee
on Animal Experimentation of the University of Barcelona
authorized the specific procedures used.This limited keeping
the animals in metabolic cages to a maximum of 24 h to
prevent unacceptable levels of stress.
Nine-week-old male Wistar rats (𝑁 = 12) (Harlan
Laboratories Models, Sant Feliu de Codines, Spain) were
used. The animals were randomly divided into two groups
andwere fed ad libitum, for 30 days on either normal rat chow
(Harlan 2014) (𝑁 = 6) or a simplified cafeteria diet (𝑁 = 6)
[21]. Both groups were housed in solid-bottomed cages with
three animals per cage, had free access to water, and were
kept in a controlled environment (lights on from 08:00 to
20:00, with a temperature of 21.5–22.5∘C; 50–60% humidity).
Body weight and food consumption were recorded daily.
Calculation of food ingested was performed as previously
described by counting the difference between food offered
and left, including the recovery of small pieces of food, and
compensating for drying [5]. The nitrogen content of the
rat chow and the different components used in the cafeteria
diet were measured with a semiautomatic Kjeldahl procedure
using a Pro-Nitro S semiautomatic system (JP Selecta, Abrera,
Spain).
On day 0 (i.e., the day before the experiment began)
and day 26, the rats were kept for 24 h in metabolic cages
(Tecniplast Gazzada, Buguggiate, Italy), recovering the urine
and feces. In the metabolic cages, all rats were fed only
standard rat chow and tap water, and their food consumption
was measured. Samples of excreta were frozen for later
analyses. Urine NO
𝑥
was estimated immediately to minimize
further oxidation andNO∙ losses, using a nitric oxide analysis
system (ISM-146NOXM system) (Lazar, Los Angeles, CA,
USA).
On day 30, rats were anesthetized with isoflurane and
then killed by exsanguination through the exposed aorta.
Blood plasma and tissue samples were obtained and frozen.
Liver samples were rapidly frozen in liquid nitrogen and
maintained at −80∘C until processed for enzyme analyses.
For tissues distributed widely throughout the body (i.e.,
subcutaneous adipose tissue), all the tissue was carefully
dissected and weighed. Hind leg muscle samples were cut
from the hind leg, obtaining part of the quadratus femoris,
biceps femoris, and semitendinosus muscle and a smaller
proportion of others.
2.2. Diet Composition. In the standard diet (Harlan 2014),
19.9% of energy was derived from protein, 13.8% from lipids,
and 65.8% from carbohydrates (10% from sugars).
The cafeteria diet included biscuits spread with liver paˆte´,
bacon, standard chow pellets, water, and milk supplemented
with 300 g/L sucrose plus 10 g/L of a mineral and vitamin
supplement (Meritene, Nestle´, Esplugues, Spain). All of these
compounds were provided fresh daily. From the analysis of
the diet components and the ingested items, we calculated
that a mean of 33% of energy was derived from lipids, 16%
of energy was derived from protein, and 51% of energy was
derived from carbohydrates (20% from sugars).
2.3. Body and Metabolite Analyses. Total body muscle mass
was estimated, as previously described [28], using the remain-
ing carcass. The method was based on the solubilization
of muscle actin and myosin with 1M LiCl and subsequent
precipitation of mainly myosin with distilled water, followed
by its estimation with a standard procedure.
Stool nitrogen was measured using the semiautomatic
Kjeldahl procedure described above. Nitrogen content and
nitrogen accrual were calculated by applying the body com-
position factors obtained from previous studies [3, 21] to our
experimental animals. These data are included as reference
values only for comparison. Urine urea was measured with
a urease-based test, and creatinine was measured with the
Jaffe´ reaction using commercial kits (BioSystems, Barcelona,
Spain).
Plasma was used for the analysis of glucose, total choles-
terol, triacylglycerol and urea (using kits from BioSystems,
Barcelona, Spain), nonesterified fatty acids (NEFA kit; Wako,
Richmond VA, USA), and L-lactate (Spinreact kit, Barcelona,
Spain). Nitrite and nitrate were measured with the Arrow-
Straight system. Plasma samples were used for amino acid
quantification after deproteinizationwith trifluoroacetic acid;
they were measured with ninhydrin, in a Biochrom 30 auto-
analyzer (Biochrom, Cambridge, UK), using L-norleucine as
internal standard, at the Scientific-Technical Services of the
University of Barcelona.
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2.4. Enzyme Assays. Frozen liver samples were homogenized
in chilled 50mM Krebs-Ringer phosphate buffer, pH 7.4,
containing 0.1% Triton X-100, 2.5mMmercaptoethanol, 0.1%
dextran, 5mM Na
2
-EDTA, and 0.5% bovine serum albumin
using amechanical tissue disruptor (IKA, Staufen, Germany).
Arginase I (EC 3.5.3.1) activity was estimated as described
elsewhere [29]. The method was based on the colorimetric
estimation of urea (Berthelot reaction) released by the action
of arginase on arginine. Homogenate protein content was
measured with a standard colorimetric method [30] against
blanks of the homogenization medium.
Other liver samples were homogenized in 50mM
triethanolamine-HCl buffer, pH 8.0 containing 1mM dithio-
threitol, and 10mM magnesium acetate. Carbamoyl-P syn-
thetase I (EC 6.3.4.16) activity was measured immedi-
ately after homogenization, as previously described [31],
by measuring the incorporation of labeled bicarbonate
(50 kBq/mmol) into carbamoyl-P in a medium containing
5mM ATP, 5mM N-acetyl-glutamate, and 0.05% bovine
serum albumin. Enzyme activities were expressed in katals
both in reference to the weight of fresh tissue and its protein
content.
2.5. Statistical Analysis. Statistical analysis was carried out
using one-way ANOVA, with the post hoc Bonferroni test,
and/or the unpaired Student’s t-test, using the Statgraphics
Centurion XVI software package (StatPoint Technologies,
Warrenton, VA, USA).
3. Results
Table 1 shows the body weights and nitrogen balance values
for control and cafeteria diet-fed rats at the beginning and
end of the study (day 27 for nitrogen data). As expected, the
increase in body weight was greater in cafeteria diet-fed rats
than in controls.The overall energy and nitrogen intake were
also higher in cafeteria diet-fed than in control rats.
In the period that the rats were kept in metabolic
cages, significant differences in nitrogen intakewere observed
between the groups, but not in urine or stool nitrogen
excretion.The proportion of urea excreted with respect to the
total daily nitrogen budget was lower in cafeteria diet-fed rats
than in controls on day 27 (65%versus 75%of nitrogen intake,
82% versus 94% of urea excreted, resp.). This difference was
not compensated for by creatinine and NO
𝑥
excretion, which
was low in comparison to urea, and showed slight changes
over time or with dietary treatment. Thus, although the data
on nitrogen balance was measured on different days, the
estimated “nitrogen gap” showed a wider margin for cafeteria
diet-fed rats than for controls.
The effects of diet on organweight on day 30 are presented
in Table 2. The only significant differences between the two
groups in organ weights were for muscle, stomach, heart, and
adipose tissues. The other organs showed remarkably similar
weights.
The plasma nitrate and nitrite concentrations are pre-
sented in Table 3. There were no significant differences
between control and cafeteria-fed rats for nitrate, nitrite,
or their sum. In both groups, however, nitrate was the
predominant component (>90%).
Table 4 shows the plasma amino acid concentrations of
the control and cafeteria diet-fed groups on day 30. The
similarity between the groups was remarkable, with only a
few amino acids showing significant differences. Cafeteria
diet-fed rats had higher levels of glutamine, threonine,
serine, glycine, and ornithine than controls, while the latter
showed higher levels of arginine with respect to the cafeteria
diet-fed animals. When analyzing the sums of concentra-
tions of groups of related amino acids, no changes were
observed for the combined concentrations of glutamate + glu-
tamine, aspartate + asparagine, branched-chain amino acids
(leucine + isoleucine + valine), or urea cycle intermediaries
(ornithine + citrulline + arginine).
The plasma concentrations of glucose, triacylglycerols,
total cholesterol, and urea for both diet groups (Table 5)
were similar, and all were within the normal range. These
concentrations were similar to data previously published by
our group, with no differences between the groups, except for
higher glucose and lower urea values in cafeteria diet-fed rats.
Figure 1 presents the measured activities of two key urea
synthesis enzymes in the livers of the control and cafeteria
diet-fed groups.The activity of carbamoyl-P synthetase I was
higher than that of arginase I in the cafeteria diet-fed group;
these rats had threefold higher activity rates for carbamoyl-P
synthetase I than controls. The results for arginase were the
reverse, since the control group had almost twice the activity
per unit of tissue weight than the cafeteria diet-fed group, and
this result was similar for protein and total tissue.
4. Discussion
The cafeteria diet is essentially hyperlipidic, with identical
mean protein and carbohydrate intakes to those of control
rats fed a standard diet [5]. As expected, a one-month
exposure to a cafeteria diet resulted in overfeeding and
increased body weight, leading to a greater increase in the
size of adipose tissue deposits and higher muscle mass than
in controls. These results are in agreement with previous
studies showing that, as with the hyperlipidic diets, a cafeteria
diet increases not only fat deposition and growth, but also
protein accrual [12, 21] and energy expenditure [32]. A
lower excretion of urea, irrespective of the maintained (or
increased) amino acid intake, was also observed, again in
agreement with previous studies [21, 26].
It has been postulated that a high-energy diet coupled
with normal or increased protein intake may hamper 2-
amino nitrogen elimination in rats, humans, and other
mammals [33]. This problem is largely a consequence of the
abundance of energy, mainly in the form of lipids, which is
used preferentially by muscle and other peripheral tissues
over glucose because of insulin resistance [34]. However,
amino acid oxidation is spared due to the availability of
energy, that is, in the form of glucose [35]; thus, is to be
expected that catabolism of dietary amino acids and, there-
fore, the production of ammonium from 2-amino nitrogen
should also decrease. Consequently, during this buildup,
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Table 2: Organ and tissue weights of male rats fed a cafeteria diet for one month compared with controls fed a standard rat chow diet.
Tissue/organ Control (g)(𝑛 = 6)
Cafeteria diet-fed
(g) (𝑛 = 6) 𝑃
Skeletal muscle 143 ± 4 164 ± 5 0.007
Skin 54.8 ± 1.14 55.5 ± 3.84 NS
Liver 9.86 ± 0.48 11.23 ± 0.38 NS
Small intestine 2.98 ± 0.22 2.90 ± 0.18 NS
Kidneys 2.14 ± 0.08 2.27 ± 0.06 NS
Brain 1.940 ± 0.073 1.884 ± 0.027 NS
Large intestine 1.46 ± 0.05 1.31 ± 0.06 NS
Lungs 1.418 ± 0.164 1.308 ± 0.041 NS
Stomach 1.265 ± 0.039 1.438 ± 0.054 0.023
Heart 0.936 ± 0.048 1.075 ± 0.024 0.027
Interscapular BAT 0.413 ± 0.042 0.442 ± 0.041 NS
Subcutaneous WAT 5.96 ± 0.69 9.11 ± 1.11 0.015
Mesenteric WAT 3.61 ± 0.52 3.86 ± 0.09 NS
Retroperitoneal WAT 2.58 ± 0.36 4.66 ± 0.36 0.002
Epididymal WAT 1.53 ± 0.26 4.43 ± 0.38 <0.001
Pericardial WAT 0.252 ± 0.047 0.311 ± 0.041 NS
Sum of five WAT sites 13.93 ± 1.89 22.23 ± 1.78 0.007
The values are the mean ± SEM for 6 different animals. BAT: brown adipose tissue;WAT: white adipose tissue. Statistical significance of the differences between
groups; 𝑃 was calculated with Student’s 𝑡 test.
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Figure 1: Carbamoyl-P synthetase I and arginase activities in the liver of rats fed a control or cafeteria diet for 30 days. CPS = carbamoyl-P
synthetase I. Control: white columns; cafeteria diet-fed: dashed columns.The values are themean± SEM for 6 different animals. Comparisons
between groups were established with Student’s t-test: ∗𝑃 < 0.05.
Table 3: Plasma nitrate and nitrite concentrations of male rats fed a
cafeteria diet for one month compared with controls fed a standard
rat chow diet.
Units Control Cafeteria diet-fed
Nitrite 𝜇M 3.4 ± 1.6 3.3 ± 1.3
Nitrate 𝜇M 48.0 ± 4.7 45.6 + 6.6
Nitrate % of total 94.5 ± 2.6 92.8 ± 2.8
NO
𝑥
total 𝜇M 51.4 ± 6.0 44.8 ± 7.3
The values are the mean ± SEM for 6 different animals. There were no
significant differences between the two groups (𝑃 > 0.05, Student’s 𝑡-test)
for any parameter. WAT: white adipose tissue, BAT: brown adipose tissue.
the mechanisms of amino nitrogen waste prevention surpris-
ingly create a surplus of available amino acids. The excess
of 2-amino nitrogen may be limited, in part, by increased
growth (e.g., increased muscle mass) and, to a lesser extent,
by increased protein turnover. However, the problem remains
that not enough ammonium can be produced from the amino
acid pool to maintain the glutamine (or free ammonium)
necessary for the splanchnic organs (i.e., the intestines, liver,
and kidney) to eliminate the excess of nitrogen as urea [36–
38].
The observed plasma levels of amino acids seem to
confirm these trends. In cafeteria diet-fed rats, glutamine
but not glutamate + glutamine levels were higher than in
control rats. High levels of glutamine suggest its decreased
splanchnic utilization to provide ammonium for the synthesis
of carbamoyl-P.The high circulating levels of ornithine again
suggest a diminished production of carbamoyl-P, perhaps
because of scarcity of ammonium donors in the liver. The
lower arginine levels in the cafeteria diet-fed group versus
controls suggest that synthesis of arginine may be insufficient
to compensate for the release of urea through arginase activity
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Table 4: Plasma amino acid concentrations of male rats fed a
cafeteria diet for one month compared with controls fed a standard
rat chow diet.
Amino acid Control(𝜇M)
Cafeteria diet-fed
(𝜇M) 𝑃
Alanine 464 ± 5 455 ± 37 NS
Aspartate∗ 31 ± 3 40 ± 8 NS
Asparagine∗ 49 ± 5 57 ± 4 NS
Σ Asp + Asn 81 ± 4 87 ± 8 NS
Glutamate∗ 149 ± 17 160 ± 11 NS
Glutamine∗ 487 ± 27 582 ± 5 0.005
Σ Glu + Gln 641 ± 48 705 ± 32 NS
Proline 139 ± 12 152 ± 12 NS
Hydroxyproline 22 ± 3 25 ± 4 NS
Threonine 165 ± 10 202 ± 7 0.010
Serine 186 ± 8 245 ± 13 0.003
Glycine 342 ± 9 417 ± 17 0.002
Leucine∗ 144 ± 7 146 ± 10 NS
Isoleucine∗ 52 ± 4 61 ± 8 NS
Valine∗ 157 ± 14 162 ± 15 NS
Σ branched chain 355 ± 36 355 ± 15 NS
Phenylalanine 76 ± 4 87 ± 6 NS
Tyrosine 87 ± 3 93 ± 6 NS
Tryptophan 95 ± 11 101 ± 7 NS
Methionine 51 ± 3 53 ± 4 NS
Cysteine 21 ± 3 22 ± 2 NS
Lysine 376 ± 18 396 ± 14 NS
Histidine 62 ± 4 69 ± 8 NS
Ornithine∗ 50 ± 3 68 ± 7 0.045
Citrulline∗ 48 ± 4 51 ± 4 NS
Arginine∗ 209 ± 10 164 ± 8 0.006
Σ urea cycle 278 ± 12 305 ± 14 NS
Σ total (mM) 3.98 ± 0.10 4.22 ± 0.19 NS
Thevalues are themean± SEM for 6 different animals. Statistical significance
of the differences between the two groups was determined with Student’s t-
test. NS:𝑃 > 0.05. Asterisks “∗” indicate the amino acids incorporated in the
sums marked in bold below them.
Table 5: Plasmametabolite levels of male rats fed a cafeteria diet for
one month compared with controls fed a standard rat chow diet.
Plasma values (mM) Control Cafeteria diet-fed 𝑃
Glucose 8.13 ± 0.36 9.20 ± 0.28 0.042
Triacylglycerols 1.91 ± 0.06 1.84 ± 0.08 NS
Cholesterol 1.75 ± 0.17 1.90 ± 0.17 NS
Urea 5.28 ± 0.24 3.94 ± 0.21 0.002
The values are themean± SEM for 6 different animals. Statistical significance
of the differences between both groups; 𝑃 was determined with Student’s 𝑡-
test.
or other uses. Arginase I in liver, which is the main site
for this enzyme to complete the urea cycle [39], showed
lower activity in the cafeteria diet-fed group. This may help
maintain circulating arginine, although at levels lower than
in control-fed animals.
The higher carbamoyl-P synthetase I activity found in
cafeteria diet-fed rats agrees with the clear surplus of 2-amino
nitrogen available for excretion, since higher liver ammo-
nium availability increases the activity of this enzyme [40].
The decrease in urea excretion agrees with lower arginase
activity, but not with the increased activity of carbamoyl-P
synthetase I, which depends on ammonium as its substrate
[40].Thus, the block in urea cycle function (and consequently
in “normal” 2-amino nitrogen disposal) should lie between
these enzymes in the urea cycle, that is, in the conversion
of ornithine to citrulline or the latter to arginine (i.e.,
argininosuccinate synthetase and argininosuccinate lyase). In
addition, the higher ornithine levels in the plasma of cafeteria
diet-fed rats suggest that the N-acetyl-glutamate pathway
for the exogenous synthesis of ornithine was not sufficiently
activated to compensate for the arginine deficit.
Because the circulating levels of citrulline and aspartate
were unchanged (or increased) in cafeteria diet-fed versus
control rats, it can be assumed that there is probably a
key regulatory path, for overall nitrogen disposal, either at
the synthesis or breakup of argininosuccinate, which would
help explain the lower production of urea. Based on kinetic
studies, argininosuccinate synthesis was initially postulated
as a key urea cycle control node [41], although normal urea
cycle operation is assumed to rely more on other parameters
such as pH, ammonium availability, and N-acetyl-glutamate
levels [42]. However, the indirect data presented here suggest
that argininosuccinate synthesis/breakupmay be a significant
control point in vivo under relatively high nitrogen (and
energy) availability.
The involvement of ammonium availability in this con-
text is enhanced by the relatively higher concentrations of
threonine, serine, glycine, and glutamine in cafeteria diet-fed
rats. These amino acids yield ammonium in their catabolism
[43] via threonine/serine dehydratase, glutaminase, or the
glycine cleavage system. Serine may also be converted to
glycine, which leads to the same fate. These results show an
unexpected picture, since, in cafeteria diet-fed rats, there is
an excess of 2-amino nitrogen and the higher levels observed
correspond to ammoniagenic amino acids. According to
the normal catabolic pathways for nitrogen excretion, this
excess should activate the production of ammonium, its
transport as glutamine, release again as ammonium, and
formation of carbamoyl-P, followed by its integration (with
more aspartate-derived amino nitrogen) into the guanido
group of arginine for its eventual release as urea. However, the
amino acids that can yield ammonium directly, in an initial
nontransaminative catabolic step, were somehow preserved
in cafeteria diet-fed rats. These amino acids were not used
in large quantities as was to be expected in a situation in
which, theoretically, the lack of 2-amino nitrogen conver-
sion to ammonium could hinder normal nitrogen excretion
through the urea cycle. The contrast between preservation
of the ammonium donors and high carbamoyl-P synthetase
I activity in the cafeteria diet-fed group suggests that the
problem does not lie in the availability of ammonium.Higher
levels of the main amino acid ammonium donors suggest
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instead a constraint on their utilization because elimination
via the urea cycle is blocked as indicated above.
The faulty operation of the urea cycle, then, suggests
that the main control mechanism sought is not centered
on the availability of ammonium-yielding substrates as is
usually postulated for normal and starvation conditions [42].
The increased activity of carbamoyl-P synthetase and the
low activity of arginase in cafeteria diet-fed rats indicate
that the control mechanism lies in the actual synthesis of
arginine, which is also essential for the operation of the
NO∙ shunt. Notwithstanding, the NO∙ shunt does not seem
to be significantly altered by the cafeteria diet, as shown
by unchanged plasma and urinary NO
𝑥
in spite of lower
circulating arginine. One possible explanation is that the
blockage of arginine production results from the need to
prevent an increase in the production of NO∙ under cafeteria
diet conditions, in which blood flow—in part dependent on
NO∙ synthesis—to a number of tissues is markedly altered
[44].
Thequestion remains of how the excess nitrogen provided
by cafeteria diets is eliminated. The widening of the nitrogen
gap under high-energy feeding suggests that nitrogen gas
[45] may be involved, since the amount of creatinine, uric
acid, and so forth, excreted is only a small fraction of
urea nitrogen [46, 47]. The synthesis of NO∙ results in the
excretion, mainly via saliva [48], of nitrite and nitrate. In
addition, there is a small direct loss of NO∙ in the breath
[49]. However, the low levels of NO
𝑥
measured in the urine
and their marked metabolic effects [50] suggest that NO
𝑥
as NO∙ derivatives, could account for at most only a very
small part of the “missing” nitrogen. The lack of changes
elicited by diet in circulating levels of nitrate and nitrite
reinforced this assumption; that is, nitrate excretion is not a
significant alternative as a nitrogen-disposal pathway to lower
urea synthesis.
The one-month period of exposure to the cafeteria diet
proved that this type of diet caused difficulties in the normal
mechanisms of amino nitrogen disposal, exemplified by a
lower urea production. These problems were not directly
related to the potential availability of ammonium as the
prime substrate for initiating the urea cycle but instead were
probably related to the availability of arginine. No changes
were observed in the levels or excretion of NO
𝑥
, which
were small, but the “nitrogen gap” [21] became significant
under cafeteria diet feeding. It is now clear that the decrease
in urea excretion is not compensated for by higher NO
𝑥
production and elimination. The main pathway for disposal
of the excess amino nitrogen generated by energy rich diets
remains unsolved, with the additional conundrum of why
the urea cycle appears to be disrupted for the only apparent
reason of limiting the availability of arginine.
5. Conclusions
The decrease in urea excretion is not compensated for
by higher NO
𝑥
production and elimination. The defective
operation of the urea cycle in rats fed a cafeteria diet seems
to be caused by a block in the urea cycle between ornithine
and arginine.
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Modulation of rat liver urea cycle and related
ammonium metabolism by sex and cafeteria diet
Silvia Agnelli,a Sof´ıa Arriara´n,a Laia Oliva,a Xavier Remesar,abc
Jose´-Antonio Ferna´ndez-Lo´pezabc and Mari`a Alemany*abc
High-energy (hyperlipidic) cafeteria diets induce insulin resistance limiting glucose oxidation, and lower
amino acid catabolism. Despite high amino-N intake, amino acids are preserved, lowering urea
excretion. We analysed how energy partition induced by cafeteria diet aﬀects liver ammonium handling
and urea cycle. Female and male rats were fed control or cafeteria diets for 30 days. There was
a remarkable constancy on enzyme activities and expressions of urea cycle and ammonium metabolism.
The key enzymes controlling urea cycle: carbamoyl-P synthase 1, arginino-succinate synthase and
arginase expressions were decreased by diet (albeit more markedly in males), and their activities were
correlated with the gene expressions. The eﬀects observed, in ammonium handling enzyme activities
and expressions behaved in a way similar to that of the urea cycle, showing a generalized
downregulation of liver amino acid catabolism. This process was aﬀected by sex. The diﬀerent strategies
of amino-N handling by females and males further modulated the preservation of 2-amino N under
suﬃcient available energy. The eﬀects of sex were more marked than those of diet were, since diﬀerent
metabolism survival strategies changed substrate partition and fate. The data presented suggest a lower
than expected N ﬂow to the liver, which overall importance for amino acid metabolism tends to
decrease with both cafeteria diet and female sex. Under standard conditions, liver availability of
ammonium was low and controlled. The situation was unchanged (or even lowered) in cafeteria-fed rats,
ultimately depending on intestinal amino acid catabolism.
Introduction
There is a considerable body of knowledge on the eﬀect of diet
on the substrate energy utilization under diﬀerent physiological
conditions. A growing consensus attributes the wide extension
of metabolic syndrome (MS) to sustained excess energy (mainly
lipid) diets on the ponderostat system.1 The most apparent
consequence of excess energy being the development of obesity2
and their MS-related co-morbidities, especially insulin resis-
tance3 and the alteration of blood lipid transport.4
High-energy diets showmarkedly diﬀerent eﬀects depending
on the sex (and age) of the subjects.5 In general, females are
more resistant to the development of MS,6 in part because of the
protective eﬀects of oestrogen,7 which hampers the obesogenic
eﬀects of inammation and insulin resistance,8 limiting the full
development of obesity.9 There is a limited antagonism between
glucocorticoids and oestrogens,10 which tend to counteract the
increase in fat stores elicited by glucocorticoids.11 In males,
however, the progressive decrease in androgens with age12 is
compounded by the increase in glucocorticoids parallel to the
development of MS.13 Androgen secretion is largely blocked by
glucocorticoids, resulting in increased fat storage (obesity, liver
steatosis) and a marked alteration of glucose and lipid metab-
olism, especially in adipose tissue, muscle and liver.14
Our knowledge of how sex inuences the deleterious eﬀects
of excess energy (lipid) intake with respect to energy expendi-
ture, and inammation is, however, rather sketchy, since sex-
related diﬀerences have been observed, but most mechanisms
remain to be fully claried.15,16
The liver plays a key role in nutrient partition and in the
maintenance of body energy homeostasis. It receives, via porta
vein, most of the nutrients extracted from the diet. However,
a large part of the siing has been done, already, by other
splanchnic bed organs, especially the intestine,17 and, probably,
mesenteric/omental adipose tissue.18 In any case, the liver
controls the ow of glucose into the systemic blood, and retains
(or metabolizes) many amino acids and short-chain fatty acids.
A sustained excess of nutrients and a critical failure of the
insulin systemmay lead to a generalized loss of eﬀectivity of the
liver, oen provoking hepatic steatosis,19 associated to insulin
resistance.20 Loss of insulin function resulting also in lower
amino acid utilization.21 The liver condition may even develop
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in a failure to detoxify the portal-carried ammonium, whichmay
result lethal.22 Of all these critical functions, the liver – in fact
the coordinate work of intestine and liver—plays an essential
role in the disposal of excess amino N and ammonia. The main
pathway for excess N elimination is the urea cycle,23,24 which has
been assumed to be fully operative only in liver.25However, both
intestine and kidney have functional (albeit complementary)
urea cycles.26,27 We have found, recently, a robust presence of
urea cycle in white adipose tissue,28 which is unaﬀected by sex
and anatomical site.29
High-fat diets, such as the cafeteria diets,30 have been
known, to decrease the operation of the urea cycle in liver,31
with lower overall urinary excretion of N.32 This decreased
excretion, in spite of maintained or increased protein intake, is
not paralleled by an increased deposition of protein (or faecal
excretion).32 In fact, nitrogen balances show that a signicant
portion of the N excreted is not accounted for.33 It has been
speculated that it may be justied (at least partly) by respiratory
loss of nitric oxide34 or, even, release of nitrogen gas.35
The control role of the liver on the disposal of ammonium-N
and excess amino-N, is a critical process for the maintenance of
N homeostasis. Thus, alteration of liver metabolic function
induced by diet necessarily inuences N homeostasis, albeit in
ways so far not known. We assume that this dramatic change
may contribute to the pathogenesis of MS. In the present study,
we analysed the eﬀects of a relatively short (one-month) expo-
sure of adult rats (female and male) to a cafeteria diet. The
objective was to check how the initial phase of development of
MS aﬀects, diﬀerentially (in adults), both sexes in the critical
function of liver as main site for disposal of ammonium
through the urea cycle.
Experimental
Ethics statement
All animal handling procedures and the experimental setup
were in accordance with the animal handling guidelines of the
corresponding European and Catalan Authorities. The
Committee on Animal Experimentation of the University of
Barcelona approved the present study.
Experimental design and animal handling
Nine week old female and male Wistar rats (Harlan Laboratory
Models, Sant Feliu de Codines, Spain) were used. The rats (N ¼
6) were kept in same-sex two-rat cages with wood shards for
bedding. The animals were maintained in a controlled animal
room (lights on from 08:00 to 20:00; 21.5–22.5 C; 50–60%
humidity). Two groups for each sex were randomly selected and
were fed ad libitum, for 30 days, with either normal rat chow
(Harlan #2014) or a simplied cafeteria diet36 made of chow
pellets, plain cookies, with liver paˆte´, bacon, whole milk con-
taining 300 g L1 sucrose and a mineral and vitamin supple-
ment. Food/nutrient consumption was measured as previously
described.30 Diet intake composition (expressed as energy
content) was: carbohydrate 67%, protein 20%, and lipid 13% for
controls; that of rats fed the cafeteria diet (i.e. aer computing
the food ingested) was (mean values, expressed as energy
content): carbohydrate 47%, protein 12% and lipid 41%. The
simplied cafeteria diet induced a signicant increase in body
fat, in line with previous studies on metabolic syndrome.32,36
The rats were killed, under isourane anaesthesia, by exsan-
guination (aortic puncture using a large dry-heparinized
syringe) at the beginning of a light cycle. Then, they were
rapidly dissected, and two lobes of the liver were excised,
blotted, and frozen in liquid nitrogen. These samples were
weighed and ground under liquid nitrogen. The coarse powder
was aliquoted and stored at 80 C until processed. Later, the
liver remains were dissected to measure its full weight. Blood
was centrifuged to obtain plasma, which was frozen and stored
as well.
Blood plasma parameters
Plasma samples were used to measure glucose (kit #11504,
Biosystems, Barcelona Spain), lactate (kit #1001330, Spinreac,
Sant Esteve de Bas, Spain), triacylglycerols and total cholesterol
(Biosystems kits #11828, and #11505, respectively). Urea was
measured with a chemical method (kit # 11537; Biosystems).
Amino acids were analysed individually with an amino acid
analyser (LKB-Alpha-plus, Uppsala, Sweden) using plasma
samples deproteinized with chilled acetone.37 Since the method
used did not provide reliable data for several amino acids (i.e.
Gln, Trp, Cys, Asn), we decided to present only the partial sum
of the other amino acids as a single indicative value.
Enzyme activity analyses
Homogenate preparation. Frozen liver samples were further
homogenized, using a tissue disruptor (Ultraturrax IKA-T10, Ika
Werke, Staufen, Germany). Homogenates for arginino-
succinate synthase and ornithine carbamoyl-transferase
activity measurement were prepared using 10 volumes of chil-
led 70 mM hepes buﬀer pH 7.4 containing 1 mM dithiothreitol
(Sigma, St Louis MO USA), 50 mM KCl, 1 g L1 Triton X-100
(Sigma), and 1 g L1 lipid-free bovine serum albumin (Sigma).
Homogenates for carbamoyl-P synthase analysis were prepared
with 10 volumes of chilled 50 mM triethanolamine buﬀer pH
8.0 containing 1 mM dithiothreitol, 0.5 g L1 Triton X-100, 1 g
L1 lipid-free bovine serum albumin and 10 mM magnesium
acetate. Homogenates for the analyses of the other enzymes
were prepared with 10 volumes of chilled Krebs-Ringer bicar-
bonate buﬀer pH 7.4 containing 1 g L1 Triton X-100, 1 mM
dithiothreitol and 1 g L1 lipid-free bovine serum albumin. The
homogenates were coarsely ltered through nylon-hose to
eliminate large debris. They were kept on ice and used for
enzyme activity analyses within 2 h. Tissue protein content was
estimated with the Lowry method,38 using the corresponding
homogenization buﬀer (containing albumin) as blank. Enzyme
activities were expressed per unit of protein weight. The
methods used were largely based in our parallel development of
methods for analysis on white adipose tissue, extensively
described in a previous publication.28
Carbamoyl-P synthase 1. Carbamoyl-P synthase 1 activity was
estimated from the incorporation of 14C-bicarbonate (Perkin
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Elmer, Bad Neuheim, Germany) into carbamoyl-P using
a method previously described by us.39 Succinctly, we measured
the incorporation of label into carbamoyl-P by the activity of the
enzyme on ammonium carbonate in the presence of N-acetyl-
glutamate (Sigma) and ushing out all remaining bicarbonate
label with a stream of unlabelled CO2.
Ornithine carbamoyl transferase. Ornithine carbamoyl
transferase activity was measured from the reaction of
condensation of carbamoyl-P and 14C-ornithine to yield
14C-citrulline. Aliquots of 25 mL of homogenates were mixed
with 50 mL of 70 mM hepes buﬀer pH 7.4 containing carbamoyl-
P, ornithine (all from Sigma), and 14C-ornithine (Perkin-Elmer);
nal concentrations were 9 mM, 13 mM and 1 kBq mL1,
respectively. The reaction was started with the homogenate, and
was carried out at 37 C during 0, 0.5,1 and 2 min. The reaction
was stopped by introducing 75 mL aliquots in tubes, kept on ice,
containing 100 mL of chilled acetone. Aer centrifugation, the
clear supernatants were dried in a vacuum-centrifuge (Thermo
Scientic, Waltham,MA USA). The residues were dissolved in 25
mL of water; they were run on TLC silica gel plates (200 mm;
Macherey-Nagel, Du¨ren, Germany). Standards of ornithine and
citrulline were included in one of the lanes of each plate. The
plates were developed with trichloromethane: methanol: acetic
acid (1 : 2 : 2 by volume). Standards were revealed with
a ninhydrin spray. The lanes were cut in 1 cm pieces and
counted. The label in the citrulline spot was expressed as
a percentage of the total label counted in each TLC lane. These
data allowed the calculation of newly formed citrulline at each
incubation time. The V0 value for each sample was plotted, and
was considered to represent the value of Vmax under the
conditions tested.
Arginino-succinate synthase. Arginino-succinate synthase
activity was measured from the reaction of condensation of
aspartate with citrulline in the presence of ATP to yield
arginino-succinate. Homogenates (55 mL) were mixed with 30 mL
of 70 mM hepes buﬀer pH 7.4, containing ATP-Na2, MgCl2,
citrulline and aspartate (Sigma); nal concentrations were 10
mM, 5 mM, 3 mM, and 2.5 mM, respectively. The reaction was
started with aspartate, and was carried out at 37 C. The reac-
tion was stopped with 40 mL of 30 g L1 perchloric acid. The
tubes were vortexed and neutralized (pH 7–8) with 10 mL of 100 g
L1 KOH containing 62 g L1 KHCO3. The tubes were vortexed
again and centrifuged in the cold 15 min at 8000  g. The
aspartate remaining in the supernatants was measured by
transamination to oxaloacetate, which was reduced by malate
dehydrogenase and NADH. Briey, 20 mL of the supernatants
were brought up to 300 mL in 96-well plates, with 66 mM
phosphate buﬀer pH 7.4 containing NADH, 2-oxoglurarate,
aspartate transaminase (pig heart) and malic acid dehydroge-
nase (pig heart) (all from Sigma); nal concentrations were,
respectively, 0.25 mM, 0.2 mM, 20 mkat L1 and 17 mkat L1. The
plates were read at 340 nM in a plate reader (Biotek, Winoosky,
VT USA) at intervals of 30 s during 20 min. The fall in NADH was
used to determine the levels of aspartate at each incubation
time. Its disappearance (versus time zero levels) was used to
calculate the aspartate incorporated into arginino-succinate by
the enzyme.
Arginino-succinate lyase. Arginino-succinate lyase activity
was measured from the breakup of arginino-succinate to yield
fumarate and arginine. This amino acid was analysed in
a second reaction, using arginase to form ornithine and urea,
which was measured using a sensitive chemical method.
Aliquots of 38 mL of homogenates were mixed with 38 mL of 66
mM hepes buﬀer pH 7.4, containing arginino-succinate
(Sigma), at a nal concentration 2 mM. Incubations were
carried out at 37 C for 0, 2.5, 5 and 10 min. The reaction was
stopped by the addition of 40 mL of 30 g L1 perchloric acid.
The tubes were vortexed and brought to pH 8–9 with 10 mL of
100 g L1 KOH, 80 g L1 HKCO3. The tubes were centrifuged for
15 min in the cold at 8000  g. Aliquots of 100 mL of the
supernatants were mixed with 50 mL of the reacting mixture,
containing 66 mM hepes buﬀer pH 7.5 (to achieve a nal pH
8.5), MnCl2 and arginase (rat liver, Lee Biosolutions, St Louis,
MO USA). The nal concentrations were 7 mM and 17 mkat L1,
respectively. Arginase already in the buﬀer containing Mn2+,
was previously activated for 5 min at 55 C. The reaction
developed for 30 min at 37 C, and was stopped by the addition
of 35 mL of 160 g L1 perchloric acid. The tubes were centri-
fuged in the cold for 15 min at 8000  g. The acidic superna-
tants (175 mL) were used for the estimation of urea. They were
mixed with 600 mL of 90 g L1 H2SO4 containing 270 g L
1
H3PO4; then 10 mL of 30 g L
1 of 1-phenyl-2-oxime-1,2-
propanodione (Sigma) in absolute ethanol were added. The
reaction was developed at 100 C for 30 min in a dry block
heater. The absorbance of the tubes (including standards and
blanks) was measured at 540 nm with a plate reader. Arginase
eﬀectivity (using the method explained above) was tested in all
batches. In all cases, conversion of arginine to urea was 100%
(i.e. there was a full coincidence of the standard curves for both
urea and arginine).
Arginase. Arginase activity was measured through the esti-
mation of the urea produced by the activity of the enzyme on
arginine in the presence of Mn2+ ions.40,41 Aliquots of 20 mL of
homogenates were mixed with 5 mL of MnCl2 in water; nal
concentration 10 mM. The tubes were heated for 5 min at 55 C
to activate arginase41,42 Aer the temperature was brought down
to 37 C, the reaction began with the addition of 75 mL of
arginine (Sigma); nal concentration 78 mM. Incubations were
carried out for 0, 8 and 16 min at 37 C. The reaction was
stopped by the addition of 35 mL 160 g L1 perchloric acid. The
tubes were centrifuged 15 min in the cold at 8000  g. Urea was
measured as described above.
Glutamine synthetase. Glutamine synthetase, activity was
estimated using a method we had used previously,43 based on
the reaction of glutamine and hydroxylamine in the presence of
ADP, Mn2+ and arsenate to yield g-glutamyl-hydroxamate. The
addition of Fe(NO3)3 in trichloroacetic acid results in the
development of colour, read at 500 nm using a plate reader.
Serine dehydratase. Serine dehydratase activity was analysed,
by measuring the pyruvate freed by the enzyme in the presence
of pyridoxal-P.44 This reaction was coupled with the reduction of
pyruvate to lactate with lactate dehydrogenase, measuring the
decrease in NADH,45 by UV spectrometry using a plate reader.
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AMP deaminase. AMP deaminase activity was estimated by
the determination of the ammonium released by the action of
the enzyme on AMP, in the presence of KCl, yielding IMP.46 The
ammonium evolved was estimated with the classical Berthelot
indophenol reaction,47 in which indophenol was formed by
reaction of ammonium with phenol in the presence of an
oxidative agent (hypochlorite) and nitroprusside as catalyser.
Gene expression analysis
Total tissue RNA was extracted from frozen samples (about 30
mg) using the GenEluteTM (Sigma-Aldrich, St Louis MO USA)
procedure, and was quantied in a ND-100 spectrophotometer
(Nanodrop Technologies, Wilmington DE USA). RNA samples
were reverse transcribed using the MMLV reverse transcriptase
(Promega, Madison, WI USA) system and oligo-dT primers. The
data were also used to determine the total RNA content of the
tissue in order to establish quantitative comparisons between
diﬀerent gene expressions.
Real-time PCR (RT-PCR) amplication was carried out using
10 mL amplication mixtures containing Power SYBR Green PCR
Master Mix (Applied Biosystems, Foster City, CA USA), 10 ng of
reverse-transcribed RNA and primers (300 nM). Reactions were run
on an ABI PRISM 7900 HT detection system (Applied Biosystems)
using a uorescent threshold manually set to 0.15 for all runs.
A semi-quantitative approach for the estimation of the
concentration of specic gene mRNAs per unit of tissue or
protein weight was used.48 Cyclophyllin A (Ppia) was used as
charge control gene.49 The data were expressed as the number of
transcript copies per gram of protein in order to obtain
comparable data between the groups. The genes analysed, and
a list of primers used, are presented in Table 1.
The possible contamination of RNA with DNA was checked,
before PCR cycling, by charging a number of samples of each
batch with known internal standards of RNA. No spurious
signals were observed. All the primers used for measurement of
the enzyme gene expressions were checked, with Northern blots
of the PCR-synthesized cDNAs. In all cases, the cDNAs obtained
had the expected molecular weights.
Total DNA was estimated with a uorimetric method.50
Approximate cellularity was calculated, assuming that the mean
mammalian cell DNA content was 6 pg.51 Mean cell volume was
estimated from liver weight, liver density: 1.1 g mL1, and the
estimated number of cells.
Statistics
Two-way ANOVA comparisons between groups, correlations and
curve tting (including Vi estimations) were carried out with the
Prism 5 program (GraphPad Soware, San Diego CA USA).
Results
General parameters
Table 2 presents the rat weights, and liver size and composition
of the four groups of rats. As expected, body and liver weight
Table 1 Primer sequences used in the analysis of liver gene expressions
Protein Gene EC number Primer sequence bp
Carbamoyl-phosphate synthase [ammonia], mitochondrial type 1 Cps1 6.3.4.16 50 > 30 ACCCATCATCCCCTCTGACT 118
30 > 5 ACACGCCACCTCTCCAGTAG
Ornithine carbamoyl-transferase Otc 2.1.3.3 50 > 30 CTTGGGCGTGAATGAAAGTC 126
30 > 5 ATTGGGATGGTTGCTTCCT
Arginino-succinate synthase 1 Ass1 6.3.4.5 50 > 30 CAAAGATGGCACTACCCACA 100
30 > 5 GTTCTCCACGATGTCAATGC
Arginino-succinate lyase Asl 4.3.2.1 50 > 30 CCGACCTTGCCTACTACCTG 104
30 > 5 GAGAGCCACCCCTTTCATCT
Arginase, liver (type 1) Arg1 3.5.3.1 50 > 30 GCAGAGACCCAGAAGAATGG 126
30 > 5 GTGAGCATCCACCCAAATG
N-Acetyl-glutamate synthase Nags 2.3.1.1 50 > 30 GCAGCCCACCAAAATCAT 82
30 > 5 CAGGTTCACATTGCTCAGGA
Nitric oxide synthase 3, endothelial cell type Nos3 1.14.13.39 50 > 30 CAAGTCCTCACCGCCTTTT 138
30 > 5 GACATCACCGCAGACAAACA
Glutamate-ammonia ligase [glutamine synthetase] Glul 6.3.1.2 50 > 30 AACCCTCACGCCAGCATA 148
30 > 5 CTGCGATGTTTTCCTCTCG
Glutaminase kidney isoform, mitochondrial Gls 3.5.1.2 50 > 30 CCGAAGGTTTGCTCTGTCA 63
30 > 5 AGGGCTGTTCTGGAGTCGTA
Glutamate dehydrogenase 1, mitochondrial Glud1 1.4.1.3 50 > 30 GGACAGAATATCGGGTGCAT 122
30 > 5 TCAGGTCCAATCCCAGGTTA
Glycine cleavage system H protein, mitochondrial Gcsh — 50 > 30 AAGCACGAATGGGTAACAGC 146
30 > 5 TCCAAAGCACCAAACTCCTC
Adenosine monophosphate deaminase 2 Ampd2 3.5.4.6 50 > 30 CGGCTTCTCTCACAAGGTG 78
30 > 5 CGGATGTCGTTACCCTCAG
Peptidyl-prolyl-cis-trans isomerase Aa Ppia — 50 > 30 CTGAGCACTGGGGAGAAAGGA 87
30 > 5 GAAGTCACCACCCTGGACA
a Housekeeping gene.
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were aﬀected by sex and diet. However, liver weight was main-
tained at about 3.1–3.3% of body weight in all groups. Whole-
liver cellularity was (mean values for groups, in 109 cells): 4.0
and 4.9 for control and cafeteria males, as well as 2.4 and 2.7 for
control and cafeteria females. Estimated cell size was higher in
females: 3.3 and 3.2 ng per cell in control and cafeteria rats,
respectively, versus 2.9 and 2.8 ng per cell in males (P < 0.05 for
both diets). However, no overall signicant eﬀects of diet and
sex were observed for DNA content in mg g1 tissue.
Concentrations of protein and RNA in liver were aﬀected by
sex; males had higher protein and females had higher RNA
concentrations; but no signicant eﬀects of diet were observed.
RNA/DNA ratios were, again, not aﬀected by diet, but sex
resulted in higher values (P < 0.05) for females (3.2 controls and
3.0 cafeteria) than males (2.4 for both dietary groups).
Table 3 shows the main plasma energy parameters of the rats.
Glucose levels were increased, and those of lactate decreased,
signicantly by feeding the cafeteria diet. Cholesterol was unaf-
fected by either sex or diet. Triacylglycerols, however, were
aﬀected by sex (but not by diet), with female values being higher
than those ofmales, especially in control rats. The sum of plasma
amino acids was also aﬀected by sex (with females showing
higher combined levels). Finally, urea concentrations were
decreased by cafeteria diet, but were overall higher in female rats.
Urea cycle
Fig. 1 depicts a scheme of the urea cycle in liver, showing the
enzyme activities (and their corresponding gene expressions) for
ornithine carbamoyl-transferase, arginino-succinate synthase,
arginino-succinate lyase and arginase 1. The gure shows also
the expressions of the genes coding for endothelial nitric oxide
synthase and N-acetyl-glutamate synthase (acetyl-transferase).
Arginase activity was about three orders of magnitude higher
than those of the arginino-succinate enzymes; ornithine
carbamoyl-transferase activity was also high, but only one order
of magnitude higher than those of the arginino-succinate
enzymes. These extreme diﬀerences in activity were less
marked when comparing the expressions of the four enzymes,
since all were in the same range except arginino-succinate syn-
thase, one order of magnitude higher. These diﬀerences resulted
in disparate activity/expression ratios.
The patterns of activity were similar for all four enzymes, but
there were signicant eﬀects of sex only in arginino-succinate
synthase and arginase, and of diet in these same enzymes
plus arginino-succinate lyase. The patterns for gene expression
of the urea cycle enzymes were also similar and followed the
same prole than their corresponding enzyme activities. Sex
aﬀected only (i.e. signicantly) the expression of arginino-
succinate synthase. The expression of their corresponding
genes was aﬀected by diet in the same enzyme plus arginino-
succinate lyase and arginine. In all enzymes of Fig. 1, except
ornithine carbamoyl-transferase, both activities and expres-
sions were decreased in cafeteria diet-fed rats vs. controls.
The possible direct relationship between gene expression
and enzyme activity (unaﬀected by post-translational modi-
cation) was checked analysing the correlation between the data
Table 2 Body and liver weight and composition of male and female rats fed control or cafeteria diets for 30 daysa
Parameter Units
Male Female P
Control Cafeteria Control Cafeteria Sex Diet
Body weight g 373  6 420  20 232  8 267  16 <0.0001 0.0074
Liver weight g 11.6  0.5 13.8  1.1 7.72  0.31 8.36  0.50 <0.0001 0.0473
DNA mg g1 2.07  0.17 2.13  0.32 1.83  0.22 1.91  0.22 NS NS
RNA mg g1 4.96  0.31 5.21  0.18 5.95  0.30 5.75  0.15 0.0065 NS
Protein mg g1 191  7 185  5 160  5 157  9 0.0003 NS
a The data correspond to the mean sem of 6 diﬀerent animals. Statistical signicance of the diﬀerences between groups was established with a 2-
way anova program.
Table 3 Main plasma metabolites of male and female rats fed control or cafeteria diets for 30 daysa
Plasma parameters (mM)
Male Female P
Control Cafeteria Control Cafeteria Sex Diet
Glucoseb 10.2  0.4 10.8  0.4 8.64  0.34 11.5  0.3 NS 0.0001
Lactate 3.10  0.29 2.64  0.21 3.78  0.24 2.57  0.21 NS 0.0023
Cholesterol 1.97  0.07 2.28  0.21 1.98  0.16 2.07  0.19 NS NS
Triacylglycerols 1.50  0.06 1.50  0.01 1.69  0.06 1.51  0.03 0.0390 NS
Urea 3.90  0.17 3.82  0.20 5.13  0.25 3.78  0.20 0.0094 0.0025
Amino acidsc 3.34  0.08 3.68  0.10 3.96  0.18 4.07  0.12 0.0007 NS
a The data correspond to the mean  sem of 6 diﬀerent animals. Statistical signicance of the diﬀerences between groups was established with
a two-way anova program. b The glucose values were higher than expected because of the necessary exposure of the animals to isourane
anaesthesia during the process of killing and sampling. c These values do not include Gln, Asn, Trp and Cys.
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for both parameters of all animals studied, irrespective of sex
and diet (i.e. N ¼ 24). There were signicant correlations
between enzyme activity and expression for arginino-succinate
synthase (R2 ¼ 0.283; P ¼ 0.023), arginase 1 (R2 ¼ 0.184; P ¼
0.037), carbamoyl-P synthase (R2¼ 0.440; P¼ 0.0008) and serine
dehydratase (R2¼ 0.635; P¼ 0.0002). No signicant correlations
were found for any of the other enzymes studied.
Acetylation of glutamate was also aﬀected by diet, following
the same pattern described above. The expression of endothelial
nitric oxide synthase showed a clear eﬀect of sex, with higher
values in females but the eﬀects of diet were not signicant.
Ammonium metabolism
Fig. 2 shows a general outline of liver ammonium metabolism,
including the activities of carbamoyl-P synthase 1, serine
dehydratase, AMP deaminase and glutamine synthetase, as well
as the expressions of their corresponding genes. The gure
includes, also the expressions of glutaminase, the cytoplasmic
(NADPH-dependent) glutamate dehydrogenase and a compo-
nent of the glycine cleavage system (H protein).
Carbamoyl-P synthetase 1 showed higher enzyme activities
in females; these eﬀects were not observed in its gene
expression, which presented considerable variability. AMP
deaminase showed no signicant eﬀects of sex or diet on
activity or gene expression. The activity of serine dehydratase
was markedly aﬀected by sex, with lower female values, an eﬀect
that was parallel to the changes in gene expression. Diet also
aﬀected the gene expression of serine dehydratase, with values
even lower for cafeteria-fed rats.
Glutamine synthetase activity in females was higher than in
males, a diﬀerence also observed in the expression of its gene.
Glutaminase expression did not show eﬀects of sex, but cafe-
teria diet decreased the expression of the enzyme. This pattern
was paralleled by glutamate dehydrogenase, which also showed
an eﬀect of sex (higher values in females). The expression of the
glycine cleavage system (in fact that of representative H protein)
was strongly inuenced by sex, with—again—higher values in
female rats.
Discussion
We have shown evidence that both sex and diet, rather inde-
pendently, aﬀected the activities and gene expressions of the
urea cycle enzymes in rat liver. However, this apparent
Fig. 1 Gene expressions and enzyme activities of the urea cycle in the liver of male and female rats fed control or cafeteria diet for 30 days. The
data correspond to the mean  sem of 6 diﬀerent animals, and are all expressed per gram of tissue protein (gP). Statistical analysis of the
diﬀerences between groups was done using a two-way anova program and the variables “sex” and “diet”. Only signiﬁcant (P < 0.05) values have
been represented. Purple data, marked with a “S” correspond to the overall eﬀect of “sex”, and red data marked with a “D” correspond to the
overall eﬀect of “diet”. MC ¼male fed the control diet; MK ¼ male fed the cafeteria diet; FC ¼ female fed the control diet; FK ¼ female fed the
cafeteria diet. Males: dashed columns; females: no-pattern columns. Enzyme gene expressions: orange: control diet; yellow: cafeteria diet
enzyme activities: blue: control diet; green: cafeteria diet.
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similarity of eﬀect shis towards more extensive eﬀects of sex
on the management of ammonium in the liver, thus aﬀecting,
albeit indirectly, the overall operation of the urea cycle and the
nal excretion of N as urea. The model used behaved as ex-
pected both in increased WAT fat deposition52,53 and relative
normalcy of plasma parameters, including insulin54 as repeat-
edly found under these same conditions in previous studies.32,36
We used a cafeteria diet model well studied by us previously,
which shows a discrete increase in body weight due to the
accumulation of fat, but the metabolic alterations induced by
inammation in the context of MS are essentially incipient.52
The eﬀects are strongly inuenced by sex;55 a question that we
also found applies to amino acid metabolism.29 The obesogenic
eﬀects of cafeteria diets are maximal during early postnatal
development,56 preventing the weaning shi from a high fat to
a high carbohydrate diet.57 The timing and extent of exposure
are critical to enhance the ability of this type of diets to induce
MS.55,58 We used young adult rats, and subjected them to
a moderate exposure time to the hyperlipidic diet in order to
obtain not a frankly pathological state but a pre-MS situation in
which the immediate eﬀects of the high-energy diet are not
confounded by the additional disorders elicited by a severe
inammation.59,60
The so far scarcely studied eﬀect of sex on amino acid
catabolism may have deeper roots than usually assumed. The
lack of direct studies on the mechanisms has driven our
attention to the overall picture of eﬀects of sex on amino-N
economy. In males, the main trend is accumulation of body
protein, largely muscle, an eﬀect facilitated by insulin,61 GH and
androgens,62 and hampered by glucocorticoids.63 In females,
however, the main drive seems to be somewhat diﬀerent: to
enhance N sparing probably to full the burden of reproduc-
tion, rst the foetuses, and then the energy economy ordeal of
lactation. In both sexes, in addition, the overall trend to
preserve amino-N is a primeval drive that prevents its
wasting64,65 even under (rare in Nature) conditions of dietary
excess of protein.66 We can speculate that androgen predomi-
nance (i.e. in males), acting as counterbalance to glucocorti-
coids, may diminish the hepatic conversion of amino acid N to
urea; oestrogen (i.e. in females) showing a less marked inu-
ence on this aspect.
Enzyme activities are not direct estimations of the enzyme
function within the cell, but are a widely accepted correlate of
the overall enzyme ability to carry out its function. Thus, the Vi
values presented are a correlate of Vmax and of functional
protein enzyme levels. These values, consequently; reect
Fig. 2 Gene expressions and enzyme activities of enzymes related to ammonia/ammoniummetabolism in the liver of female and male rats fed
control or cafeteria diet for 30 days. The data correspond to the mean sem of 6 diﬀerent animals, and are expressed per gram of tissue protein
(gP). Statistical analysis, abbreviations and colour conventions are the same described for Fig. 1.
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potential ability of the tissue to catalyse the reaction, albeit
being estimated under result-maximizing non-physiological
conditions. The closeness of gene expression patterns and
enzyme activities mutually support the data presented.
However, the large diﬀerences in activity observed between
enzymes (i.e. arginase vs. arginino-succinate synthase) but also
between expression and activity may be a consequence of
diﬀerent turnover number or enzyme (as protein) turnover,67
but place the control of the cycle, precisely on these key
enzymes. In arginino-succinate synthase as rate limiting step;68
and arginase as nal factor in the release of urea,69 but also as
the main site for arginine break-up and maintenance of body
arginine-citrulline equilibrium.70 In the urea cycle, N disposal
and guanido-amino acid maintenance for their multiple regu-
latory tasks intermix to a considerable extent, as can be deduced
from themodel presented here. The diﬀerent needs for arginine
possibly modulate the sex diﬀerences in expression, but the
enzyme activities follow more closely the regulation mecha-
nisms for N handling.
It has been known for long, that urea production is
decreased by diets rich both in energy and in protein,31
assumedly because of lower urea cycle enzyme activities in the
liver. Our results are consistent with this observation, but, at the
same time, we provide evidence that these diﬀerences, largely
down regulation of enzyme activities, were described, essen-
tially, in males. No suﬃcient data for comparison is available
for females. This is best observed in the halving of three key
enzyme activities in males by feeding a cafeteria diet: arginino-
succinate synthase, arginino-succinate lyase and arginase. Of
these, female rats maintained only the eﬀect on arginino-
succinate lyase; thus, males' downregulation may be traced to
more control points than females, which may help explain the
sex-related diﬀerences in regulation described above. The
consequences on overall function of the cycle are consistent
with the lower urea production observed in rats fed a cafeteria
diet, in studies using mainly males.31,32,71
The relatively low and largely unchanged expression of
endothelial nitric oxide synthase suggests a relatively low
activity, compared with arginase, in their competence for argi-
nine, an eﬀect best seen in peripheral tissues.72 In the present
study, the expression of the enzyme did not change signicantly
at all, which seems to disconnect this enzyme from the main
hepatic degradative pathway represented by the urea cycle. The
fate of the “unaccounted for” dietary nitrogen i.e. that portion of
dietary N not excreted in urine (mainly urea) or faeces, and
neither accumulated in body protein does not seem, thus, to be
related to changes in the capacity of liver for higher nitric oxide
synthesis. Limiting its contribution to the excess nitric oxide
production caused by metabolic syndrome and/or cafeteria diet
feeding.33,73
Liver ability to synthesize citrulline was not decreased by
diet, which suggests that liver may also contribute to the overall
production of citrulline,74 as that observed in adipose tissue.29
The relative inability of the liver to retain and process citrul-
line74 hints at this amino acid not being, in the liver, a critical
factor in the regulation of the cycle, in addition to its overall
importance for arginine metabolism regulation.75
It has been generally assumed that ammonia arriving to the
liver (and that produced in its own catabolism of amino acids) is
a main factor for the control of its disposal through the urea
cycle.76,77 It is obvious that the liver is a formidable barrier that
prevents ammonium from entering the systemic circulation
and thus possibly damaging the nervous system.78 The liver
counts not only with the urea cycle (essentially carbamoyl-P
synthase 1) to incorporate it into urea with amino-N taken
from aspartate, but also with two additional and powerful
ammonium-handling systems (and nitrogen salvage79): gluta-
mine synthetase,80 and glutamate dehydrogenases81 within the
mitochondrion and in the cytoplasm. Compartmentation of
ammonium/ammonia in the cell is also an important82 aspect
that has not been suﬃciently studied.
Carbamoyl-P synthases convert ammonium (or glutamine
amido N) into carbamoyl-P in liver, were practically only the
isozyme 1 has signicant activity.83 The reaction provides
carbon and nitrogen to start the formation of the guanido group
on ornithine, via ornithine carbamoyl-transferase. Following
the trend described for the urea cycle enzymes, no diﬀerences
were observed in gene expressions but cafeteria diet slightly
decreased the enzyme activity in both sexes. These diﬀerences
support the overall function of the cycle described above, since
this enzyme incorporation of ammonia is a key control point in
the synthesis of urea.77
The existence of signicant correlations between activity and
expression for carbamoyl-P synthase and the key regulatory urea
cycle enzymes arginino-succinate synthase and arginase, attest
to a direct translational control of the urea cycle in liver. As
indicated above, these three enzymes have been postulated as
main control points for urea cycle operation. It is worth noting
that only these enzymes, and serine dehydratase, which gene
expression is controlled only by serine availability,84 showed
a direct (statistically signicant) relationship between expres-
sion and measured enzyme activity. Since the analyses have
been done under diﬀerent dietary and sex conditions, the
maintenance of this basic process shows that regulation of gene
translation is a key mechanism of control of the cycle.
The liver is a main site for amino acid partition and N
disposal. This is a consequence of its peculiar placement, at the
end of the portal system, which carries the N debris of intestinal
and microbiota catabolism, modulated by intestinal function.85
In addition, liver has the advantage of using the ammonia
evolved from catabolic reactions directly in its cells. Glutamine
synthetase is placed essentially in the peri-venous cells,86 acting
as last defence barrier against release of ammonium into the
systemic circulation; this enzyme shows a marked sex diﬀer-
ence. NADP+-glutamate dehydrogenase showed a similar
pattern with respect to sex, but cafeteria diet tended to decrease
its expression. Since glutamate dehydrogenase is assumed to
act (in the liver) mainly in the direction of glutamate
synthesis,81,87 its increase in females agrees with the hypothesis
of their enhanced focussing on amino-N sparing.
The signicant (from a quantitative point of view) functional
urea cycle in white adipose tissue introduces a critical question
on the primacy of liver in overall 2-amino N disposal.28,29
Probably, the main role of adipose tissue urea cycle is
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complementary to that of liver, providing arginine and citrul-
line to the rest of the body28 and, perhaps acting as backup
system for the liver amino-N elimination. The limited eﬀect of
diet on the urea cycle of adipose tissue28,29 contrasts with the
marked eﬀects observed here in liver, and help support the
hypothesis that the function of the cycle is not subjected to the
same parameters of control, nor, probably, shares the same
metabolic function in both organs.
The main liver ammonium producing mechanisms are the
purine nucleotide cycle,88 i.e. AMP deaminase,89 glutaminase,90
serine (and threonine) dehydratase91 and the glycine cleavage
system.92 There are other sources, such as amine-oxidases, amino
acid oxidases and a number of enzymes acting on the catabolism
of essential amino acids, but the nature of the N donors suggest
a conjointly limited contribution to the liver ammonium pool.
However, a main source is the ammonia/ammonium carried
from the intestine (and microbiota) by the portal blood.93
The role of AMP deaminase in liver is more complex than its
simple participation in the purine nucleotide cycle,94 since it is
part of the purine salvage pathway.95 In addition, the enzyme
breaks up the AMP generated by adenylate kinase under
conditions of scarcity of ATP or nutrients,96 as a way to control
glycolysis, oen in conjunction with ammonium production.97
Breakup of AMP to IMP also aﬀects AMP-kinases and their
control of energy partition.98 The varied functions of AMP-
deaminase in liver, do not seem to include a signicant role
in the in situ production of ammonium,99 a condition largely
diﬀerent from that of the muscle enzyme, which places the
purine nucleotide cycle as a main mechanism for mineraliza-
tion of amino-N.
The analysis of diet/sex eﬀects on serine dehydratase are
consistent with a sex-related preservation of amino-N in
females, enhanced by the additional protective eﬀects of cafe-
teria diet. Serine dehydratase is a classic example of substrate-
controlled expression/activity,84 and thus, both are correlated.
The expression of protein H of the glycine cleavage system
showed, again an eﬀect of sex. Glycine is also a by-product of
serine, thus the probable increase in its cleavage may not only
represent a way of amino-N disposal, but a much needed source
of 1C fragments for synthesis,100 especially under conditions of
excess energy and amino acids.
It may be assumed that, under conditions of suﬃcient
glucose and energy availability (controls) or in their excess
(compounded by the presence of large amounts of lipid in
cafeteria diet), amino acid metabolism must be hampered in
intestine (and liver) by the ultimate need to preserve amino-N.101
In consequence, it is probable that the porta vein ammonia
would not be increased by cafeteria diet. The nal picture, then,
could be summarized in a controlled, relatively low, availability
of ammonium in the liver under standard conditions, which
may be unchanged or even lowered in cafeteria-fed rats,
depending on intestinal amino acid catabolism.93
Conclusions
The eﬀects observed, both in enzyme activities and expressions
contributing to remove ammonium and those producing it tend
to run in a way similar to that described for the urea cycle:
a generalized down regulation of amino acidmetabolism.71 This
conclusion is in agreement with a decreased urea production,
andmarkedly contrasts with the actually higher availability of 2-
amino N in the rats fed a cafeteria diet.102
This complex intertwining of mechanisms is aﬀected by sex,
in a way that the diﬀerent strategies of amino-N handling by
females and males further modulate the preservation of
2-amino-N when suﬃcient energy is available. The sex-related
diﬀerences are important both in direction and in extension,
and open new avenues for understanding how amino acids are
used for energy, but also how survival and/or sex-related
metabolism strategies modify substrate partition and fate.
The confrontation between amino-N preservation and the
need to dispose of its excess seem to show a winning hand for
preservation as all the data presented above suggest. In any
case, elimination of excess N is necessary and cannot be easily
carried out through the metabolic pathways we know. In any
case, the experimental data show that excess N is removed. The
problem is that we have not yet identied which (necessarily
major) pathway is used for that elimination, so far, we can only
add that it is not urea, and also that the main agent does not
seem to be the liver. In any case, the critical question of the fate
of the 2-amino N ingested but not excreted (faeces, urine) or
accrued in the body of rats fed a high-energy protein-rich self-
selected (cafeteria) diet, remains open.
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ABSTRACT
Background. A ‘‘cafeteria’’ diet is a self-selected high-fat diet, providing an excess of
energy, which can induce obesity. Excess of lipids in the diet hampers glucose utilization
eliciting insulin resistance, which, further limits amino acid oxidation for energy.
Methods. Male Wistar rats were exposed for a month to ‘‘cafeteria’’ diet. Rats were
cannulated and fluorescent microspheres were used to determine blood flow.
Results. Exposure to the cafeteria diet did not change cardiac output, but there was a
marked shift in organ irrigation. Skin blood flow decreased to compensate increases
in lungs and heart. Blood flow through adipose tissue tended to increase in relation to
controls, but was considerably increased in brown adipose tissue (on a weight basis).
Discussion. The results suggest that the cafeteria diet-induced changes were related to
heat transfer and disposal.
Subjects Anatomy and Physiology, Diabetes and Endocrinology, Hematology, Nutrition,
Metabolic Sciences
Keywords Flux, Cafeteria diet, Rat, Tissue blood flow
INTRODUCTION
The cafeteria diets (CD) were devised as a dietary model in which palatability could
overcome the intrinsic control of energy intake of experimental animals and induce
hyperphagia, consequently, its basis is taste and variety (Sclafani & Springer, 1976). There
is a wide variety of formulations of cafeteria diets, all based on these principles, and
have been widely used for the study of late-onset hyperphagic obesity and metabolic
syndrome in animal models (Sampey et al., 2011), since it induces the increase of fat
storage (Rothwell & Stock, 1976). These models have the advantage of being comparable,
at least in its basic characteristics (self-selection, excess energy intake), to human obesity
induced by energy-dense diets (Romero, Esteve & Alemany, 2006). In general, the lipid
intake with CD is grossly increased, while other nutrients are consumed in proportions
barely different from controls: most CD are, thus, hyperlipidic (Prats et al., 1989), and
their effects are more marked in males (Prats et al., 1989; Coatmellec-Taglioni et al., 2003),
not protected by estrogen, and are thus more prone to be affected by glucocorticoids
(Bouclaous et al., 2003; Carsia et al., 2008), which in turn compound the obesogenic effect
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by decreasing the anabolic and protective effects of androgens (MacAdams, White & Chipps,
1986; Retana-Márquez et al., 2003).
In rats, CD increase the accumulation of body fat, but also affect their lean body
mass by favoring growth and protein deposition (Harris, 1993; Lladó et al., 1995). The
hedonic component of CD initially elicits marked increase in food consumption (Rogers &
Blundell, 1984); however, when obesity has been already developed, hyperphagia decreases,
often down to normal food intake. Nevertheless, the accumulated excess persists even
after normalization of energy intake (Davidson & Garvey, 1993; Coatmellec-Taglioni et al.,
2003). The variable presence of sucrose in a number of CD diets can elicit binge eating in
humans (Latner, 2008) and in rodents induce similar situations to metabolic syndrome
(Santuré et al., 2002), probably because of the additional obesogenic effects of fructose
availability (Bocarsly et al., 2010).
All the changes elicited by CD-induced excess energy intake, necessarily influence
the interorgan metabolic relationships, changing their ability to control and metabolize
substrates (Macedo et al., 2015), the storage of excess energy as reserves (mostly fat),
affecting the whole body energy economy to the new pathologic situation. Since dietary-
restricted (Nutter et al., 1979) or malnourished rats (Sakanashi, Brigham & Rasmussen,
1987) show decreased heart blood output, in connection with their decreased energy
consumption mode, we expected that overfed animals, with excess energy available could
show a reverse blood output pattern. The hypothesis was to assume that a higher blood
flow in the rat tissues would favor the metabolic interchange and thus help increase energy
expenditure and substrate disposal (including storage). Thus, in the present study we have
intended to determine whether a common hyperlipidic CD could affect significantly the
overall and individual organ blood flow.
MATERIALS & METHODS
Animal handling conditions
The experimental setup and all the animal handling procedures were carried out in accor-
dance with the guidelines established by the European, Spanish and Catalan Authorities.
The specific procedures used in this study were authorized by the Committee on Animal
Experimentation and Ethics of the University of Barcelona (Procedure DAAM 6911).
Animals and diets
Nine week oldmaleWistar rats (Harlan Laboratories Models, Sant Feliu de Codines, Spain)
(initial weight 288±2 g) were used. Two groups of 12 animals were randomly selected and
were fed ad libitum for 30 days with either normal rat chow (#2014 Harlan) or a simplified
hyperlipidic cafeteria diet (Esteve et al., 1992b); the groups were named ‘‘control’’ and
‘‘cafeteria,’’ respectively. The rats were housed in 2-rat cages, and were kept in a controlled
environment (lights on from 08:00 to 20:00; 21.5–22.5 ◦C; 50–60% humidity). They had
free access to water. The rats in the Cafeteria group were fed with fresh offerings of excess
chow pellet, liver pâté spread on cookies, bacon and milk enriched with 300 g/L sucrose
and 10 g/L of a protein, vitamin and mineral supplement (Meritene, Nestlé Nutrition,
Barcelona, Spain) (Esteve et al., 1992a; Esteve et al., 1992b). Consumption of every item in
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the CD was recorded daily and converted into nutrient/energy equivalents to establish
the actual intake of nutrients in their food selected by the cafeteria group. Body weight
was recorded along with food consumption. In the standard diet, 13% of total energy
was derived from lipids, 20% from protein and 67% from carbohydrates. In the cafeteria
diet, those percentages (mean values) were 43%, 14% and 43%, respectively for the whole
period analyzed.
Permanent cannulations
On day 27, all rats were implanted with two cannulas through the left carotid artery using
Intramedic PE-10 polyethylene tubing (BectonDickinson, Parsipanny, NJ, USA), (0.28mm
id/0.61 mm od) under isoflurane anesthesia. The first carotid cannula was used to draw
blood from the descending aorta and the other to inject microspheres directly into the
heart outflow as previously described (Ardévol et al., 1998). At 12 h intervals, the viability
of the cannulas was checked (without disturbing the animals) by drawing blood up a few
mm into the capillary tube, followed by refilling with heparinized saline. On day 30, the
rats were injected through the left ventricle cannula with 105 red latex beads (Molecular
Probes, Carlsbad, CA, USA) suspended in 0.1 ml of 9 g/L NaCl. At the same time, about 0.2
ml of blood were slowly drawn through the other cannula for exactly one minute. Then,
the rats were anesthetized with isoflurane, and larger blood samples were drawn by aortic
puncture, euthanizing them. The blood was used to obtain plasma, which was frozen and
kept at −80 ◦C. After sacrifice, the position of the cannulas was checked; no placement
errors nor cannula clotting were found. Tissue samples were obtained, frozen, and then
maintained at −80 ◦C. The weights of all organs sampled were also recorded.
Blood flow analysis
Blood and tissue samples of known volume/weight were digested with 4 M KOH at
25 ◦C for 24 h with occasional stirring. The samples were filtered through glass-fiber
filters (GF/D, 2.5 µm; Whatman, Maidstone, Kent, UK), which retained the colored latex
microspheres. The filters were washed with 20 g/L Tween-20 followed by distilled water.
Then, the fluorospheres were extracted from the filter with 2.5 ml of etoxyethyl acetate.
A fluorimeter (RF1501 Shimadzu, Kyoto, Japan) was used to measure the fluorescence
(at 598 nm emission wavelength) under a red excitation light (565 nm), using adequately
diluted samples compared against tissue blanks (i.e., pieces of the same tissue of rats from
other experiments which had not received fluorescent beads). At least two samples for each
tissue and rat were analyzed. The whole procedure was performed in accordance with the
instructions provided by the supplied of the fluorescent beads. The number of beads in the
tissue samples were estimated from the differential bead extract fluorescence, which was,
then, extrapolated to the whole tissue or organ mass. Percent distribution of bead numbers
between the different organs was used to determine the distribution of blood flow between
the different organs (as percentage), since the total amount of beads injected was known.
A sample of the injected material was also analyzed to correct for possible errors in the
evaluation of injected bead numbers (Bassingthwaighte et al., 1990).
The calculation of cardiac output was performed by measuring the amount of beads in
the blood drawn from the artery for exactly one minute. The estimated bead concentration
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and the known amount of beads injected allowed the calculation of cardiac output
(Closa et al., 1993). In any case, as additional checking, an indirect value of heart output
was calculated from body mass (Delp, Evans & Duan, 1998) at rest; the data obtained using
both approaches were similar, and thus we used the experimental value for the ensuing
calculations.
Absolute blood flows were calculated from the number of beads leaving the heart per unit
of time (i.e., absolute heart output), blood volume and the percentage of beads distributed
between the different organs of each rat.
Other analyses
Total bodymusclemass was estimated from selectivemyosin precipitation from theminced
and high-concentration lithium chloride-dissolved rat carcass, as previously described
(Arola, Herrera & Alemany, 1979). Glucose in plasma with a glucose oxidase kit #11504
(Biosystems, Barcelona, Spain) supplemented with mutarotase (490 nkat/mL of reagent)
(Calzyme, San Luis Obispo CA, USA). Mutaroratase was added to speed up epimerization
equilibrium of α- and β-D-glucose and thus facilitate the oxidation of β-D-glucose by
glucose oxidase (Miwa et al., 1972).
Statistical analysis
The data were expressed as mean± standard error. The unpaired Student’s t test was used
for comparisons between groups (n= 12). Statistical analyses were performed using the
Prism 5 program (Graph Pad Software, La Jolla, CA USA). Significant differences were
stablished at p< 0.05.
RESULTS
After one moth of treatment, control animals weighted 370 ± 15 g and those in the
cafeteria-fed group 450 ± 11 g (p< 0.05 vs. controls), these values and those of plasma
metabolites were similar to other previously described obtained the same dietarymodel and
handling setup (Herrero et al., 1997).Mean dailymetabolizable energy intake of control rats
was 7.34 ± 0.36 kJ, rats in the cafeteria group ingested 18.4 ± 0.76 kJ/per day (p< 0.05 vs.
controls). Plama glucose values were similar in both groups (9.97 ± 0.18 mM for controls
and 9.68 ± 0.33 mM for cafeteria group).
Table 1 presents the effects 30-day exposure to the cafeteria or standard chow diet
on relative organ weight, blood flow and cardiac output. The only significant individual
differences in relative organ weight between both groups corresponded to brain, large
intestine, lungs and a couple of white adipose tissue sites. The rest of organs showed
remarkably similar weights in spite of a slight trend of cafeteria diet-fed rats to increase
their size in, in accordance with their higher body size.
The cardiac output data were similar in both dietary groups. However, in absolute
terms, blood flows were higher in most organs and tissues of cafeteria group compared
to those in the control group but their weight/size were also higher. The ratios of blood
flow for each organ (irrespective of size) between the cafeteria and control groups were
higher than 1 for all tissues, except for skin, with IBAT (x4), heart (x3) and lungs (x2.5)
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Table 1 Organ and tissue weight and blood flow of rats fed a cafeteria diet for one month compared with controls on a standard rat chow diet.
Tissue/organ Control diet Cafeteria diet Absolute
blood flow
ratios:
cafeteria/control
P values
Organ/tissue
weight (%bw)
Relative
blood flow
(mL/min g)
Absolute
blood flow
(mL/min)
Organ/tissue
weight
(%bw)
Relative
blood flow
(ml/min g)
Absolute
blood flow
(mL/min)
Weight Relative
flow
Absolute
flow
Skeletal muscle 39.51± 2.41 0.29± 0.029 37.7± 6.3 39.23± 3.11 0.31± 0.042 56.0± 5.1 1.49 NS NS 0.049
Skin 15.14± 0.63 0.48± 0.19 26.3± 6.3 13.27± 0.64 0.12± 0.03 6.8± 1.7 0.26 NS NS 0.014
Liver (arterial) 2.72± 0.11 0.24± 0.067 2.27± 0.64 2.67± 0.18 0.56± 0.11 5.34± 0.60 2.35 NS 0.032 0.006
Liver (total) 14.6± 3.98 17.2± 3.07 1.18 NS
Small intestine 0.82± 0.02 1.77± 0.75 8.47± 3.57 0.69± 0.06 2.34± 0.2 8.65± 1.90 1.02 NS NS NS
Kidneys 0.59± 0.02 4.56± 1.23 9.43± 2.46 0.54± 0.02 4.77± 0.69 10.8± 1.7 1.15 NS NS NS
Brain 0.53± 0.01 0.65± 0.24 1.27± 0.47 0.45± 0.02 1.09± 0.31 2.09± 0.61 1.65 0.005 NS NS
Large intestine 0.41± 0.02 1.46± 0.37 2.17± 0.59 0.31± 0.01 2.29± 0.38 2.88± 0.46 1.33 0.001 NS NS
Lungs 0.39± 0.01 0.47± 0.11 0.60± 0.10 0.31± 0.01 1.08± 0.41 1.49± 0.24 2.48 <0.001 NS 0.006
Stomach 0.34± 0.02 0.91± 0.3 1.14± 0.38 0.34± 0.02 1.1± 0.15 1.60± 0.26 1.40 NS NS NS
Heart 0.26± 0.01 0.34± 0.18 0.31± 0.17 0.26± 0.01 0.81± 0.38 0.94± 0.22 3.03 NS NS 0.043
Pancreas 0.14± 0.003 1.68± 0.46 0.62± 0.16 0.12± 0.003 1.62± 0.41 0.80± 0.18 1.29 NS NS NS
Adrenal glands 0.020± 0.005 3.12± 0.67 0.22± 0.04 0.017± 0.004 5.11± 0.77 0.35± 0.04 1.59 NS NS NS
Interscapular BAT 0.11± 0.002 0.21± 0.074 0.073± 0.021 0.11± 0.001 0.59± 0.22 0.30± 0.09 4.11 NS NS 0.034
Subcutaneous WAT 1.65± 0.03 0.12± 0.049 0.70± 0.30 2.17± 0.02 0.084± 0.036 0.77± 0.33 1.10 <0.001 NS NS
Mesenteric WAT 0.92± 0.02 0.27± 0.038 0.49± 0.16 0.92± 0.02 0.18± 0.06 0.71± 0.25 1.46 NS NS NS
Retroperitoneal WAT 0.72± 0.02 0.062± 0.02 0.18± 0.05 1.11± 0.01 0.039± 0.008 0.35± 0.18 1.94 <0.001 NS NS
Epididymal WAT 0.42± 0.01 0.093± 0.04 0.12± 0.06 1.06± 0.02 0.041± 0.008 0.30± 0.13 2.50 <0.001 NS NS
Pericardial WAT 0.07± 0.007 0.40± 0.125 0.088± 0.029 0.07± 0.004 1.79± 0.51 0.45± 0.11 1.16 NS 0.024 0.009
Sum of 5 WAT sites 3.84± 0.02 1.34± 0.25 5.31± 0.04 2.29± 0.34 1.71 <0.001 0.045
Cardiac output 111± 10 116± 14 NS
Notes.
Values are presented as means ± sem.
Liver (total)= 6 liver (arterial)+ small intestine+ pancreas+ stomach+ large intestine; BAT= brown adipose tissue; WAT= white adipose tissue.
Statistical significance of the differences between groups was estimated with Student’s t test.
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showing the maximal differences between both dietary groups. The maximum differences
observed were in the interscapular brown adipose tissue mass, which irrigation was more
than four-fold higher in the cafeteria than in controls. This contrasts with the case of skin,
which, in cafeteria group, only received about one fourth of the blood than controls. In
white adipose tissue, when compared on a tissue weight basis, the only significant increase
in irrigation corresponded to the small but highly active pericardialWATmass, followed (in
decreasing order) by epididymal, retroperitoneal and mesenteric sites, which did not show
significant increases in cafeteria vs. control groups in spite of their larger size. However,
the combined total adipose mass showed a significant increase in blood flow.
In the liver, experimental microsphere data represent only the arterial inflow, which
was higher in cafeteria than in the control group. Total liver blood flow, which can be
calculated adding the arterial inflow to the plus portal flow data (i.e., approximately the
sumof pancreas, stomach, intestines andmesentericWAT) did not show, either, differences
between both groups.
When the absolute blood flows were corrected by weight, most of the differences
described above disappeared, leaving only those for pericardial adipose tissue and liver
arterial, but not total, blood inflow. These data suggest that the cafeteria diet altered only
partialy, but significantly, blood flow distribution; the differences observed being largely a
consequence of different tissue or organ relative mass, ultimately a consequence of excess
energy availability and deposition.
DISCUSSION
The cafeteria diets are essentially hyper-energetic, tipically hyperlipidic, with mean protein
and total carbohydrate intakes proportionally not different from controls fed standard rat
chow (Prats et al., 1989; Ferrer-Lorente et al., 2007). As expected, a one-month exposure
to the cafeteria diet caused overfeeding and resulted in higher body weights, which
translated into a marked increase in adipose tissue depot size and higher muscle mass
than those of controls. This is in agreement with previous studies showing that cafeteria
(and other high-energy, self-selected tasty hyperlipidic diets) increased fat deposition
(Sclafani & Springer, 1976), growth, protein accrual (Harris, 1993; Esteve et al., 1992a) and,
also, increased energy output (Ma & Foster, 1989). Glucose plasma levels did not show
differences caused by dietary treatment, as a direct consequence of increase in plasma
glucose caused by anaesthesia (Zuurbier et al., 2008).
The comparison of the patterns of distribution of blood flow between the control and
cafeteria groups agrees with the increase in the importance of brown adipose tissue-related
thermogenesis (Tulp, Frink & Danforth, 1982; Ma & Foster, 1989) since this tissue blood
flow in was almost four-fold higer in cafeteria group then in controls. Thermogenesis was
essentially based on the uncoupling of the mitochondrial proton inflow (used to drive the
synthesis of ATP via the directional ATPase system) generated in the oxidative part of the
respiratory chain because of the adrenergic activation of a specific uncoupling protein in
the inner mitochodrial membrane (Ricquier et al., 1984; Rial & González-Barroso, 2001).
This mechanism allows dissipating energy as a heat, and its presence is magnified in small
mammals such as rodents, with a high surface to volume ratio.
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The blood flow of heart and lungs were also higher in the cafeteria group, which
contrasts with the similar heart output of both groups. Consequently, more oxygen
was available to maintain the activity of the heart in the rats of cafeteria group, despite
showing a similar pumping effectiveness than in controls. The same can be said of lungs.
However, the skin blood flow in cafeteria rats was greatly reduced compared with controls.
We know that cafeteria diets increase the body energy expenditure and heat output
(Ma & Foster, 1989), and, in rats, most of this heat is eliminated through evaporation,
largely throughout the respiratory tract rather than from the loss through the skin surface
observed in larger mammals as man, by means of higher blood circulation (conduction,
radiation, convection). This lowered skin blood flow has been previously observed in
other metabolic conditions in which energy expenditure was increased, such as active
exercise in obese rats, in which skin circulation was maintained in lean but decreased in
obese rats (Ardévol et al., 1998). This suggests that heat loss through skin radiation in rats
may be inversely related to body size (including changes in fat stores), thus favoring lung
evaporation as main heat-loss control mechanism. Probably, this form of control is more
flexible and has less thermic inertia and effectiveness than the loss of heat though a skin
evolutively prepared (at least in small, furry mammals) to prevent heat loss. The data
on blood flow presented here, under standard, i.e., non-exercise, conditions, supports the
postulated heat loss control mechanism shift.
The similarity of blood flows to the liver suggests that the intestine is already efficient
organ for the extraction of nutrients, nutrients does not need additional blood (essentially
oxygen input and substrates output) supply compared with controls. This may be, in part,
a consequence of the global easier digestibility overall of the non-lipid components of the
fiber-laden chow compared with the heavy disaccharide content of the CD. The CD energy
density is larger than that of the control diet, but the volume of solids actually ingested was
not much different between both groups.
The trend to increase blood flow in white adipose tissue suggests a harmonic growth
pattern affecting all of them, which is probably a consequence of being part of a single
disperse organ (Cinti, 2005), but also by the uniform metabolic response to excess energy.
This includes fairly uniform distribution of fat stores in adipose and non-adipose tissues
(Romero et al., 2014).
The higher blood flow to striated muscle observed in the cafeteria group is in agreement
with a steadier (and increased) supply of substrates to sustain muscle growth and
maintenance, coincident with the described increase of amino acid availability (Herrero et
al., 1997) and body protein accrual of cafeteria diet-fed rats.
The ingestion of a self-selected hyperlipidic cafeteria diet induces the modification of
energy partition (Sclafani & Springer, 1976), insulin resistance (Davidson & Garvey, 1993),
accumulation of fat (Rogers & Blundell, 1984; Harris, 1993), increased energy expenditure
(Tulp, Frink & Danforth, 1982; Ma & Foster, 1989) and decreased production of urea
(Barber et al., 1985). To this list we should add that after a relatively short-time (one
month) of exposure to the diet, thermogenesis is most likely kept high, but blood flow
distribution is markedly changed in a waymost likely related (at least in part) to the disposal
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of excess heat (i.e., lungs’ evaporation vs. skin radiation and conduction) and to support
normal function and body groth and accrual of protein and fat.
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Abstract 
Objective. To determine whether doubling the protein content in the diet induced significant changes in 
enzymes of amino acid metabolism along the intestine. 
Design. Six adult male rats were fed a standard (control diet), and six more were given a hyperproteic 
diet (HPD) for 30 days. Then they were killed and the small intestine divided in three equal-length 
segments. These were used for the measurement of amino acid (AA) metabolism enzyme activities 
and enzyme gene expressions. 
Results Most AA enzyme genes were expressed along a marked gradient: higher near the stomach. 
AMP-deaminase, and carbamoyl-P synthetase activities followed this pattern, but there were no 
changes in Orn-transcarbamylase. There was a fair coincidence between gene expression and 
enzyme activities. There were no significant differences between HPD and control diets. However, the 
longitudinal patterns of expression and activity were less marked in HPD than in control rats. 
Conclusion In conclusion, we observed an anisotropic distribution of the main amino acid metabolism 
enzymes along the small intestine, with generally highest expressions (and activities) in the upper 
segments and lowest near the gross intestine. Feeding for one-month HPD induced little change (not 
significant) in the distribution of enzyme activities and expressions per unit of protein weight. It is 
speculated that this lack of changes may be part of a mechanism preventing amino acid wasting. 
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Summary box 
What is already known about this subject: 
 Hyperproteic diets result in increased nitrogen excretion 
 Excess amino-nitrogen in the intestine elicits the activation of urea cycle in the intestine, 
exporting its intermediary metabolites and ammonia to the liver for completion of the cycle 
 Hyperproteic diets have been used (with mixed success) for the treatment of obesity, but the 
mechanisms are unknown 
What are the new findings 
 Doubling the protein content in the diet does not affect the expression of genes or activities of 
the main amino acid metabolism enzymes in the intestine 
 There is a marked gradient in gene expression and activities of the enzymes from (maximal) 
duodenum to the end of ilion 
 Maximal amino acid enzyme activities and gene expressions do not coincide with the 
expected intestinal zones of amino acid absorption resulting from dietary protein digestion 
How might it impact on clinical practice in the foreseeable future? 
 Hyperproteic diets should not be used to treat obesity, since the small intestine amino acid 
metabolism is not altered by dietary protein, i.e. not acting on the problems posed by the 
handling of excess amino nitrogen 
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Introduction 
In spite of the wide use of hyperproteic diets for the treatment of obesity and related diseases (1;2), 
our knowledge of their actual metabolic effects on energy partition and on general regulation of 
metabolism are largely unknown (3;4). There are several reasons explaining the limited interest for 
this important field, which reached its zenith in the late seventies of last century (5), namely, the 
considerable difficulties posed by the fast interconversion of amino acids, with the N moiety being 
processed by a complex network of inter-organ paths, and the hydrocarbon moieties being 
incorporated, again in different organs and multiple paths, in the intermediate metabolism (such as 
glycolysis / gluconeogenesis, Krebs cycle, One-carbon pathways). These functions add to the role of 
amino acids as building bricks for proteins and as donor of N for the synthesis of purine, pyrimidine, 
porphyrins and a number of signalling molecules (i.e. nitric oxide, catecholamines) of critical 
importance in regulation. 
In addition, the whole of body protein may be considered a reserve of energy and potential energy and 
gluconeogenic substrates (6), with intricately complex mechanisms set in place to preserve body N, 
for the salvage and turnover of amino N under conditions of starvation (5;7;8). However, under excess 
substrate availability, these mechanisms may pose a serious problem for energy and N homoeostasis 
(9). Unfortunately, most of the studies available refer to conditions of scarcity, malnutrition and 
starvation (7;8), and thus we keep using high-energy high-protein diets for a number of assumed 
physiological effects, but too often without analyzing the fate of the excess of dietary protein (or amino 
acid) intake (10;11). 
Since protein digestion is slow, and requires the sequential denaturation and breakup of peptide bonds 
in dietary proteins, set at different places along the gut, we hypothesized that a high protein diet may 
alter this process, in concordance with changes in the microbiota, already known (12), and a 
modulation of the N balance, favouring a higher N excretion (13;14), largely via increased urea 
production (15). However, the use of high-energy, high-protein diets (i.e. cafeteria diets) in 
experimental animals results in a lower production of urea (10), excess N being eliminated through so 
far not fully identified pathways (16). The alteration of N balance under conditions of excess energy 
availability results in a deeply altered excretion of N (11;16). In the present study we have studied the 
expression of some of the most critical enzymes in overall amino acid metabolism in the splanchnic 
bed along the small intestine. In this case we selected the small intestine because in the stomach, 
dietary proteins are cut down by endopeptidases to produce peptones, with no significant amino acid 
uptake and metabolism. Similarly, in the large intestine contents, most of the dietary protein amino 
acids have been already released and absorbed, with most of the remaining catabolic activity being 
carried out by the microbiota. It is in the small intestine where most of the protein digestion takes 
place, where amino acids are assimilated, and in a significant part modified (7). It is in the small 
intestine (in parallel and in coordination with the kidney and other splanchnic organs) where most of 
the urea cycle is initiated under conditions of excess amino-N, and urea cycle precursors are 
conducted to the liver via porta vein for the cycle to continue there (17). Thus, we analyzed a number 
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of genes controlling the synthesis of amino acid metabolism enzymes along the small intestine, 
complementing the study with the measurement of the specific activities of key enzymes of the 
intestinal leg of the urea cycle, under conditions of high-protein feeding. We expected the pattern of 
enzyme gene expression (and activities) to change in parallel to the increased supply of amino acids. 
 
Materials and Methods 
Ethics statement 
All animal handling procedures and the experimental setup were carried out in accordance with the 
animal handling guidelines of the European, Spanish and Catalan Authorities. The Committee on 
Animal Experimentation of the University of Barcelona authorized the specific procedures used. 
Diet 
Common rat chow (Teklad global 14% protein rodent maintenance diet, Harlan Laboratories, Madison 
WI) was used after weaning and for the duration of the experiment in control animals, and up to 14 
weeks in animals later receiving hyperproteic-diet (HPD). The HPD was prepared by crushing to a 
coarse powder the common rat chow described above. To produce about 1 kg of HPD pellets, a 
mixture 87 g of powdered alimentation-grade pure gelatin, 100 g of purified powdered casein, 702 g of 
crushed standard chow, and 9.5 g of sunflower oil were suspended in 725 mL of water, and stirred, 
forming a paste which was thoroughly mixed and then extruded through cut-off syringes to form 
pellets; they were dried in an oven at 45ºC for 24 h. 
The final composition of the pellets, compared with control chow is shown in Table 1. The consistency 
of the dried HPD pellets was comparable to that of the standard one. Their composition was the 
expected with respect to N content (about twice that of control pellets), and its calculated (from its 
composition) and crude energy (adiabatic bomb calorimeter, IKA C7000; IKA, Staufen, Germany) per 
g were comparable (Table 1). The main difference between control and HPD diets were limited to 
lower carbohydrate versus protein and a relative decrease in mineral and specific micronutrient 
content in the HPD. 
Animals 
Fourteen-week-old male Zucker lean rats (Harlan Laboratories Models, Sant Feliu de Codines, Spain) 
were used. Half of the rats (N=6 for each group, randomly selected) were shifted to the HPD for 30 
days, while the controls continued ingesting the standard chow. The animals were kept in 3-rat solid-
bottom cages (with wood shards as bedding material, changed every 2 days) in a controlled 
environment: free access to their diet and tap water, lights on from 08:00 to 20:00, humidity 60-70 %, 
temperature 20.5-21.5ºC. 
Food intake was measured, as well as the weights of the animals (in fact consumption per cage) on 
alternate days. On day 30, the rats were killed by exsanguination under isoflurane anesthesia. 
Dissection and intestine sampling 
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The rats were dissected immediately after death, their small intestine cut out of the visceral cavity, 
cleaned of mesentery and fat cordons, their contents carefully extruded out and then internally washed 
with a gentle stream of ice-cold KCl (9 g/L). The excess water was extruded and the intestine blotted 
and weighed; then it was extended unstretched, and cut in three equal length parts: I, II and III, I being 
that closer to the stomach and III to the gross intestine. I contained the duodenum and part of jejunum, 
II jejunum and part of ilion, and III ilion alone. The parts were frozen in liquid nitrogen, crushed to a fine 
powder, and distributed in several containers, before storage at -80ºC until processed. 
Gene expression analysis 
Tissue total RNA was extracted from frozen tissue samples (about 30 mg) using the GenEluteTM 
procedure. Total RNA was quantified using a ND-100 spectrophotometer (Nanodrop Technologies, 
Wilmington DE USA). RNA samples were reverse transcribed using the MMLV reverse transcriptase 
(Promega, Madison, WI USA) and oligo-dT primers. 
Real-time PCR amplification was carried out using 10 μL amplification mixtures containing Power 
SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA USA), equivalent to 4 ng of 
reverse-transcribed RNA and 300 nM primers. Reactions were run on an ABI PRISM 7900 HT 
detection system (Applied Biosystems) using a fluorescent threshold manually set to OD 0.150 for all 
runs. 
A semiquantitative approach for the estimation of the concentration of specific gene mRNAs per cell or 
unit of tissue weight was used (18). Rplp0 was used as charge control gene. The data were presented 
as the number of transcript copies per gram of protein. The genes analyzed and a list of primers used 
is presented in Table 2. 
Measurement of enzyme activities 
Frozen intestine samples were homogenized using a tissue disruptor (IKA-T10 basic Ultra-Turrax, 
IKA, Stauffen Germany) in 10 volumes of chilled Krebs-Ringer bicarbonate solution, pH 7.8 containing 
5 mM dithiothreitol, 0.5% bovine serum albumin, 1% dextran (MW 200,000), 0.1% Triton X-100, and 1 
mM EDTA (19). All incubations were carried out at 37ºC using freshly homogenized homogenates. 
Adenylate deaminase (EC 3.4.5.6) was estimated with a previously described method (20), based 
essentially on incubation of the crude homogenate with AMP, stopping the reaction from 0 up to 16 
minutes (3-4 time-points) with cold trichoroacetic acid and then measuring the ammonia released with 
the Berthelot reaction. Initial (V0) activities were determined from the course of the reaction at different 
times. V0 was assumed to correspond to Vmax under the conditions of analysis. Activity was expressed 
as nkat/g of protein. 
Carbamoyl-P synthetase 1 (EC 6.3.4.16) was measured with a method developed by us and 
previously published (21), based essentially on the utilization of 
14
C bicarbonate and ammonium (in the 
presence of N-acetyl-glutamate) to synthesize carbamoyl-P. Excess 
14
CO2 was flushed with a current 
of cold CO2 and the remaining label (i.e. 
14
C-carbamoyl-P) was counted. The same multiple measured 
and analyses of V0 described above were also used for this enzyme. 
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Ornithine carbamoyl-transferase (EC 2.1.3.3) was measured using the incubation conditions described 
by McLaren and Ng (22), in a setting of multiple measurements along time as described above for 
other enzymes. The homogenization medium was a pH 7.4 HEPES 75 mM buffer, containing 1 mM 
dithiothreitol, 50 mM KCl and 10 g/L defatted bovine serum albumin (Sigma-Aldrich, St.Louis, MO 
USA). The method was based on the incorporation of carbamoyl-P to 
14
C-ornithine to yield 
14
C-
citrulline. The amino acids were separated through thin-layer chromatography (silicagel sheets SIL 
G25 Macherey-Nagel, Düren, Germany) and counted. After correction for blanks and specific activity 
of labelled amino acids, production of citrulline was estimated. 
Protein content in each of the homogenates used for enzyme analysis was estimated with a 
colorimetric method (23). These data were also used to establish the tissue protein content. 
Statistical analyses 
Comparisons between groups were done using two-way ANOVA analyses and the Bonferroni post-
hoc test with the Prism 5 (GraphPad Software, San Diego CA USA) graphics/statistics package. 
Analyses of correlations and curve fitting (i.e. for V0 estimation) were carried out using the same 
program set.  
 
Results 
Table 3 shows the comparison of rat and intestine weights, and intake at the end of the 30-day dietary 
treatment. There were no differences in body weight (neither in body composition, data not shown). 
Intestine weight was slightly (albeit significantly) smaller in HPD-treated rats than in controls (mean 
1.4% of body weight versus 1.6%). 
There were no differences in mean gross energy intake between both groups, but N intake was about 
twice (as expected) in HPD than in controls; the proportion of energy derived from diet protein versus 
total diet energy was twice in HPD than in controls. 
Tissue protein content was uniform for the three segments and there were no differences between 
control and HPD groups (range: 17-18 g/kg fresh weight; maximal difference between segments about 
6%). 
Figure 1 presents the patterns of gene expression for the amino acid metabolism enzymes studied. 
There were no differences between expressions for any gene between HPD and control intestines. 
However, in most cases, there were significant differences in expressions along the three intestine 
segments (alanine transaminase 1, AMP deaminase, both carbamoyl-P synthetases, arginino-
succinate synthetase, arginase 2, glutamine synthetase, N-acetyl-glutamate synthetase and neural 
nitric oxide synthetase). No detectable expression of the gene for arginase 1 was found in intestine. 
In general, most patterns showed the highest levels of expression in segment I and the lower in III (i.e. 
the pattern showed by AMP deaminase), this general pattern showed slight modifications, with the II 
fraction expression levels being closer either to those of I or III, but in general, the loss of expression 
along the intestine was the norm for most genes analyzed, the differences being significant for the 
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gene-enzymes listed above. In a number of cases there were no appreciable differences in gene 
expression between the three segments (controls of ornithine transcarbamylase, glutamine 
synthetase, and both groups of glutaminase and arginino-succinate lyase). 
Figure 2 shows the results for enzyme activites in the intestine fractions of rats fed control of HPD 
protein. The pattern for AMP deaminase activity closely followed that of its gene expression (Figure 1), 
with a pattern of rapidly decreasing activity in controls, and a more contained decrease (observed only 
in fraction III) for HPD-fed rats. The differences were significant for diet and segment. The decrease in 
activity of carbamoyl-P-synthetase 1 in controls was similar (decreased along the length of the 
intestine) than its expression, with little, if any, change in HPD-fed rats; no significant differences were 
observed between groups. Ornithine transcarbamylase activity showed also some differences with the 
data for gene expression, especially in controls, where the maximal activity was found in segment II, 
making the differences between segments significant. 
 
Discussion 
The most remarkable finding of this study is the lack of changes elicited on the expression (and largely 
on activity) of enzymes of amino acid metabolism in the intestine of rats subjected to a hyperproteic 
diet. We expected an adaptive modulation of the intestinal capacity to begin the process of disposal of 
excess amino-N (24), but the changes observed were minimal, with no reflection on statistical 
significance, which contrasts with the adaptive uptake of amino acids and adjustment of the rate of 
digestion to amino acid availability (25-27). 
It is known that excess protein intake favours the utilization of intestinal amino acids for the synthesis 
of urea cycle intermediates (15), thus initiating an urea cycle that is later completed in the liver via 
formation of arginine (28), largely from portal vein-carried urea cycle intermediaries (29;30). Their 
origin of this citrulline can be traced to the production of ammonia, or utilization of glutamine (31) 
followed by the combined actuation of carbamoyl-P synthetases and ornithine transcarbamylase 
(28;32): This process is in part modulated by enterocyte  NADPH, which is dependent on glucose 
availability (29). Thus, protein amino acids are partially spared under conditions of high dietary glucose 
content (or release through digestion), in a way parallel to N sparing under starvation (7;8).  
The results obtained for enzyme activities and their gene expression show similar patterns, which 
helps reinforce the assumption that the lack of changes elicited by diet is only of limited extent. The 
rather uniform energy intake, lack of changes in body weight and composition, in spite of doubling the 
intake of 2-amino N, agree with this “passive” role of intestine in the control of amino acid availability.  
We have found a significant presence of all urea cycle enzymes in intestine, including arginase 2 but 
not arginase 1 (unpublished results). Not all genes for amino acid enzymes behaved in the same way: 
maximal differences between control and HPD were found for neural-type nitric oxide synthase, and 
the limited change observed in glutamine metabolism enzymes, in spite of glutamine being a critical 
nutrient for intestine (30) and this splanchnic organ one of the main sites for glutamine conversion to 
ammonia (33;34).  
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In addition to the lack of effect of a hyperproteic diet, we also observed a clear distribution of amino 
acid metabolism enzymes (through the differential expression of the genes for these enzymes) that 
tends to accumulate most activities in the upper (duodenum, jejunum) segments in detriment of the 
lower small intestine (ilion). This is, again, counterintuitive, since protein digestion is a slow process 
(25), needing the sequential action of endopeptidases, exopeptidades and, finally dipeptidases and 
transport systems. Logically, the maximal availability of amino acids released from dietary protein 
would be found in the farthest parts of the intestine, where the digestion took more time. Precisely, the 
short extent of duodenum, and the perennial absence of contents in the jejunum (etymologically “I 
fast”) loads the brunt of protein digestion in the ilion. We have found, consistently, that both enzyme 
activities and gene expression were lowest for the distal small intestine, where most of amino acid 
absorption is supposed to take place (35;36) in spite of the highest transporting capacity of amino 
acids in small intestine having been identified --too-- in its initial segments (37). However, absorption is 
regulated by dietary protein load as a way to regulate the flow of 2-amino N to the liver (26) . 
Then, why most amino acid degrading enzymes, including the starters of urea cycle (and even 
transporters) are concentrated in the fractions I or I+II?. We can speculate that this disposition 
prevents a massive oxidation of dietary amino acids, since most of them would be released in the III or 
II+III segments, where they have more probabilities of being absorbed and transferred to the portal 
vein intact. However, when the diet is frankly rich in amino acids, the secretion of peptidases increases 
(24;27), and probably a significant part of amino acids may be released in the upper small intestine 
within reach of catabolic pathways. We can further speculate that the imperviousness of intestine 
amino acid enzyme distribution to excess protein intake (and expected parallel increase in 2-amino N 
availability) is in itself a mechanism to limit amino acid oxidation, leaving to the automatic release of 
peptidases and transport (26;27) the brunt of control of digestion (and that of absorption and 
oxidation). 
A particular case is that of ornithine transcarbamylase activity, which pattern resembles that of of its 
gene expression, but the peak activity is (in both groups) placed in fraction II, which suggests that a 
key enzyme in the intestine side of the urea cycle operation (38) works along the whole length of the 
intestine, with a maximum at the center of the organ length.  
Another peculiar finding is the marked differences observed in AMP deaminase, a critical enzyme of 
the purine nucleotide cycle (39), which produces ammonia from aspartate (in fact from almost any 
amino acid (40)) for local use by carbamoyl-P synthetase or exportation to the liver (41). In controls, 
the fall of gene expression and enzyme activity is clear and linear, but in HPD-fed rats, the fall only is 
observed in fraction III. This “delay” may be part of a mechanism in which the only sensitive part of the 
intestine to a protein load may reside in its median part. AMP deaminase is a critical regulatory 
enzyme controlling the levels of AMP (42), and thus AMP-kinases (43) and the control of glycolysis 
(44). AMP deaminase is inhibited by metformin (43), a fundamental drug for the treatment of 
hyperglycemia. But most of AMP deaminase is present in the upper part of the intestine, precisely 
where free glucose is absorbed and not in the rest of the intestine, which absorbs the glucose, 
released from polysaccharide digestion. The placing of AMP deaminase largely in the duodenum 
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suggests that its main role is related to control glucose uptake/metabolism through AMP-kinase (45) 
rather than its participation in ammoniagenesis of the purine nucleotide cycle. 
In any case, the data from rats fed HPD show a less marked precipitous fall of expression/activity from 
fractions I to III, suggesting a possible localized extension of highly catabolic upper intestine 
environmental conditions as a response to HPD, but this is only an observation apparent in Figures 1 
and 2 but not clearly backed by hard statistical data. 
In conclusion, we observed an anisotropic distribution of the main amino acid metabolism enzymes 
along the small intestine, with generally highest expressions (and activities) in the upper segments and 
lowest near the gross intestine. Feeding for one-month a hyperproteic diet induced little change (not 
significant) in the distribution of enzyme activities and expressions per unit of protein weight. It is 
speculated that this lack of changes may be part of a mechanism preventing amino acid wasting. 
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Table 1  Composition of control and hyperproteic diet fed to the experimental animals for the 
duration of the experiment 
 
diet composition units control diet HPD 
protein g/kg 143 286 
% of energy 20 41 
    plant-derived protein % of protein 100
 1
 35 
    gelatin % of protein 0 30 
    casein % of protein 0 35 
fibre g/kg 180 125 
carbohydrates g/kg 480 334 
% of energy 67 47 
lipid g/kg 40 38 
% of energy 13 12 
water g/kg 95 123 
mineral and vitamin mix g/kg 47 33 
total metabolizable energy (calculated) 
))from nutrients) 
kJ/g 11.9 11.7 
total energy (bomb calorimeter) kJ/g 16.5 17.6 
 
1
 Essential amino acids (lysine and methionine) were added to supplement the this protein source 
(natural cereal protein content and gluten concentrate)(manufacturer’s specifications). 
Dietary protein was measured by its N content (Kjeldahl), and total energy was either calculated from 
the composition of metabolizable nutrients in the diet (Atwater factors), or measured as crude energy 
with a bomb calorimeter. Water was estimated by differential weighing after 24 h at 105ºC. Fibre was 
estimated with a neutral detergent method. Control diet was used without changes, and the data 
correspond to the manufacturer’s specifications (except for total energy and water estimations). 
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Table 2   Primers used for the analysis of gene expression 
 
enzyme gene 5'➔3' 3'➔5' bp 
alanine transaminase 1 Gpt GTATTCCACGCAGCAGGAG CACATAGCCACCACGAAACC 85 
alanine transaminase 2 Gpt2 CATTCCCTCGGATTCTCATC GCCTTCTCGCTGTCCAAA 146 
AMP deaminase Ampd2 CGGCTTCTCTCACAAGGTG CGGATGTCGTTACCCTCAG 78 
carbamoyl-P synthetase 1 Cps1 ACCCATCATCCCCTCTGACT ACACGCCACCTCTCCAGTAG 118 
carbamoyl-P synthetase 2 Cad AGTTGGAGGAGGAGGCTGAG ATTGATGGACAGGTGCTGGT 90 
ornithine transcarbamylase Otc CTTGGGCGTGAATGAAAGTC ATTGGGATGGTTGCTTCCT 126 
arginino-succinate synthetase Ass1 CAAAGATGGCACTACCCACA GTTCTCCACGATGTCAATGC 100 
arginino-succinate lyase Asl CCGACCTTGCCTACTACCTG GAGAGCCACCCCTTTCATCT 104 
arginase 1 Arg1 GCAGAGACCCAGAAGAATGG GTGAGCATCCACCCAAATG 126 
arginase 2 Arg2 GCAGCCTCTTTCCTTTCTCA CCACATCTCGTAAGCCAATG 122 
glutamine synthetase Glul AACCCTCACGCCAGCATA CTGCGATGTTTTCCTCTCG 148 
glutaminase Gls CCGAAGGTTTGCTCTGTCA AGGGCTGTTCTGGAGTCGTA 63 
N-acetyl glutamate synthetase Nags GCAGCCCACCAAAATCAT CAGGTTCACATTGCTCAGGA 82 
endothelial nitric oxide synthetase Nos3 CAAGTCCTCACCGCCTTTT GACATCACCGCAGACAAACA 138 
neural nitric oxide synthetase Nos1 CCTGAGAACGGGGAGAAAT GCTGTTGAATCGGACCTTGT 99 
   housekeeping gene Rplp0 GAGCCAGCGAAGCCACACT GATCAGCCCGAAGGAGAAGG 62 
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Table 3   Body weight, food intake and diet composition for male rats subjected to 30 days of a 
hyperproteic diet. 
 
parameter units control diet HPD P 
rat final weight g 389±9 371±14 NS 
intestine weight g 6.24±0.07 5.24±0.23 0.0021 
intestine protein g/kg 17.4±0.45 17.8±0.68 NS 
energy intake  kJ/day 272±19 263±23 NS 
amino-N intake mgN/day 514±18 1019±65 0.0008 
% of energy 20.0 40.6 - 
 
The values are the mean ± sem of 6 rats for each group; food consumption was measured in 2 cages 
per group and are the composite mean of 15 different measurement days.  
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Legends to Figures 
Figure 1 Amino acid metabolism enzyme gene expression in the small intestine of male rats 
fed control or hyperproteic diet for 30 days 
The values correspond to the mean ± sem of 6 different animals per group. White = control diet; gray 
= HPD; I, II and III are the three intestine segments (I was closer to the stomach). Statistical 
comparison between groups (2-way ANOVA): the P values for diet and site (i.e. intestine fraction) are 
presented in each graph. All expressions are related to tissue protein (gP or g of protein). 
Figure 2 Amino acid enzyme activities in the small intestine of male rats fed control or 
hyperproteic diet for 30 days 
The values correspond to the mean ± sem of 6 different animals per group. dashed = control diet; 
black = HPD; I, II and III are the three intestine segments (I was closer to the stomach). Statistical 
comparison between groups (2-way ANOVA): the P values for diet and site (i.e. intestine fraction) are 
presented in each graph. All activities are related to tissue protein (gP or g of protein). 
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Abstract 
Objective. To determine whether doubling diet 
protein content induced significant changes in 
amino acid metabolism of lean and obese rats. 
Design. Adult male rats (fourteen weeks old) 
of the Zucker strain (lean and obese) were fed 
either a standard (control diet), or a high-
protein diet (HPD) for 30 days. Then they were 
killed and the liver and small intestine were 
used for the measurement of enzyme 
activities. The whole carcass was used to 
measure protein and lipid, and thus calculate 
their balances. Plasma was used for 
metabolite quantification, including individual 
amino acids. 
Results. 
Rats fed a high-protein diet ingested less 
energy than lean animals; both in those fed 
standard or high-protein diet. Obese rats 
showed a higher lipid, and unchanged protein 
balances that were not affected by diet. 
Obesity altered more markedly plasma amino 
acids than diet. Glucose and lipid-related 
metabolites were increased in obese animals. 
However, the increased levels of plasma urea 
showed different patterns for lean and obese 
animals, since the latter did not reflect higher 
levels with a high-protein diet. The lower 
ornithine transcarbamylase activity in high-
protein diet-fed hints at this change being 
critical for the differences in urea production. 
Conclusion. 
The administration of a moderate high-protein 
diet alters amino acid metabolism, increasing, 
selectively, the levels of a number of them; 
however, the effects of obesity were more 
marked, also affecting lipid metabolism, and 
especially the lipid balance. Nevertheless, the 
most significant change induced by a high-
protein diet on the obese was the decrease in 
urea synthesis, largely attributable to a 
decrease of ornithine transcarbamylase 
activity.   
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Introduction 
There is a growing disenchantment 
with the effectiveness of most hypocaloric 
diets in the treatment of obesity,
1
 This includes
their usage alone or combined with drugs and 
exercise. Ketogenic, dissociate, and high-
protein diets have been also widely used (not 
always tested, however) with limited success, 
if any.
2,3,4
 High-protein diets, are currently
used by sportsmen and body builders, in the 
assumption that excess dietary protein 
increases body muscle mass and helps 
eliminate fat tissue.
5
 Most of the subjects
consuming these diets also limit the intake of 
lipid and carbohydrate; and often combine this 
dietary manipulation with strenuous exercise 
training and the consumption of anabolic 
hormones and dietary supplements.
6 
The
problem is, however, that our knowledge of 
body amino acid metabolism, and the fate of 
dietary amino acids, and even which are their 
pathways, has been severely neglected in the 
last decades.
7
 High-protein diets have been
used for the treatment of obesity without 
actually knowing how the dietary modification 
may alter the body energy homeostasis,  and, 
especially, ignoring the elaborated 
mechanisms that prevent the loss of 
"precious" 2-amino N, especially that of 
essential amino acids.
8
 This well-known
evolutionary trend helps maintain alive, the 
most disfavoured half of the World’s 
population, but we do not know yet (in their full 
extent) the mechanisms and regulative paths 
that determine this fundamental biological 
trait.
9
The results obtained so far using high-
protein diets for obesity are a widely 
discordant mixed bag, since there is no 
uniform pattern of results obtained from 
different experimental designs, and more often 
than not the effects observed fall well within 
the wide range of variation of "normal" diets.
10
In many experiments done on rodents, the 
additional dietary N load often consists of 
purified, high quality protein. This fact makes 
even more complicated the evaluation of the 
results, since they combine the alteration of 
the proportion of N in the diet with the often 
higher (and unnatural) essential amino acid 
availability; in addition, this practice modifies 
the energy density and the proportions of other  
nutrients provoking havoc in the regulation of 
energy partition and disposal.
11,12
 The case of
cafeteria diets is paradigmatic: they are 
hyperlipidic,
13
 but their protein content is
usually in the higher range of normalcy.
14
Notwithstanding, urea production, i.e. amino 
acid oxidation, decreases, and the altered 
balance is not compensated by a parallel body 
protein accrual.
15
Obesity affects the management of 
dietary nitrogen in different ways depending 
on the origin of the obesity. Hyperphagia-
induced models, such as that induced by 
the palatability of the cafeteria diet 
components, often result in the 
development of amino nitrogen sparing 
mechanisms, such as decreased urea cycle 
enzyme activities,
16
 that may conduce to
higher carcass retention of N
17 
and
increased amino acid availability.
18,19 
On the
other hand, the genetically obese Zucker 
fa/fa rats do not show this altered urea 
production/nitrogen excretion despite being 
also obese.
20 
This situation coexists with
increased protein accrual, in part related to 
extreme fat storage.
21
The effects of
cafeteria diet-induced hyperphagia on 
genetically obese rat result in additive effects 
with respect to N management, since the 
amino acid sparing effect of the excess energy 
available, counteracts, in some way, the 
nitrogen-wasting effect associated to genetic 
obesity energy handling.
22
 Most studies on
nitrogen retention and efficiency of deposition 
have been focussed on the effects of diet 
protein on growth, energy balances or the fight 
against malnutrition.
23
The relative scarcity of some 
individual (essential) amino acids in the diet 
is partly counteracted by an increase in their 
intestinal absorption 
24
and tissue
reutilization, with decreased oxidation and 
urea excretion rates. 
25
When protein constitutes a large proportion of 
the diet energy, especially under condition so 
limited energy availability, as in starvation or 
dieting,
 26 
much of this dietary proteins 
necessarily used for energy, which results in 
negative N balance,
27 
lowered protein
synthesis and very often net loss of body 
protein
28
.The dietary excess of amino nitrogen
when their energy substrate availability is 
limited requires the oxidation of part of the s e 
amino acids far energy. We assume that 
doubling the diet amino acid content will affect 
the amino acid metabolism in the whole 
animal, affecting especially the liver, but we 
also expect that these effects will induce 
different effects in genetically obese animals 
since their more efficient energy metabolism 
will be severely stretched.  
Materials and Methods 
Ethics statement 
All animal handling procedures and 
the experimental setup were carried out in 
accordance with the animal handling 
guidelines established by the corresponding 
Catalan, Spanish and European, Authorities. 
The Committee on Animal Experimentation of 
the University of Barcelona authorized the 
specific procedures used in this study. 
Diet 
Common rat chow pellets (C) (Teklad 
global 14% protein rodent maintenance diet, 
Harlan Laboratories, Madison, WI USA) was 
used after weaning and for the duration of the 
experiment in control animals, and up to 14 
weeks in animals later receiving a hyperproteic 
diet (HPD). The HPD was prepared by 
crushing to a coarse powder the common rat 
chow described above. To produce about 1 kg 
of HPD pellets, a mixture 87 g of powdered 
alimentation-grade pure gelatin, 100 g of 
purified powdered casein, 702 g of crushed 
standard chow, and 9.5 g of sunflower oil were 
suspended in 725 mL of water, and stirred, 
forming a paste which was thoroughly mixed 
and then extruded through cut-off syringes to 
form pellets; they were dried in an oven at 
45ºC for 24 h. 
The final composition of the pellets, 
compared with control chow is shown in Table 
1. The consistency of the dried HPD pellets
was comparable to that of the standard one. 
Their analysed composition was as expected 
with respect to N content (about twice that of 
control pellets). In addition, the calculated 
energy content estimated from its composition) 
and the measured crude energy (using and 
adiabatic bomb calorimeter, IKA C7000; IKA, 
Staufen, Germany) per g were the same 
(Table 1). The main difference between control 
and HPD were a lower carbohydrate versus 
protein ratio and a relative decrease in mineral 
and specific micronutrient content in the HPD. 
Animals 
Fourteen-week-old male Zucker lean 
and obese rats (Harlan Laboratories Models, 
Sant Feliu de Codines, Spain) were used. 
After 30 d of acclimation using the standard 
diet, half of the rats (N=6 for each group, 
randomly selected) were shifted to the HPD for 
30 days, while the controls continued under 
the standard chow. All animals were kept in 2-
rat solid-bottom cages (with wood shards as 
bedding material, changed every 2 days) in a 
controlled environment: free access to diet and 
water, lights on from 08:00 to 20:00, humidity 
60-70 %, temperature 20.5-21.5ºC. 
Food intake (in fact consumption per 
cage) was measured daily, as well as the 
weights of the animals. On day 30, the rats 
were killed by exsanguination under isoflurane 
anaesthesia, using a dried-heparinized 
syringe. Blood was maintained in an ice bath 
until centrifugation to obtain plasma.  
Additional groups of six lean and 
obese control diet-fed animals (30 days 
acclimation only), were used to obtain the 
basal values of protein and lipid content in 
order to calculate the nutrient balances. 
Dissection and sampling 
The small intestine of the rats was 
dissected immediately after death. The organs 
were blotted, cleaned of mesentery and fat 
cordons. The intestine contents were carefully 
extruded out with a wide glass rod, and then 
internally washed with a gentle stream of ice-
cold KCl (9 g/L). The excess water was 
extruded and the intestine blotted and 
weighed. Samples of the tissues were frozen 
in liquid nitrogen, crushed to a fine powder, 
and distributed in several containers, before 
storage at -80ºC until processed. 
Metabolite analysis 
Urine and plasma parameters were 
measured using commercial kits (BioSystems, 
Barcelona, Spain): urea (#11537), glucose 
(#11504), total cholesterol (#11505) and 
triacylglycerols (#11528). Plasma samples 
were deproteinized with acetone 
29
, and the 
supernatants were used for amino acid 
analysis as previously described.
30
Measurement of enzyme activities 
Frozen tissue samples were 
homogenized using a tissue disruptor (IKA-
T10 basic Ultra-Turrax, IKA, Stauffen 
Germany) in 10 volumes of chilled Krebs-
Ringer bicarbonate solution, pH 7.8 containing 
5 mM dithiothreitol, 5 g/L bovine serum 
albumin, 10 g/L dextran, º10g/L Triton X-100 , 
and 1 mM EDTA (all from Sigma-Aldrich, St 
Louis MO USA). Incubations were carried out 
at 37ºC using freshly homogenized 
homogenates.  
Adenylate deaminase (AMD) 
(EC3.4.5.6) was estimated using  a previously 
described method,
31
 based essentially on
incubation of the crude homogenate with AMP, 
stopping the reaction from 0 up to 16 minutes 
(3-4 time-points) with cold trichloroacetic acid, 
and then measuring the ammonia produced 
with the Berthelot reaction. Initial (V0) activities 
were determined from the course of the 
reaction at different times. V0 was assumed to 
correspond to Vmax under the conditions of 
analysis. Activity was expressed as nkat/g of 
protein. 
Ornithine carbamoyl-transferase 
(OTC) (EC 2.1.3.3) was measured using the 
incubation conditions described previously, 
32
 
in a setting of multiple measurements along 
time as described above for other enzymes. 
The homogenization medium was a pH 7.4 
HEPES75 mM buffer, containing 1 mM 
dithiothreitol, 50 mM KCl and 10 g/L defatted 
bovine serum albumin (Sigma-Aldrich). The 
method was based on the incorporation of 
carbamoyl-P to 
14
C-ornithine to yield 
14
C-
citrulline. The amino acids were separated 
through thin-layer chromatography (Silicagel 
sheets SIL G25 Macherey-Nagel, Düren, 
Germany), identified, cut and counted. After 
correction for blanks and specific activity of 
labelled amino acids, production of citrulline 
was estimated. 
Arginase (ARG) (EC 3.5.3.1) activity was 
measured through the estimation of the urea 
produced by the activity of the enzyme on 
arginine in the presence of Mn
2+
 ions. Aliquots
of 20 mL of homogenates were mixed with 5 
mL of MnCl2 in water; final concentration 10 
mM. The tubes were heated for 5 min at 55ºC 
to activate arginase.
33
 The reaction began with
the addition of 75 mL of arginine (Sigma); final 
concentration 78 mM. Incubations were 
carried out for 0, 8 and 16 min at 37°C. The 
reaction was stopped by the addition of 35 mL 
160 g/L perchloric acid. The tubes were 
centrifuged 15 min in the cold at 8000 x g. 
Urea was measured as described above. 
Glutamine synthetase (GST) (EC 
6.3.1.2)activity was estimated using a method 
we had used previously, 
34
 based on the 
reaction of glutamine and hydroxylamine in the 
presence of ADP, Mn
2+
 and arsenate to yield
4-glutamyl-hydroxamate. The addition of 
Fe(NO3)3 in trichloroacetic acid results in the 
development of colour, read at 500 nm using a 
plate reader. 
Protein content in each of the 
homogenates used for enzyme analysis was 
estimated with a colorimetric method.
35
Analytical procedures 
Diet components and animal’s total 
homogenates were used for nitrogen, lipid an 
energy analysis. Nitrogen content was 
measured with a semi-automatic Kjeldah 
lprocedure using a ProNitro S system (JP 
Selecta, Abrera, Spain), whereas lipid content 
was measured with a classical 
trichloromethane : methanol extraction 
method. 
36
Total energy content was 
determined using a calorimetric pump as 
described above. 
Statistical comparisons Groupswere 
compared with two-way ANOVA analyses and 
the Bonferroni post-hoc test using the Prism 5 
(GraphPad Software, San Diego CA USA) 
graphics/ statistics package.  
Results 
Figure 1 shows the weights of the rats 
during the experiment.  Obese rats weighed 
more than the other groups, but the increase 
was smaller in the rats fed the HPD compared 
with its controls. Energy and lipid content were 
higher in obese animals, but their protein 
content was lower than that of controls. No 
differences were observed between controls 
and HPD groups. 
The animals fed with HPD ingested a 
significantly lower amount of energy than 
controls (Figure2), in spite that obese rats 
ingested more energy than the lean ones. 
There were no differences in protein balance. 
Since obese animals showed an increased 
lipid balance, their cost of accrual was 
significantly lower than that of controls.  
Figure 3 shows that glucose, 
cholesterol and triacylglycerol values of obese 
animals were significantly higher than the 
corresponding values for lean rats. However, 
urea concentrations did not follow this pattern, 
although the levels of lean HPD group were 
markedly higher than those of controls.  
Table 1 depicts the plasma individual 
amino acid levels. Obesity caused increases in 
Arg, Thr, Ser, Asn, Asp, Gly, Met and Lys, in 
contrast with decreased values for Ala, Val 
and Ile. The effect of HP diet resulted in 
increased levels of Ser, Gly, Orn, Val, Leu, Ile, 
Cys and Lys with decreases in Thr, Tyr and 
His values. 
Figure 4 shows the changes observed 
in liver enzyme activities with the diets tested. 
Obesity increased the activities of glutamine 
synthetase, ornithine transcarbamylase and 
arginase, with no significant changes in AMP-
deaminase activity. Diet caused a decrease in 
GST activity. The activity of OTC was clearly 
decreased in obese HPD group. 
Figure 5 shows the activities of 
enzymes in intestine that indicate points out a 
clear increase caused by obesity except in 
AMD. However, the activity of this enzyme, 
decreased under the effect of the HPD diet. 
Discussion 
As expected, obese rats showed a 
higher rate of increase in body weight than 
their lean counterparts, both when fed 
standard or high-protein diet, in agreement 
with previous results. 
37
 Consequently, the 
total energy (and lipid) content of the obese 
animals we also higher than in the lean; and, 
as a consequence, the accrual cost was lower 
in obese animals, independently of diet. The 
described decrease in energy intake caused 
by high-protein diets in rats
38
was also
observed in the obese. These data suggest 
that the mechanisms inducing satiation are not 
limited by obesity. Obviously, the increased 
lipid balance is a direct consequence of the 
higher energy intake and lower accretion rate 
of the obese. The maintained protein balance 
in adult obese animals is in agreement with 
the data obtained in young Zucker rats. 
39
The fact that HPD did not induce 
patent changes in essential metabolic 
parameters such as glucose, cholesterol and 
triacylglycerols, in contrast with the marked 
increases caused by obesity, coincides with 
the pattern observed in younger animals. 
37
However, in this case, the absence of an 
increase in urea levels did not match with the 
usual pattern. .The maintenance of normal 
urea levels in the obese fed HPD hints to a 
differential regulation of amino acid 
metabolism in the liver, resulting in changes in 
the regulation of the urea cycle activity. 
The effects on liver amino acid 
metabolism depend on the maintenance of 
equilibrium in the amino acid flux from 
intestine and the systemic circulation. From 
the plasma amino acid levels, we can assume 
that obesity affects more deeply the amino 
acid profile than HPD did. The ornithine levels 
were higher in HPD-fed animals, whereas 
arginine and citrulline maintained levels similar 
to those of controls. Thus, the arterial supply 
to the liver did not limit the supply of 
precursors to sustain the urea cycle. Other 
potential ureogenic amino acids, such as 
glycine, were increased levels in HPD-treated 
animals. Furthermore, increased activity of the 
amino acid transport systems has been 
described in the liver of obese animals, 
37
that
bring us to conclude that liver, under a HPD 
maintains an unaltered substrate amino acid 
supply. 
Since HPD necessarily induce a 
higher portal vein flow of absorbed 2-amino 
nitrogen from the diet towards liver, 
40
 and 
considering that in obese rats there is a lower 
fractional extraction of ammonia by the liver, 
41
we can assume that the ability of liver to 
dispose of N for urea synthesis should be 
affected, because the portal flow represents 
almost 2/3rds of the blood supply to the liver.
42
On the other hand, the maintenance of 
ornithine transcarbamilase and arginase 
activities in small intestine may help guarantee 
a sustained supply to the liver, via portal vein, 
of ornithine, citrulline and arginine. This is in 
agreement with the well-known fact that liver 
overall metabolic status plays a critical role in 
the control of ureagenesis.  
Obese rats fed HPD showed a marked 
decrease in the ornithine transcarbamilase 
activity, a fact which may affect the normal 
function of the urea cycle, despite 
transcarbamylase being considered to be the 
main point of control of the urea cycle .
43
Since the protein balance in HPD-fed 
obese rats remained unaltered in comparison 
with controls, the animals can maintain their 
lean mass, assumedly maintaining the same 
protein synthesis rates. The maintenance, in 
the obese, of activities as in HPD fed rat liver 
should be interpreted as a proof that amino 
acid catabolism was not increased in spite of 
the higher supply of dietary amino acids. The 
logical consequence to this apparent 
conundrum lies on the fate of the excess 
amino-N that simply disappears. As of today, 
this question remains unanswered although 
the possible alternative pathways for amino N 
to form nitrogen gas should be taken in 
consideration.
44
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Table 1 Composition of control and hyperproteic diet fed to the experimental animals for the 
duration of the experiment 
diet composition units control diet HPD 
protein g/kg 143 286 
% of energy 20 41 
    plant-derived protein % of protein 100
 1
35 
gelatine % of protein 0 30 
    casein % of protein 0 35 
fibre g/kg 180 125 
metabolizable carbohydrates g/kg 480 334 
% of energy 67 47 
lipid g/kg 40 38 
% of energy 13 12 
water g/kg 95 123 
mineral and vitamin mix g/kg 47 33 
total metabolizable energy (calculated) 
))from nutrients)
kJ/g 11.9 11.7 
total energy (bomb calorimeter) kJ/g 16.5 17.6 
1
 Essential amino acids (Lys and Met) were added to supplement the protein source (natural cereal 
protein content and gluten concentrate according to the manufacturer’s specifications). 
Dietary protein was measured by its N content (Kjeldahl), and total energy was either calculated from 
the composition of metabolizable nutrients in the diet (Atwater factors), or measured as crude energy 
with a bomb calorimeter. Water was estimated by differential weighing after 24 h at 105ºC. Fibre was 
estimated with a neutral detergent method. Control diet was used without changes, and the data 
correspond to the manufacturer’s specifications (except for totalenergy and water estimations). 
LEGENDS TO FIGURES 1 
Figure 1. Weight, weight increase and protein, lipid and energy content of animals fed standard or 
high-protein diet. White columns represents animals fed with standard diet, and brown columns 
represent animals fed high-protein diet. Statistical comparisons: Two-way ANOVA: O (Obesity), 
D(Diet). O and D = P<0.05. Post-hoc Bonferroni test: * = P<0.05. 
Figure 2. Energy intake, accrual cost and lipid and protein balances of animals fed standard or high-
protein diet. White columns represents animals fed with standard diet, and brown columns represent 
animals fed high-protein diet. Statistical comparisons: Two-way ANOVA: O (Obesity), D(Diet). O and 
D = P<0.05. Post-hoc Bonferroni test: * = P<0.05. 
Figure 3. Plasma glucose, cholesterol, triacylglycerols and urea of animals fed standard or high-
protein diet. White columns represents animals fed with standard diet, and brown columns represent 
animals fed high-protein diet. Statistical comparisons: Two-way ANOVA: O (Obesity), D(Diet). O and 
D = P<0.05. Post-hoc Bonferroni test: * = P<0.05. 
Figure 4. Activities of AMD, OTC, ARG and GST in liver of of animals fed standard or high-protein 
diet. White columns represents animals fed with standard diet, and brown columns represent animals 
fed high-protein diet. Statistical comparisons: Two-way ANOVA: O (Obesity), D(Diet). O and D = 
P<0.05. Post-hoc Bonferroni test: * = P<0.05. 
Figure 5. Activities of AMD, OTC, ARG and GST in small intestine of animals fed standard or high-
protein diet. White columns represents animals fed with standard diet, and brown columns represent 
animals fed high-protein diet. Statistical comparisons: Two-way ANOVA: O (Obesity), D(Diet). O and 
D = P<0.05. Post-hoc Bonferroni test: * = P<0.05. 
Table 2. Plasma amino acid levels of animals fed standard or high-protein diet. 
Statistical differences: two-way ANOVA: O (obesity) and D (diet). Bonferroni post-hoc test: * P<0.05 
vs. Control. NS: not significant 
Amino acid Control Lean 
µM 
HPD Lean 
µM 
Control 
ObeseµM 
HPD Obese 
µM 
ANOVA 
Arginine 101 ± 13 137 ± 19 62.0 ± 9.25 12.3 ± 5.85 * Obesity P<0.0001 
Taurine 177 ± 2.1 121 ± 5.50 152 ± 13.0 193 ± 17.0 NS 
Threonine 247 ± 7.84 235 ± 9.28 237 ± 17.0 194 ± 12.1 * Diet p=0.030 
Obesity p=0.042 
Serine 231 ± 6.54 285 ± 12.1 * 179 ± 14.1 198 ± 18.3 Diet p= 0.0171 
Obesity P<0.0001 
Aspartate 26.2 ± 4.87 19.0 ± 1.47 34.4 ± 3.71 31.2 ± 3.77 Obesity P=0.0079 
Asparagine 29.0 ± 1.53 28.2 ± 1.22 20.0 ± 1.44 20.9 ± 1.88 Obesity P<0.0001 
Glu+Gln 282 ± 28.0 285 ± 32.9 369 ± 22.8 275 ± 21.7 NS 
Proline 66.1 ± 4.80 92.1 ± 7.11 77.6 ± 6.44 62.4 ± 10.2 NS 
Glycine 210 ± 16.8 415 ± 16.1 * 84.2 ± 6.85 176 ± 20.7 * Obesity and Diet 
p>0.0001 
Alanine 335 ± 9.95 339 ± 10.8 492 ± 31.0 487 ± 47.3 Obesity p>0.0001 
Citrulline 37.1 ± 4.19 37.2 ± 1.93 48.2 ± 4.08 37.1 ± 3.61 NS 
Ornithine 231 ± 17.8 354 ± 37.9 * 183 ± 34.0 354 ± 37.5 * Diet p=0.0004 
Arginine 105 ± 13.7 152 ± 14.1 * 61.1 ± 9.26 42.6 ± 18.4 Obesity p>0.0001 
Valine 133 ± 5.43 179 ± 9.90 167 ± 15.2 266 ±19.9 * Diet p>0.0001 
Obesity p=0.0004 
Isoleucine 58.0 ± 4.44 69.2 ± 3.72 78.4 ± 6.86 105 ± 5.27 * Diet P=0.0011 
Obesity P>0.0001 
Leucine 160 ± 5.42 169 ± 8.79 157 ± 11.8 217 ± 14.0 * Diet p=0.0049 
Cysteine 30.4 ± 3.41 30.9 ± 4.60 4.69 ± 0.50 47.8 ± 6.62 * Diet p=0.0002 
Methionine 75.1 ± 2.27 64.0 ± 3.45 55.5 ± 5.60 47.6 ± 6.62 Obesity p=0.0018 
Tyrosine 166 ± 5.81 136 ± 9.50 181 ± 22.1 144 ± 15.7 Diet p=0.0293 
Phenylalanine 69.1 ± 0.92 71.1 ± 3.46 82.4 ± 5.28 73.2 ± 2.54 Obesity 0.0380 
Lysine 583 ± 22.9 656 ± 35.5 472 ± 33.9 547 ± 27.7 Diet P=0.0277 
Obesity p=0.0019 
Histidine 84.1 ± 2.95 75.1 ± 3.22 98.5 ± 6.90 79.2 ± 7.05 * Diet p=0.0154 
Tryptophan 22.4 ± 1.17 52.6 ± 8.03 * 37.5 ± 7.03 34.2 ± 8.51 NS 
Total AA 3358 ± 80.3 3744 ± 126 3280 ± 212 3615 ± 225 Diet 0.0049 
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Effect of an obesogenic diet on N metabolism in liver and blood flow 
in Wistar rats 
As expected, one month of CAFD caused overfeeding of adult rats resulted in higher body 
weight, increasing visceral adipose tissue, muscle and liver weight in when compared to controls. A 
lower urea excretion, largely due to lower enzyme activities in liver, was observed besides the 
identical (or higher protein) intake of CAFD-fed rats and their controls. These results are in 
agreement with previous studies that showed not only a higher body weight but also increased 
energy expenditure
241
 and protein accrual
242
. In fact, it was assumed that high-energy diets, coupled 
with normal or high protein intake, interferes with 2-amino N elimination in mammals, and are 
related to an imbalance in N excretion, through pathways are which are still unknown.  
Amino-N retention is a primeval drive that prevents or limits its wasting even under condition of 
dietary excess of protein. Thus, in presence of high load of nutrients, lipids are preferred over 
glucose by muscle and peripheral tissues because of insulin resistance; furthermore the high 
presence of glucose too hinders amino acid oxidation. As a consequence, the production of 
ammonia from 2-amino-N decreased. This is confirmed by the high levels of glutamine in plasma of 
CAFD-fed rats suggesting its decreased splanchnic utilisation to provide ammonium for the 
synthesis of carbamoyl-P, as well as the high levels of ornithine in CAFD-fed rats confirms a 
diminished production of carbamoyl-P. Instead, the unchanged levels of citrulline and aspartate in 
CAFD versus control rats seem to indicate that there is a key regulatory point either at synthesis or 
breakup of argininosuccinate for the overall nitrogen disposal that justifies the lower urea 
production. The control of urea cycle may be recognized in ASS, as the rate limiting step but also in 
ARG as final factor in the release of urea and as main site for arginine break up.  
The lower production of urea in CAFD occurred in spite of high circulating levels of 
ammoniagenic amino acids (threonine, serine, glycine, and glutamine) which should trigger the 
production of ammonium, its transport as glutamine, its release again, and the formation of 
carbamoyl-P, powering the urea cycle. Thus, high levels of the most common ammonia-generating 
amino acids can be explained because the urea cycle is blocked and unable to absorb the N load, not 
responding to the stimulus of excess substrate. This is in agreement with a possible blockage in the 
control of the synthesis of arginine which is also essential for the operation of the NO· shunt. Since 
both plasma and urinary NOx levels did not change significantly, a possible explanation to this 
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situation may lie on the lower activity of arginase to prevent an excessive production of NO· during 
CAFD.  
The effects of CAFD as well as the amino acid metabolism in liver were strongly influenced by 
sex. In general, females were more resistant to the development of MS
131,132
 mainly because of the 
protective effects of estrogen
243
 which prevents the obesogenic effects of inflammation and insulin 
resistance, limiting the full development of obesity. In fact, estrogens tend to counteract the increase 
in fat stores elicited by glucorticoids
244
. In males, the progressive decrease of androgens with 
advancing age is blended with an increase of glucocorticoids that run parallel to the development of 
MS. Furthermore, N sparing is managed in a different way according to sex. In males, the main 
trend is the accumulation of body protein, an effect facilitated by insulin
245
, GH and androgens, and 
hampered by glucocorticoids
85
. In females, the N-sparing seems to be more related to save energy 
(and N) in preparation for pregnancy. Both in males and in females the urea cycle was down-
regulated, but, apparently, the control points were not the same: ASS, ASL and ARG were halved in 
CAFD-fed male rats while in females only ASL follows this tendency. The low and unchanged 
expression of eNOS in both sexes suggests a relatively low activity, compared with arginase in their 
competence for arginine. The lack of changes in the expression of eNOS seems to disconnect this 
enzyme from the main degradative pathway represented by the urea cycle. 
The liver is a formidable barrier that prevents ammonium from entering the systemic circulation 
and thus damaging the nervous system
189
, and is also the main site for amino acids partition and N 
disposal. The liver counts not only with the urea cycle to incorporate ammonium into urea but also 
with other powerful ammonium-handling systems influenced by sex and diet as well. Glutamine 
synthetase represents the last line of defence to avoid the release of ammonium into systemic 
circulation; this enzyme did not change with diet but showed a marked sex-related difference; 
furthermore, NADP
+
-glutamate dehydrogenase (cytoplasmic) was affected by both sex and diet; in 
particular it is down regulated by CAFD and shows increased values in females backing up the 
hypothesis of their focus on amino-N sparing. 
The main liver ammonium producing mechanisms are purine nucleotide cycle, i.e. AMP 
deaminase
139
, glutaminase
191–193
, serine/threonine dehydratase and the glycine-cleavage system. 
Other sources, such as amine-oxidases and amino acid oxidases, may contribute in a limited manner 
to the liver ammonium pool. AMP deaminase participates in the purine nucleotide cycle which is 
also part of purine catabolism and the purine salvage pathway. Furthermore, AMPD is responsible 
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to breakup of the AMP generated by adenylate kinase under conditions of scarcity of ATP or 
nutients
202
 as a way to control glycolysis, often together with ammonium production
246
. The 
breakup of AMP to IMP obviously modifies the substrate for AMP-kinase, consequently 
modulating the glycolytic pathway and overall energy partition
247
. The several functions of AMP-
deaminase in liver, do not seem to include a significant role in the in situ production of 
ammonium
205
, contrary to what happens in muscle where the purine nucleotide cycle is a main 
mechanism for mineralization of amino-N. 
Serine dehydratase was also affected by sex and diet; favouring, in both cases the preservation of 
N. The expression/activity of this enzyme is substrate-controlled; we observed these correlations, as 
expected
200
. The protein H of glycine-cleavage system-expression was, again, influenced by sex: 
females showed higher expression values, suggesting a higher activity of the complex. However 
that might not represent only an increased amino-N disposal but, more probably, a key source of 1C 
fragments for synthesis
248
, of purines and other critical building blocks. 
CAFD also affects the blood flow distribution. In particular in CAFD-fed male rats, BAT shows 
a four-fold higher absolute blood flow than that of the control group. BAT is involved in 
thermogenesis and this higher blood flow towards BAT agrees with an increased heat dissipation of 
excess energy as heat. 
In CAFD-fed rats, the heart showed a higher absolute blood flow than controls, despite heart 
output was not influenced by diet. This suggests that sufficient oxygen was available to maintain the 
activity of the heart of CAFD-fed rats despite showing similar pumping capacity than that of control 
rats.  
Skin is the only organ that shows a decreased absolute blood flow in CAFD rats. It is known 
that in rats most of the excess heat is eliminated by evaporation throughout the respiratory tract, 
rather than from the skin surface, and that CAFD increase the body energy expenditure and heat 
output
241
. The lower absolute blood flow to the skin and the higher blood flow to the lungs suggest 
that lung evaporation was enhanced with this diet, becoming the main heat-loss mechanism (at the 
expense of increased water loss).  
The lack of differences elicited by diet on liver blood flow suggests an already well-kept and 
adjusted balance of portal and arterial blood flows that cover sufficiently the different load of 
substrates and intestinal products to the liver, in a way that no changes are needed to adapt the 
blood supply to the widely different metabolic situation. 
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The trend to increase the blood flow in parallel in all sub-location of WAT of CAFD-fed rats 
compared to controls suggest their belonging to a single dispense organ
50
 and support their uniform 
metabolic response to excess energy. The higher blood flow to striated muscle in CAFD-fed rats 
suggests a steadier or increased supply of substrates to sustain muscle growth and maintenance. 
Effect of high protein ingestion on N metabolism in obese and lean 
male Zucker rats 
At the end of the dietary treatment, the HPD groups increased their weight less than their 
controls. As expected, obese rats ingested more energy than the lean ones, showed a higher rate of 
increase in body weight than their lean counterparts and consequently their total energy and lipid 
content was higher than in the lean. Obviously, the obese showed a marked increase in metabolic 
parameters such as glucose, cholesterol and triacylglycerols in contrast with the lack of changes 
induced by HPD. Urea increased significantly in lean HPD-fed rats while in the obese urea levels 
were maintained, suggesting a differential regulation of amino acid metabolism in liver, resulting in 
changes in the regulation of the urea cycle activity. The effects on liver amino acid metabolism 
depend on the maintenance of equilibrium in the amino acid flux from intestine and the systemic 
circulation. Observing plasma amino acid concentrations we can postulate that obesity affected 
amino acid concentrations more intensely than exposure to a HPD did. In short: circulating glycine 
and ornithine increased in HPD-fed rats whereas arginine and citrulline maintained similar levels; 
and there was a higher amino acid transport systems activity in the liver of obese animals
174
; we can 
assume that, during HPD, liver maintained an unaltered substrate amino acid supply. 
Since liver overall metabolic status plays a critical role in the control of ureagenesis, the 
unaltered activity of ornithine transcarbamylase and arginase activities in small intestine may help 
to guarantee a sustained supply to the liver, via portal vein, of ornithine, citrulline and arginine. The 
significant decrease in OTC activity observed in liver of HPD-fed obese rats may affect the normal 
function of urea cycle; the lack of changes in the liver enzyme activity of HPD-fed rats suggests 
that amino acids catabolism was not increased in spite of the higher supply of dietary amino acids. 
Furthermore, it has been recently found that amino-N disposal depends essentially on amino acids 
availability
249
, in fact HPD rats excreted higher amounts of amino-N in the urine than controls, but 
the quantitative importance of the alternative (unknown) pathway of N disposal has not yet 
evaluated in this model.  
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One month of HPD was used as well to study the effects of a dietary protein load on the activity 
of amino acid metabolism enzymes along the small intestine of male lean Zucker rats. The 
treatment did not result in significant changes of activity and expression of the enzymes involved in 
N metabolism in the small intestine. This was an unexpected result, since the intestine is known to 
adapt its metabolism to the composition of the diet, especially when there are amino acids in excess 
for disposal
250
. An excess of protein intake favours the utilization of intestinal amino acids for the 
synthesis of urea cycle intermediates
251
, carried to the liver by the portal vein, where the urea cycle 
is completed
252
. 
Another unexpected finding was the limited changes observed in glutamine metabolism 
enzymes, although glutamine is a pivotal amino acid for nitrogen homeostasis and intestinal energy 
supply
252
. In addition, we found a clear polarization of the activities of the enzymes analysed, with 
high activity in the proximal intestine (duodenum and jejunum segments) than in the distal, ileum, 
part. In fact, protein digestion is a slow process that foresees sequential actions of different 
proteases and peptidases that seem to logically point to the distal part of the small intestine as the 
place where more free amino acids could be found, absorbed and eventually metabolised. Higher 
presence of amino acid metabolism enzymes in the proximal segment can be tentatively explained 
as a way to prevent the massive oxidation of dietary amino acids in the distal part of intestine. The 
paradoxical longitudinal distribution of amino acid catabolism enzymes along the small intestine 
perhaps, in addition to be a mechanism to limit amino acids oxidation, leaves most of the control of 
digestion to the automatic release of peptidases and amino acid or peptide transport
253
. 
Curiously OTC did not follow this pattern suggesting that this enzyme works along the whole 
length of small intestine with a peak of activity in the central segment following a need for its 
activity unrelated to the direct events of digestion occurring along the gut. 
Another finding of this study is the marked differences in activity and expression of AMP 
deaminase, an enzyme that produces ammonium for local use by carbamoyl-P or exportation to the 
liver. Activity and expression show the same trend: in control rats, the enzyme decrease its 
activity/expression along the length of the small intestine, while in HPD-fed rats the fall can be 
observed only in distal segment. AMP deaminase controls AMP levels
142
 and thus AMP-kinase
254
, 
which regulates glycolysis
255
, and it is inhibited by metformin, the first-line medication for 
hyperglycaemia. The presence of AMP deaminase mainly in the duodenum, where free glucose is 
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absorbed suggests that its main role may lie on the control glucose uptake/metabolism through 
AMP-kinase rather than (or in addition to) its role in the purine nucleotide cycle. 
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One month of CAFD overfeeding increased body and liver weight, largely because of increased 
WAT and muscle mass compared to controls. The excess substrate and energy ingested increased 
thermogenesis and promoted protein and fat accrual. The excess energy was largely lost as heat, 
with a significant deviation in the overall blood flow, favouring heat dissipation by lung (evapo-
transpiration) rather than through the skin (conduction-radiation). 
 
CAFD induced a marked decrease in urea synthesis in comparison with controls and despite 
higher protein intake. In CAFD, the operation of urea cycle was decreased. This effect was 
extended to the main liver enzymes providing ammonia as substrate for the urea cycle, which were 
down-regulated. Both urea cycle and these other enzymes were not only influenced by diet but also 
by sex. In fact females and males implemented different strategies to prevent amino-N wasting 
under excess of energy. By the way, the elimination of amino-N is mandatory but it was not 
performed by already discovered pathways. 
 
One month of HPD decreased the energy ingested both in lean and obese male Zucker rats, 
suggesting that obesity didn't interfere with mechanisms responsible of inducing satiation, didn't 
alter amino acids metabolism and didn't increased some plasmatic amino acids. However, deeper 
changes were caused by obesity that affected also lipid balance and lipid metabolism. A significant 
change was observed in OTC activity that decreased significantly in the liver of HPD-fed obese 
rats, thus decreasing the ability to synthesize urea. The lack of changes in enzyme activity in the 
liver of HPD-fed rats suggests that amino acid catabolism was not increased in spite of the higher 
supply of dietary amino acids. 
 
Along the small intestine of lean male Zucker rats, a not polarized distribution of the main amino 
N handling enzymes was observed, with highest activity and expression in the proximal segments. 
However, exposure for one month to HPD did not induce significant changes in this pattern, which 
recesses the probable availability of free amino acids liberated by digestion. It is postulated that this 
enzyme distribution helps protect the integrity of amino acids for eventual distribution, and to 
prevent amino-N wasting. 
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Both CAFD and HPD-fed rats showed nitrogen balances incomplete, with a large portion (higher 
than that of controls) of N ingested but not accrued, excreted in the urine or stool. The lower the 
urea excretion, the higher the size of this fraction which catabolic pathway is so far unknown, but 
which importance seems magnified in the case of HPD, coexisting with a normal synthesis and 
excretion of urea. 
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In the CAFD-fed rats, operation of urea cycle was decreased. This effect was extended to the main 
liver enzymes that provide ammonia as substrate for the urea cycle. 
The changes in urea cycle and other related enzymes were influenced not only by diet but also by 
sex. 
The excess energy ingested during a CAFD was largely lost as heat, with a significant deviation in 
the overall blood flow, favouring heat dissipation by lung (evapo-transpiration) rather than through 
the skin (conduction-radiation). 
In HPD-fed rats, genetic obesity didn't interfere with mechanisms responsible of inducing satiation. 
The low OTC activity justified the decreased ability to synthesize urea in high protein diet-fed 
obese rats. 
A not polarized distribution of the main amino-N handling enzymes was observed in the small 
intestine of rats. Exposure for one month to high protein diet did not provoke marked changes in 
male Zucker rats. 
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